












Submitted in partial fulfillment of the 
Requirements for the degree of 
Doctor of Philosophy 
under the Executive Committee 

































The role of CtIP in lymphocyte development and lymphomagenesis 
Xiaobin Wang 
Chromosomal translocation is a characteristic feature of human lymphoid malignancies and a 
driver of the initiation and progression of the disease. They arise from the mis-repair of 
physiological DNA double-strand breaks (DSBs) generated during the assembly and 
subsequent modifications of the antigen receptor gene loci, namely V(D)J recombination and 
class switch recombination (CSR). Mammalian cells have three DSB repair pathways –classical 
non-homologous end-joining (cNHEJ), alternative end-joining (A-EJ), and homologous 
recombination. DNA end-resection that generates a single-strand 3’ overhang is a critical 
regulator for the repair pathway choice. Specifically, localized end-resection prevents cNHEJ 
and exposes flanking microhomology (MH) to promote error-prone A-EJ. In addition to DNA 
repair, DNA end-resection generates extended single-strand DNA, which activates the ATR-
mediated cell cycle checkpoint and indirectly contributes to genomic integrity. The central goal 
of my thesis research is to investigate the physiological role of DNA end-resection initiation in 
lymphocyte development and lymphomagenesis.  
DNA end-resection in mammalian cells is mostly initiated by the endonuclease activity of 
MRE11-RAD50-NBS1 (MRN) complex aided by CtIP. In addition, MRN protein also recruits 
EXO1 and DNA2 nucleases in combination with Top3 helicase complex for more extensive 
resection. The CtIP protein is essential for the endonuclease activity of the MRN complex that 
initiates DNA end-resection. CtIP is essential for embryonic development. Here I utilized B cell-
specific conditional deletion models and loss-of-function mutations to investigate the role and 




The level and extent of CtIP-mediated resection are tightly regulated. For the first aim, we 
applied the ATAC-Seq and EndSeq methods to test whether chromatin accessibility determines 
the level of DNA end-resection. Specially, we found that chromatin-bound DNA damage 
response factors – H2AX and 53BP1- reduced the accessibility of the DNA around the DSBs 
and antagonized end-resection. Our data also suggest that during DNA damage response, the 
nucleosome-free or accessible regions are more prone to secondary DNA breakages. 
Mechanistically, the preferential vulnerability is correlated with the availability of chromatin-
bound DNA damage response factor 53BP1, which protects the nucleosome covered region at 
the price of the nucleosome-free regions. The work provides one explanation for tissue and cell 
type-specific translocations in transcriptionally active regions and super-enhancers.  
For the second and third aims, I investigated the role of CtIP and CtIP-mediated end-resection 
in lymphocyte development and lymphomagenesis in vivo using the conditional deletional CtIP 
allele and a phosphorylation-deficient CtIP-T855A mutant. T855 phosphorylation promotes end-
resection but is not essential for cellular viability. I identified a sequence-context-dependent role 
of CtIP and end-resection in A-EJ mediated repair. We found that the reduced level of end-
resection did not alter the frequency of the A-EJ mediated joining during B cell CSR, nor the 
levels of micro-homology at the junction, a defining feature of A-EJ mediated repair. These 
findings, for the first time, showed that DNA end-resection is not essential for A-EJ-mediated 
chromosomal DSBs repair nor for the generation of MH at the junction in vivo. This unexpected 
observation also highlights a tissue- and cell type-specific regulation of A-EJ and the importance 
of sequence context for A-EJ. Moreover, we found that ATM kinase suppresses A-EJ mediated 
translocation and reported the very first cell cycle-dependent analyses of CSR junctions.  
In cNHEJ-deficient B cells (e.g., Xrcc4- or DNA-PKcs- deficient), the A-EJ pathway is 
responsible for both the residual CSR events and the generation of the oncogenic IgH-Myc 
chromosomal translocations. In the last chapter, I determined how CtIP contributes to 
 
 
oncogenesis using the CtIP-T855A phospho-deficient mouse model. The result showed that 
CtIP T855 phosphorylation is critical for the neonatal development of Xrcc4-/-p53-/- mice and IgH-
Myc translocation driven lymphomagenesis in DNA-PKcs-/-Tp53-/- mice. Mechanistically, 
phospho-deficient CtIP compromises the extent of end-resection without affecting the initiation. 
Reduced end-resection in CtIP-T855A mice and cells attenuated G2/M checkpoints and 
reduced the tolerance to the oncogene-induced replication stress, thereby limit 
lymphomagenesis.  
Collectively, our data provided the first in vivo characterization for the role of CtIP and its related 
end-resection pathway in lymphocyte development and lymphomagenesis. The results highlight 
the importance of end-resection for checkpoint maintenance (§ 4) and the context-dependent 
regulation of A-EJ and DNA repair pathway choice in vivo (§ 3), explaining why A-EJ is more 
robust at the repetitive switch regions. Finally, the application of HTGTS, EndSeq, and ATAC-
Seq technologies in lymphocyte-specific gene rearrangements markedly improved the analysis 
depth and sensitivity while reducing the cost of repair-junction sequencing, allowing the 
quantitative detection of subtle changes and additional mechanistic insights. Specifically, we 
showed that end-resection could be regulated at the level of chromatin accessibility, which is 
determined by both baseline chromatin occupancy and DNA damage-induced changes (§ 2). 
These findings provide one explanation for the tissue and cell type-specificity of translocation 
targeting. These techniques can be used to analyze the impact of other DNA repair factors 
during lymphocyte development and lymphomagenesis and in translocation in general.   
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Chapter 1: Introduction 
Overview 
The DNA of eukaryotic cells experiences various types of damages. One of the most 
toxic types of DNA damage is the double-strand break (DSB). Besides exogenous sources 
(e.g., radiation, genotoxic chemicals), DSBs can occur during a series of regular cellular events, 
such as DNA replication and programmed gene rearrangements in developing lymphocytes and 
germ cells. Specifically, developing lymphocytes experience two programmed gene 
rearrangement events: V(D)J recombination (§1-3.1) that assembles the functional antigen 
receptor genes in B and T cells, and class switch recombination (CSR) (§1-3.2) that modifies 
antibody isotypes in mature B cells. While lymphocyte-specific factors initiate both 
rearrangements, the repair phase is mediated by ubiquitously expressed DNA repair proteins 
and activates the DNA damage response (DDR). Unrepaired DSBs in developing lymphocytes 
trigger lymphocyte progenitor apoptosis, development blockade, and eventually lead to 
immunodeficiency. Mis-repair of those developmental breaks can cause chromosomal 
translocations and eventually tumorigenesis.   
Mammalian cells have three known DNA DSB repair pathways: homologous 
recombination (HR), classical nonhomologous end-joining (cNHEJ), and alternative end-joining 
(A-EJ) pathway (§1-1.1 & 1.2). HR utilizes a homologous template, often sister chromatid, for 
repair and is error-free by definition. The cNHEJ pathway directly ligates two broken DNA ends 
together and can be error-prone. A-EJ is used to describe end-ligation in cells lacking core 
cNHEJ factors (e.g., KU and XRCC4) and preferentially uses microhomology (MH) at the 
junctions. V(D)J recombination exclusively utilizes the cNHEJ pathway, while CSR can be 
achieved via cNHEJ and in part through A-EJ. One main factor that determines the choice 
between cNHEJ and A-EJ is DNA end-resection (§1-1.2 & 2.2), which generates 3' single-
stranded DNA (ssDNA) overhangs through a nucleolytic process. End-resection exposes MHs 
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(MH) flanking the DSBs to facilitate A-EJ mediated repair. In eukaryotes, DNA end-resection is 
initiated by the Mre11-Rad50-Nbs1 (MRN) complex with the help of CtIP (§1-2). While both 
cNHEJ and A-EJ contribute to oncogenic translocations (Ghezraoui et al., 2014), MHs are often 
found at the junction of oncogenic chromosomal translocations in lymphoid malignancies 
(Nussenzweig & Nussenzweig, 2010). While MRN has other functions beyond end-resection, 
such as activating ATM kinase, CtIP is critical for the endonuclease activity of the MRN 
complex. My thesis research uses CtIP conditional or mutant mouse models to investigate the 
role of CtIP and its phosphorylation in the repair of programmed DSBs (§3) and their associated 
oncogenic chromosomal translocations (§4). 
1. DNA double-stranded break repair pathways in mammalian cells 
A breakage in both strands of the DNA double helix, DSB, is the most severe form of 
DNA damage and triggers the widespread DDR that halts cell cycle progression, gene 
transcription, and replication. Mammalian cells have two well-characterized DSB repair 
pathways –cNHEJ and HR. In recent years, a third pathway, A-EJ has been used to describe 
end-ligation in cells lacking core cNHEJ factors (e.g., KU, LIG4, XRCC4). A-EJ preferentially 
uses microhomology (MH) at the junctions and partially overlaps with the microhomology-
mediated end-joining (MMEJ) pathway (McVey & Lee, 2008). Like cNHEJ, A-EJ can occur 
throughout the cell cycle. This section will review the mammalian DSB repair pathways with a 
focus on the cNHEJ and A-EJ pathways directly implicated in lymphocyte-specific gene 
rearrangements. In addition to the specific repair pathways that work on the DNA, DSBs also 
activate ATM kinase and a cascade of post-translational modifications, collectively referred to as 
the DDR, which promotes precise and efficient DSB repair.  
1.1 The classical nonhomologous end-joining pathway 
The cNHEJ pathway is conserved in almost all eukaryotes. As its name implies, cNHEJ 
directly ligates two DNA ends without a requirement for homology (Lieber, 2010). Thus, cNHEJ 
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functions throughout the cell cycle and is the major repair pathway for radiation-induced DNA 
damages, and is exclusively required for lymphocyte development (§1-3). In vertebrates, the 
cNHEJ pathway entails both the evolutionarily conserved end-ligation component and the 
vertebrate-specific end-processing component. Ku70 (gene name XRCC6) and Ku80 (gene 
name XRCC5) form an obligatory heterodimer – KU, which initiates cNHEJ by encircling the 
DNA ends with high affinity. DNA-bound KU then recruits the LIG4-XRCC4-XLF complex for 
DNA end-ligation. Among them, XRCC4 is required for the protein stability of LIG4. Loss of 
either LIG4 or XRCC4 completely abrogates cNHEJ in cell lines and mouse models (Grawunder 
et al., 1997; Lieber, 2010; Schar, Herrmann, Daly, & Lindahl, 1997; Teo & Jackson, 1997; 
Wilson, Grawunder, & Lieber, 1997). XLF (gene name NHEJ1), on the other hand, is only 
required for a subset of cNHEJ in otherwise wildtype cells (Buck et al., 2006; G. Li et al., 2008). 
KU and LIG4-XRCC4-XLF together constitute the end-ligation components of cNHEJ. Mouse 
models that carry a null mutation of LIG4 or XRCC4 have elevated post-mitotic neuronal 
apoptosis (Frank et al., 2000; Gao, Sun, et al., 1998; Karanjawala et al., 2002). As such, Lig4-/- 
and Xrcc4-/- mice die at embryonic day E16.5 with p53-dependent neuronal apoptosis (Barnes, 
Stamp, Rosewell, Denzel, & Lindahl, 1998; Frank et al., 2000; Gao et al., 2000). Ku70-/- and 
Ku80-/- mice are viable but significantly smaller than their wildtype or heterozygous littermates 
(Gu, Seidl, et al., 1997; Nussenzweig et al., 1996). Consistent with the non-essential role of XLF 
in cNHEJ, Xlf-/- mice are born at the expected ratio and of normal size (G. Li et al., 2008).   
In jawed vertebrates, including humans and mice, DNA-bounded KU also recruits and 
activates the large catalytic subunit of the DNA-dependent protein kinase (DNA-PKcs, gene 
name PRDKC). Together, KU and DNA-PKcs form the DNA-PK holoenzyme, which 
phosphorylates DNA-PKcs itself and other cNHEJ factors (Davis, Chen, & Chen, 2014). 
Moreover, DNA-PK holoenzyme recruits and activates Artemis endonuclease, which modifies 
the DNA ends, including opening hairpins, during vertebrate cNHEJ (Y. Ma, Pannicke, Schwarz, 
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& Lieber, 2002; Meek, Dang, & Lees-Miller, 2008). It is estimated that Artemis-mediated end-
processing is important for the repair of ~10% of ionizing radiation (IR)-generated DSBs (Riballo 
et al., 2004). DNA-PKcs and Artemis are also required for opening the hairpin coding ends 
(CEs) during V(D)J recombination (Y. Ma et al., 2002; Moshous et al., 2001) (§1-3). Consistent 
with end-processing functions that are only required for a subset of DSBs, loss of DNA-PKcs or 
Artemis only cause moderately increased IR sensitivity, and DNA-PKcs-/- and Artemis-/- mice are 
born of normal size with isolated lymphocyte development defects (Gao, Chaudhuri, et al., 
1998; Y. Ma et al., 2004; Rooney et al., 2002; Taccioli et al., 1998) (§1-3).   
DNA-PKcs is the best-characterized substrate of DNA-PK. In contrast to the normal 
development of DNA-PKcs null mice (M. Bosma, Schuler, & Bosma, 1988; Gao, Chaudhuri, et 
al., 1998; Taccioli et al., 1998), early work from our lab showed that mice expressing solely 
kinase-dead (KD) DNA-PKcs (D3922A, DNA-PKcsKD/KD) die in utero with severe neuronal 
apoptosis, like Lig4- or Xrcc4-deficient mice (W. Jiang et al., 2015). Complete deletion of Ku70 
or Ku80 rescues the embryonic lethality of DNA-PKcsKD/KD mice (W. Jiang et al., 2015), 
indicating a kinase-activity-dependent structural role of DNA-PKcs in regulating end-ligation. In 
this context, purified DNA-PKcs blocks DNA ligation by a T4 DNA ligase in the absence of 
hydrolyzable ATP (Block et al., 2004), suggesting this block in end-ligation by DNA-PKcs is not 
limited to the cNHEJ pathway. Consistent with this notion, the recent Cryo-EM structure of 
active DNA-PK holoenzyme on DNA shows that DNA-PKcs N-terminal HEAT repeats directly 
engage the 3’-OH end of the model DNA substrate upon activation (X. Chen et al., 2020). 
Meanwhile, DNA-PKcsKD/KD cells are competent for Artemis recruitment, and Artemis mediated 
hairpin opening, suggesting DNA-PKcs protein, but not its own kinase activity is required for 
end-processing. In this context, ATM kinase inhibitor blocks hairpin opening in DNA-PKcsKD/KD 
cells, but not in DNA-PKcs+/+ cells, indicating ATM kinase activity complements DNA-PKcs' 
kinase activity for Artemis activation in vivo (W. Jiang et al., 2015; Y. Ma et al., 2002).  
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In the past few years, several new cNHEJ factors have been identified- PAXX and MRI 
(gene name CYREN) based on their interaction with KU and their essential role in cNHEJ in 
mice or cells lacking XLF (Grundy et al., 2016; G. Li et al., 2008; Roch, Abramowski, Chaumeil, 
& de Villartay, 2019). More recently, ERCC6L2 has also been identified as an essential cNHEJ 
factor in XLF-deficient cells(X. Liu et al., 2020; Olivieri et al., 2020). Paxx-/-, Mri-/-, and Ercc6L2-/- 
mice develop normally and are of normal size, but Xlf/Paxx, Xlf/Mri, Xlf/Ercc6L2-double deficient 
mice are embryonic lethal with several neuronal apoptosis and hypersensitivity to IR (Arnoult et 
al., 2017; Hung et al., 2018; Kumar, Alt, & Frock, 2016; Lescale et al., 2016; X. Liu et al., 2020; 
X. Liu, Shao, Jiang, Lee, & Zha, 2017). Unlike the evolutionarily conserved core cNHEJ factors 
(KU, XRCC4, LIG4, and XLF), the exact roles of PAXX, MRI, and recently identified ERCC6L2 
proteins in cNHEJ remain elusive. In comparison to HR, the regulation of cNHEJ has grown 
significantly even within the vertebrate domains, highlighting the expanded roles of cNHEJ as a 
rapid and straight-forward DSB repair pathway in multicellular organisms with long life 
expectance.     
1.2 The alternative end-joining pathway  
A-EJ is used to describe the significant end-joining in cells lacking essential cNHEJ 
factors (e.g., XRCC4 or KU). In particular, the residual (up to 25-50% of WT levels) CSR in 
XRCC4-deficient B cells provide a piece of strong evidence for the existence of A-EJ pathway(s) 
for chromosomal DSB repair (Yan et al., 2007a).  Although the genetic components of A-EJ are 
not fully understood (see below), A-EJ shares significant similarity with the MH-mediated end-
joining (MMEJ) first characterized on plasmid substrates (Boulton & Jackson, 1996; 
Kabotyanski, Gomelsky, Han, Stamato, & Roth, 1998; H. Wang, Perrault, Takeda, Qin, & Iliakis, 
2003). Specifically, plasmids ligations recovered from Ku-deficient cells often contain 3-18 bp 
MH (J. L. Ma, Kim, Haber, & Lee, 2003; X. Yu & Gabriel, 2003). Similarly, residual CSR 
junctions recovered from Xrcc4-/- B cells often have increased MH (Yan et al., 2007a). While the 
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length and frequency of MHs decrease in CSR junctions recovered from Lig4-/-Ku70-/- B cells 
(Boboila, Yan, et al., 2010).  
Mechanistically, A-EJ and the related MMEJ are thought to be initiated by DNA end-
resection and annealing of MHs, followed by ends modification and gap filling, and then finally 
accomplished by ligation steps. The MRN/CtIP complex and their yeast orthologs MRX/Sae2 
initiate the 5’-3' nucleolytic end-processing, which exposes the flanking  MH sequences 
(Mimitou & Symington, 2008). Mre11 attacks the 5' DNA end internally and introduces 
endonucleolytic cleavage upon activation (Cannavo & Cejka, 2014; Garcia, Phelps, Gray, & 
Neale, 2011). Extensive 5’-3' processing can be continued by exonuclease Exo1. MRN also 
promotes the recruitment of DNA2, which together with BLM helicase (and its yeast ortholog 
Sgs1) or WRN (Symington & Gautier, 2011), to serve as a parallel end-resection pathway to 
clean DNA ends. My thesis focuses on CtIP, which will be discussed in greater detail in §1-2. 
The MH length at the junctions varies among different experimental systems, depending on the 
sequence context and the nature of the missing NHEJ factor, suggesting that there might be 
more than one A-EJ (and likely MMEJ) pathway (Boboila, Yan, et al., 2010). Yeast cells tend to 
use homology sequences ≥ 6nt, with longer MHs promoting repair efficiency (Villarreal et al., 
2012). Moreover, replication protein A (RPA) can bind to ssDNA and prevent annealing 
(Symington, Rothstein, & Lisby, 2014). While Rad52 can anneal ssDNA and promote end 
joining, it is not required to antagonize RPA's inhibition role with the annealing of short MHs 
(<14 nt) (Deng, Gibb, de Almeida, Greene, & Symington, 2014; Villarreal et al., 2012). Upon 
ssDNA annealing, the gap-filling step is carried out by different DNA polymerases. Yeast cells 
mostly utilize Polδ and Polβ, while mammalian cells can also rely on Polθ (K. Lee & Lee, 2007; 
Sfeir & Symington, 2015), and insertions can be generated de novo to create compatible ends 
(Sfeir & Symington, 2015). Therefore, insertions can be found at a subset of A-EJ mediated 
repair junctions. Polθ contributes A-EJ mediated telomere maintenances, in reporter assays, 
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and chromosomal translocations (Chan, Yu, & McVey, 2010; Mateos-Gomez et al., 2015; 
Roerink, van Schendel, & Tijsterman, 2014; A. M. Yu & McVey, 2010). Biochemistry studies 
showed that Polθ homodimer can stabilize annealed ssDNA partners with just one or two 
annealed bases and greatly reduce the basic requirement of MH lengths and promote A-EJ 
(Brissett et al., 2007; Zahn, Averill, Aller, Wood, & Doublie, 2015). Next, the incompatible 
overhang is removed by the XPF-ERCC1 (Rad1-Rad10 in yeast) endonucleases on the 5' flap 
and FEN1 on the 3' flaps (Decottignies, 2007; Y. Liu et al., 2005; J. L. Ma et al., 2003). Finally, 
two single-strand DNA ligases - Lig3 and Lig1 seal the gaps (Audebert, Salles, & Calsou, 2004; 
Simsek, Brunet, et al., 2011; H. Wang et al., 2005).  In mammalian cells, the DNA single-strand 
breaks also activate poly ADP-ribose polymerase 1 (PARP1), which promotes A-EJ by 
facilitating the recruitment of single-stranded DNA ligase –LIG3-XRCC1 as well as LIG1 by 
generating poly-ADP ribose chains (Audebert, Salles, & Calsou, 2004). XRCC1 is an obligatory 
partner of nuclear LIG3 (Ellenberger & Tomkinson, 2008), but neither PARP1-null nor XRCC1-
null cells show defects in CSR or alternated MH patterns in the presence or absence of cNHEJ 
(Audebert et al., 2004; Boboila, Alt, & Schwer, 2012). While mice lacking Parp1 is healthy and 
fertile, Xrcc1 is essential for embryonic development (Tebbs et al., 1999; Z. Q. Wang et al., 
1995), suggesting additional heterogenicity within the A-EJ pathways. 
1.3 The role of DNA damage response in DNA double-stranded break repair.  
In addition to the specific DNA repair pathways mentioned above, DSBs activate the 
ATM kinase, and to a lesser extent DNA-PK, mediated signaling cascades referred to as DDR. 
Briefly, the MRN complex recruits and activates ATM kinase, which phosphorylates many 
substrates, including the histones H2AX flanking the DNA breaks at S139 to form H2AX 
(Rogakou, Pilch, Orr, Ivanova, & Bonner, 1998). MDC1 directly binds to H2AX (Lou et al., 
2006; Stewart, Wang, Bignell, Taylor, & Elledge, 2003; Stucki et al., 2005) and recruits the E3 
ubiquitin ligases RNF8 and RNF168, which further modify H2A and eventually lead to the 
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recruitment of 53BP1, RIF1, and the Shieldin complex (SHLD1, 2, 3 and REV7) (Dev et al., 
2018; Findlay et al., 2018; Ghezraoui et al., 2018; Xu et al., 2015). ATM and its chromatin 
substrate H2AX, MDC1, and 53BP1 are not required for chromosomal cNHEJ in otherwise 
wildtype cells, but in XLF-deficient cells or mice with sub-optimal cNHEJ, they become essential 
for chromosomal cNHEJ (Beck, Castaneda-Zegarra, Huse, Xing, & Oksenych, 2019; X. Liu et 
al., 2012; Oksenych et al., 2012; Zha, Guo, et al., 2011). Mechanistically, the extended DNA 
damage foci promote efficient and accurate DNA repair by modulating end-resection and repair 
pathway choices and also limits the DNA ends to a defined chromatin domain (Arnould et al., 
2021). In chapter 2, I used the ATAC-seq analyses to measure whether chromatin-bound ATM 
substrates prevent end-resection by regulating chromatin accessibility. In Chapter 4, I showed 
for the first time that ATM promotes A-EJ in addition to cNHEJ (X. S. Wang, Zhao, et al., 2020). 
In addition to its direct role in regulating the chromatin surrounding DSBs, ATM also promotes 
cell cycle arrest by phosphorylating TP53, CHK1, CHK2, and other checkpoint proteins, and 
suppresses ongoing transcription on the broken DNA (Hirao et al., 2000; Shanbhag, Rafalska-
Metcalf, Balane-Bolivar, Janicki, & Greenberg, 2010). All of these functions serve to promote 
accurate repair and limit the growth of cells carrying unrepaired breaks in order to suppress 
oncogenic translocations. 
2. DNA end-resection and the role and regulation of CtIP 
Which repair pathway is used at a specific DSB is influenced by many factors. DNA end-
resection plays a major role in the DNA repair pathway choice. The long ssDNA overhangs 
generated via end-resection are coated by RPA and then Rad51 to direct homology search 
during HR. The limited ssDNA overhang can promote A-EJ by exposing flanking MHs while 
suppressing cNHEJ by limiting KU binding, while short MHs (< 4nt) are tolerable for NHEJ 
products (Pannunzio, Watanabe, & Lieber, 2018). Thus, it is not surprising that the initiation and 
the extent of DNA end-resection are tightly regulated through the cell cycle and during DDR. In 
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mammalian cells, DNA end-resection can be initiated by the MRN complex and extensively 
processed by the EXO1 nuclease or DNA2 with Sgs1/BLM (Symington & Gautier, 2011). CtIP, 
and its yeast ortholog Sae2, is critical for the endonuclease activity of MRN (Anand, Ranjha, 
Cannavo, & Cejka, 2016; Cannavo & Cejka, 2014). This section will summarize the known 
functions and the major regulations of CtIP with an emphasis on DNA end-resection. 
2.1 The domain structure and the functions of CtIP 
CtIP protein contains several functional domains. Despite their primary sequence 
divergence, the N-terminal region of CtIP and Sae2 both mediate oligomerization necessary for 
end-resection (Andres et al., 2015; Dubin et al., 2004; H. Wang et al., 2012). CtIP (897 amino 
acids in humans) is much larger than Sae2 (345 amino acids). The middle part of CtIP contains 
several motifs unique for CtIP, including those essential for its interaction with CtBP 
transcriptional repressor (PLDLS) (Schaeper, Subramanian, Lim, Boyd, & Chinnadurai, 1998), 
BRCA1 (after CDK mediated phosphorylation at S327) (Wong et al., 1998; X. Yu, Wu, Bowcock, 
Aronheim, & Baer, 1998) and Rb (E157) (F. Liu & Lee, 2006) tumor suppressors as well as its 
proposed intrinsic nuclease activities (Makharashvili et al., 2014; H. Wang et al., 2014). The C-
terminus of CtIP shares the highest degree of homology with Sae2 (Sartori et al., 2007), 
including two conserved phosphorylation sites implicated in end-resection (see below).  
CtIP is essential for murine embryonic development (P. L. Chen et al., 2005) and the 
viability of proliferating mammalian cells (P. L. Chen et al., 2005). A conditional CtIP deletion 
allele was developed to overcome these hurdles (Bothmer et al., 2013). Conditional inactivation 
of CtIP in mammalian epithelial cells delayed the development of BRCA1-deficient and p53-
deficient breast cancer in vivo (Reczek et al., 2016). We note, given the essential role of CtIP in 
cell proliferation, complete loss of CtIP is rare in cancer. About 5% of lymphoid or myeloid tumor 
samples carry mutations or amplifications involving CtIP (Fig. 1.1A). The most prominent 
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alteration is found in pancreatic cancer cases, where CtIP is amplified in about 15% of reported 
samples (Fig. 1.1B) and is associated with a significantly lower overall survival rate (Fig. 1.1C, 
p=0.0018), suggesting CtIP overexpression might aid the tolerance to oncogenic replication 
stress.  
2.2 CtIP and MRN complex-mediated DNA end-resection   
CtIP is best known as the mammalian ortholog of yeast Sae2, which initiates DNA end-
resection together with the MRN complex (Cannavo & Cejka, 2014; Deshpande, Lee, Arora, & 
Paull, 2016; Mimitou & Symington, 2008; Sartori et al., 2007). Specifically, CtIP interacts with 
the NBS1 component of the MRN complex to promote endonuclease cleavage by the MRN 





is required to recruit Exo1 or Dna2/Sgs1 to proceed with the 5' to 3' exonucleolytic processing 
(Mimitou & Symington, 2008, 2009; Shim et al., 2010). As discussed in the previous section, the 
status of the DNA ends is accountable for repair pathway choice. The dependence on 
MRN/CtIP (MRX/Sae2) for end-resection is also influenced by the type of DNA ends and the 
flanking sequences. Resection can take place at free DNA ends generated from endonuclease 
cleavage independent from the MRN/CtIP complex. However, processing modified ends, such 
as topoisomerase-generated covalently linked DNA ends, highly depends on the MRN complex 
activity (Aparicio, Baer, Gottesman, & Gautier, 2016; Deshpande et al., 2016; Nakamura et al., 
2010; Symington & Gautier, 2011). For example, the MRX/Sae2 complex is necessary to 
resolve Spo11-bound DNA ends during meiosis in yeasts (Furuse et al., 1998; McKee & 
Kleckner, 1997; Moreau, Ferguson, & Symington, 1999). The active MRX/Sae2 can perform 
endonucleolytic cleavage away from the ends (40 bps or up to around 270 bp) (Zakharyevich et 
al., 2010), which can release covalently bound Spo11 and create nicks for other processing 
events to happen (Mimitou, Yamada, & Keeney, 2017). In addition to DNA end-resection, 
MRN/CtIP has also been implicated in nucleolytic processing of DNA hairpins (H. Chen et al., 
2015; Lengsfeld, Rattray, Bhaskara, Ghirlando, & Paull, 2007; Lobachev, Gordenin, & Resnick, 
2002; Makharashvili et al., 2014; H. Wang et al., 2014) and termination of checkpoint signaling 
(H. Chen et al., 2015; Lengsfeld et al., 2007; Makharashvili et al., 2014; H. Wang et al., 2014). 
Moreover, an intrinsic endonuclease activity of CtIP has also been proposed and implicated in 
DNA repair and replication at complex structures (Makharashvili et al., 2014; H. Wang et al., 
2014). CtIP is also shown to interact with FANCD2 and contribute to DNA inter-stranded 
1. Figure 1-1: Known alterations in cancer and post-translational modifications in CtIP.  
(A) Alteration frequency from 12845 samples from 12112 patients analyzed in 20 lymphoid 
studies and 11 myeloid studies. (B-C) Abnormalities found in 1207 samples from 10 pancreatic 
cancer studies (B), and overall survival of 465 patients (C). (D) Accumulated number of 
published studies on known modification site on CtIP protein. 
https://www.phosphosite.org/homeAction 
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crosslink repair via the Fanconi pathway (Murina et al., 2014). Taken together, the MRN/CtIP 
complex serves as one of the key aspects of the cellular activities of CtIP through participating 
in free DNA ends processing upon DNA damage. Therefore, it stands to reason that a 
comprehensive regulatory network must exist to ensure the performance of such activities.  
2.3. The regulation of CtIP protein levels and its post-translational modifications  
CtIP protein level is cell cycle-regulated with high expression in S and G2 phases and 
low in G1. The regulation is achieved through both transcriptional and post-translational 
mechanisms. CtIP mRNA is low in G1 arrested cells and increases upon release to the S phase 
(X. Yu & Baer, 2000). CtIP interacts directly with Rb at the G1/S transition to regulate its own 
and Cyclin D promoter activity (F. Liu & Lee, 2006). Recent studies also identified microRNAs 
miR-335 and miR-19 as negative regulators of CtIP expression (Huhn, Kousholt, Sorensen, & 
Sartori, 2015; Martin et al., 2013), providing a post-transcriptional means to regulate CtIP levels 
during oncogenic transformation (Srinivasan et al., 2019). The stability of CtIP protein is also 
controlled through the cell cycle via ubiquitination (Lafranchi et al., 2014; X. Yu, Fu, Lai, Baer, & 
Chen, 2006) (Fig. 1.1D). The Cullin3-KLHL15 ubiquitin ligase targets CtIP for ubiquitination and 
degradation through binding of Y842 on CtIP protein with KLHL15, independent from Y842 
phosphorylation but dependent on the aromatic ring (Ferretti et al., 2016). Additionally, the 
APC/C-Cdh1 complex targets CtIP for proteasome degradation at the end of G2 (Lafranchi et 
al., 2014).  
Moreover, the ability for CtIP to promote end-resection is also extensively regulated 
through post-translational modifications (Fig. 1.1D). Specifically, CtIP and Sae2 can be 
phosphorylated by S phase CDKs at T847 human/S267 yeast to promote MRN-mediated end-
resection, providing the mechanism for enhanced HR activity in S/G2 phase cells (Barton et al., 
2014; Huertas, Cortes-Ledesma, Sartori, Aguilera, & Jackson, 2008; Makharashvili et al., 2014). 
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Moreover, CDK phosphorylation at S327 promotes interaction with BRCA1 (Wong et al., 1998; 
X. Yu et al., 1998). However, the mouse model carrying the S327A mutation does not have 
severe end-resection defects (Polato et al., 2014). Moreover, CDK-mediated phosphorylation at 
S276 and S347 can promote CtIP binding with Nbs1 and is necessary for downstream ATM 
phosphorylation (H. Wang et al., 2013). In addition to the cell cycle phase, CtIP is also 
phosphorylated by ATM and ATR kinase upon DNA damage to promote end-resection. 
Specifically, ATM/ATR phosphorylates CtIP at T859 (T855 in mouse CtIP) within the region 
conserved between CtIP and Sae2 to promote end-resection in part by promoting the chromatin 
retention of CtIP (Peterson et al., 2012; H. Wang et al., 2013). Several other ATM-mediated 
phosphorylation sites (e.g., S231, S664, S745) were found to be essential for CtIP nuclease 
activity in vitro, while CDK-phosphorylation at T847 and ATM/ATR-phosphorylation at T859 was 
found to promote the HR activity independent of NBS1 (Makharashvili & Paull, 2015). Taken 
together, transcriptional, translational, and post-translational regulations of CtIP contribute to the 
increased end-resection in the S/G2 phase and upon DNA damage. In recent years, an 
increased effort has been put into studying the effect of modifications on CtIP protein. In chapter 
3, I will try to address the physiological impact of the T859A (mouse T855A) phospho-mutant, 
especially its novel role in cell cycle checkpoint regulation.  
3. Lymphocyte development and lymphocyte-specific gene rearrangement  
The mammalian adaptive immune system is renowned for its specificity, diversity, and 
memory. This is achieved at the DNA level through three programmed gene rearrangement 
events– V(D)J recombination, Immunoglobulin class switch recombination (CSR), and somatic 
hypermutation (SHM). Among them, V(D)J recombination assembles the functional antigen 
receptor genes and occurs in progenitor B and T cells in the bone marrow and thymus, 
respectively, while CSR and SHM occur in the germinal centers of naïve and mature B cells. 
SHM introduces mutations in the variable regions of Immunoglobulin (Ig) genes without 
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generating DNA DSBs (Methot & Di Noia, 2017). In contrast, lymphocyte-specific genes initiate 
V(D)J recombination and CSR by introducing DSBs. Those DSB intermediates activate the ATM 
kinase-mediated DDR and use the ubiquitously expressed cNHEJ pathway, and, in the case of 
CSR, also the A-EJ pathway for completion (Alt, Zhang, Meng, Guo, & Schwer, 2013). Both 
V(D)J recombination and CSR are initiated in the G1 phase of the cell cycle. V(D)J 
recombination is completed within the G1 phase of the cell cycle and involves hairpin end 
intermediates(Schatz & Swanson, 2011). In contrast, CSR occurs in proliferating cells and 
involves DSBs at highly repetitive and GC-rich switch regions (K. Yu & Lieber, 2019). Mis-repair 
of programmed DSBs generated during V(D)J recombination or CSR leads to the underlying 
oncogenic chromosomal translocations in human lymphoid malignancies. Here I will discuss the 
mechanisms of V(D)J recombination and CSR, and the role of CtIP in both normal lymphocyte 
development and lymphomagenesis. 
3.1. V(D)J recombination 
V(D)J recombination occurs in progenitor B and T lymphocytes, where the variable 
region exons are assembled from individual Variable (V), Diversity (D), and Joining (J) gene 
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segments through a cut and paste mechanism (Fig. 1.2). V(D)J recombination occurs in all T 
 
2. Figure 1-2: The overview of V(D)J recombination and CSR. 
The Immunoglobulin (Ig) gene product, an antibody, is shown at the top. An antibody is formed 
by a pair of Ig Heavy chain gene products (IgH, in orange and green) and a pair of Ig light chain 
(IgL, in white and blue). The V(D)J recombination (on the lower left) assembles the variable 
gene exon that encodes the antigen-specific portion of the antibody (orange) from individual V, 
D or J gene segments in a two-step process, D to J first, then V to DJ. The reaction is initiated 
by RAG endonucleases, which introduces DNA double-strand breaks. An insert above shows 
the pair of RAG cleavage products at Dh and Jh with the hairpin coding ends and blunt signal 
ends adjacent to RSSs (triangles). Upon ligation by the cNHEJ pathway, the intermediate 
sequence is removed and the participating V, D, and J segments are fused to form the variable 
region exon that is spliced with downstream constant region exons (on the right) to form the IgH. 
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4 T cell receptor (TCRσ/δ, TCRγ, TCRβ) gene loci. In naïve B cells, the IgH undergoes two 
additional modifications initiated by activating induced deaminase (AID). Somatic hypermutation 
(SHM) introduces point mutations in the variable region exon without creating DNA double-
strand breaks. Class switch recombination (CSR) occurs in the constant region (on the right) 
and joins DNA double-strand breaks from two different switch (S) regions and effectively 
replaces the initially expressed IgM constant region (Cµ) with a downstream constant region, 
such as the Cγ1 for IgG1 depicted in the illustration. The constant region exons dictate the 
effector function of the antibody. CSR only occurs in the IgH locus of B cells, not in IgL or TCR 
loci. In contrast to RAG, which directly introduces DNA breaks, AID introduces U:G mismatches, 
which are processed by the base excision repair and mismatch repair pathways to generate 
mutations for somatic hypermutation (SHM) and DNA double-strand breaks for CSR.  
cell receptor (TCR, α/δ, β, γ) and Ig (h, , λ) gene loci (Jung, Giallourakis, Mostoslavsky, & Alt, 
2006), including the Ig Heavy Chain (IgH). Recombination activating gene (RAG) - RAG1 and 
RAG2 - initiates V(D)J recombination in progenitor lymphocytes by recognizing a pair of 
compatible recombination signal sequences (RSSs, one with 12bp and one with 23bp spacer) 
and introducing a DSB between the RSSs and the participating V, D, or J gene segments (Teng 
& Schatz, 2015) (Fig. 1.2). RAG cleavage generates a pair of covalently sealed hairpin coding 
ends (CEs) and a pair of blunt and 5' phosphorylated signal ends (SEs). RAG mRNA 
expression and protein stability are restricted to G1-arrested progenitor lymphocytes (H. Jiang 
et al., 2005), which contributes to the exclusive dependence of V(D)J recombination on cNHEJ. 
RAG cleavage only occurs in transcriptionally active and epigenetically poised V, D, and J gene 
segments (Jung et al., 2006; Y. Liu, Zhang, & Desiderio, 2009), leading to the cell type (B vs. T) 
and developmental stage (pro- vs. pre-) specificity of V(D)J recombination. RAG also dictates 
the orientation-specific repair outcome of V(D)J recombination.  
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3.1.1. V(D)J recombination requires cNHEJ exclusively. 
The cNHEJ pathway is exclusively required for V(D)J recombination (Deriano et al., 
2011). During V(D)J recombination, KU heterodimer binds to both the hairpin CEs and blunt 
SEs. The blunt SEs can be directly ligated via LIG4-XRCC4-XLF precisely to form a signal join 
(SJ) (Ahnesorg, Smith, & Jackson, 2006; Buck et al., 2006; Lieber, 2010). The CEs hairpin, 
however, has to be opened by Artemis endonuclease with the help of DNA-PKcs (Y. Ma et al., 
2002; Moshous et al., 2001) before they can be ligated to form a coding join (CJ). Hairpin 
opening outside the apex introduces palindromic insertions (P elements) (Lieber et al., 1988; Y. 
Ma et al., 2002; Moshous et al., 2001; Tonegawa, 1983; Wood & Tonegawa, 1983). Terminal 
deoxynucleotidyl transferase (TDT) adds non-templated insertions (N nucleotides) (Gilfillan, 
Dierich, Lemeur, Benoist, & Mathis, 1993; Komori, Okada, Stewart, & Alt, 1993) to further 
increase the diversity of the variable region exons. Correspondingly, mouse models deficient in 
end-ligation (e.g., loss of Ku70, Ku80, Lig4, or Xrcc4) accumulate both CEs and SEs (Frank et 
al., 2000; Gao et al., 2000; Gu, Jin, Gao, Weaver, & Alt, 1997; Nussenzweig et al., 1996; Zhu, 
Bogue, Lim, Hasty, & Roth, 1996).  Mice deficient for either DNA-PKcs or Artemis have isolated 
immunodeficiency due to CE hairpin opening defects but form SJs efficiently (Gao, Chaudhuri, 
et al., 1998; Rooney et al., 2002; Taccioli et al., 1998). Moreover, RAG heterodimer is 
suggested to antagonize A-EJ during V(D)J via its interaction with DNA (Corneo et al., 2007). 
3.1.2. The impact of DNA damage response on V(D)J recombination 
DSBs generated during V(D)J recombination activate the DDR. Briefly, the MRN 
complex recruits and activates ATM kinase, which phosphorylates many substrates, including 
the histones H2AX flanking the DNA break at S139 to form H2AX (Rogakou et al., 1998). 
MDC1 directly binds to  H2AX (Lou et al., 2006; Stewart et al., 2003; Stucki et al., 2005) and 
recruits the E3 ubiquitin ligases RNF8 and RNF168, which further modify H2A and eventually 
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leads to the recruitment of 53BP1 (Ciccia & Elledge, 2010).  ATM and the downstream factors 
H2AX and 53BP1 are not required for lymphocyte development, but in mouse models, their 
absence causes a mild reduction in surface TCRβ/CD3ε levels in CD4+CD8+ double-positive T 
cells (Borghesani et al., 2000; Difilippantonio et al., 2008; Zha et al., 2010) and the 
accumulation of unrepaired RAG-dependent DSBs in ~4% of Atm-deficient B cells(Callen et al., 
2007). The need for sequential V(D)J recombination at the TCRα/δ (Carico & Krangel, 2015) 
likely contributes to its hypersensitivity to DNA repair defects. Correspondingly, loss of ATM, 
H2AX, or 53BP1 causes a measurable development blockade associated with V(D)J 
recombination in the Ig and TCR loci. Using an inversional chromosomal V(D)J recombination 
substrate, Sleckman and colleagues showed that MRN and ATM prevent hybrid joins – the 
aberrant ligation of a CE with a SE during inversional V(D)J recombination (Bredemeyer et al., 
2006; Helmink et al., 2009) - providing a mechanism for the mild lymphocyte development 
defects associated with ATM-deficiency(Callen et al., 2007). Interestingly, ATM and ATM kinase 
activities are required for SJ formation in DNA-PKcs null cells (Gapud et al., 2011; Zha, Jiang, et 
al., 2011), supporting the possibility of overlapping roles between ATM and DNA-PKcs kinase 
activity. Moreover, in cells and mice lacking XLF, a non-essential cNHEJ factor, ATM kinase 
activity, and its substrates H2AX and 53BP1 are required for SJ formation and end-ligation (X. 
Liu et al., 2012; Oksenych et al., 2012; Zha, Guo, et al., 2011), providing genetic evidence for 
an important role of the DDR in V(D)J recombination. In this context, whether DDR factors have 
an additional role in V(D)J recombination beyond ligation, such as end-protection, remains to be 
tested. A major focus of chapter 2 is using the ATAC-Seq technique to measure the role of 
53BP1 in chromosomal accessibility regulation during V(D)J recombination.  
3.2. Class switch recombination    
CSR occurs in naïve B cells in the spleen and lymph nodes secondary lymphoid organs. 
Upon antigen exposure and T cell contact, naïve B cells replace the initially expressed IgM 
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constant region (C) with another constant region (e.g., C1 for IgG1) to generate an antibody 
with a different isotype, thus conferring a different effector function (Fig. 1.2). B cell-specific 
activation-induced cytidine deaminase (AID) initiates CSR by converting cytosine to uracil in the 
transcribed S regions preceding each set of constant region coding exons (Franco, Alt, & Manis, 
2006). These mismatches are processed by both base excision repair and mismatch repair 
machinery and are eventually converted to DSBs in proliferating B cells. In the second phase, 
DSBs in the upstream IgM switch region (S) are joined with DSBs in the downstream switch 
region (e.g., S1 for IgG1) to complete IgH isotype switching and generate antibodies with 
different isotypes. The DSB repair that completes CSR is mediated by the cNHEJ and the A-EJ 
pathways with the help of ATM kinase and its chromatin substrates H2AX, 53BP1, etc.  
3.2.1. The function of cNHEJ during CSR 
Different from V(D)J recombination, CSR is not completed in G1 phase-arrested cells, 
and therefore can access the end-resection mechanism in the S phase. Correspondingly, B 
cells lacking core cNHEJ factors, such as Xrcc4 or Lig4, can undergo CSR at 25-50% of the WT 
levels (Boboila, Jankovic, et al., 2010; Yan et al., 2007a), leading to the discovery of the robust 
chromosomal A-EJ mechanism. The loss of the newly discovered cNHEJ factor PAXX does not 
affect CSR efficiency (X. Liu et al., 2017). The recently developed high throughput genome-wide 
translocation sequencing (HTGTS) (Hu et al., 2016) can isolate thousands of CSR junctions. 
This assay uses a linear-amplification-based method to isolate junctions involving one or a 
cluster of DSBs. In the case of CSR, the assay has been used to measure joins involving the 5' 
end of the S region. The process isolates both internal deletions within S and IgH isotype 
switching junctions between S and a DSB in the downstream switch regions (e.g., S1). The 
detailed procedure and primer sequences can be found in the method section of chapter 6. 
Using this technology, we and others showed that CSR junctions recovered from Xrcc4-/- and 
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DNA-PKcsKD/KD B cells are enriched for MHs, with nearly 50% of junctions containing 2-3 nt 
MHs, in contrast to 20-25% in WT cells (Crowe et al., 2018a). Perhaps most surprising is that 
the CSR junctions from DNA-PKcs-/- B cells with nearly 90% of WT levels of CSR are also 
equally enriched for MHs (Crowe et al., 2018a), suggesting MHs facilitate CSR. But whether this 
MH-mediated CSR in DNA-PKcs-/- B cells depends on Alt-EJ or LIG4-mediated cNHEJ remains 
to be determined. Two features of CSR might contribute to the robust residual CSR in cNHEJ 
deficient cells that prefer the MH-mediated end-joining – the highly repetitive and GC rich switch 
region that is ideal for MH-mediated repair (Dunnick, Hertz, Scappino, & Gritzmacher, 1993) 
and the S/G2 phase of the cell cycle that allows resection and promotes end-annealing.  
3.2.2. The contribution of A-EJ to CSR 
The robustness of Alt-EJ mediated CSR provides a unique tool to study the Alt-EJ 
pathway. In contrast to cNHEJ that ligates both strands of the DNA double helix simultaneously, 
the Alt-EJ pathway uses MH-mediated annealing to convert one DSB into two single-strand 
nicks. The conversion of a DSB to two single-strand nicks bypasses the requirement for LIG4 
and allows the single-strand DNA ligases - LIG3 in complex with XRCC1 or LIG1 with PCNA – 
to complete the A-EJ mediated CSR (Boboila, Oksenych, et al., 2012). End-resection, which is 
required for MH-mediated repair to expose flanking MHs, is also evident in Xrcc4-/-, DNA-PKcs-/- 
and DNA-PKcsKD/KD B cells (Crowe et al., 2018a). However, it remains unknown whether end-
resection is required for A-EJ mediated CSR in the highly repetitive switch region, a question 
that we will address in chapter 4. Moreover, the deletion of Ku70 in Lig4-/- B cells reduces the 
bias toward MHs (Boboila, Jankovic, et al., 2010; Boboila, Yan, et al., 2010), suggesting there 
might be more than one A-EJ pathway – one that requires long MHs and the that does not. 
Also, pol θ expression increases in activating B cells (Kawamura et al., 2004) and might 
contributes to A-EJ through templated nucleotide insertions. Although Polq-/- B cells have 
normal CSR efficiency (Y. Li, Gao, & Wang, 2011), the percentage of recovered junctions with 
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insertions is significantly lowered (X. Zhang et al., 2019). Interestingly, Polq-/- B cells also show 
increased IgH-Myc chromosomal translocations (X. Zhang et al., 2019), suggesting a role of pol 
θ in suppressing MH-mediated translocations. The genetic requirement for A-EJ mediated CSR 
is still being investigated. Loss of A-EJ factors, including XRCC1, an obligatory partner of Lig3 in 
the nucleus (Simsek, Furda, et al., 2011), PARP1, or POLQ, all did not compromise CSR 
efficiency alone (Boboila, Oksenych, et al., 2012; Ghosh, Roy, Kamyab, Danzter, & Franco, 
2016; Y. Li et al., 2011; Rybanska et al., 2013).  Loss of DNA-PKcs (Bjorkman et al., 2015; G. 
C. Bosma et al., 2002; Franco et al., 2008; Kiefer et al., 2007; Manis, Dudley, Kaylor, & Alt, 
2002) or DNA-PKcs phosphorylation at the T2609 cluster (Crowe et al., 2020) has a mild effect 
on IgG1 CSR efficiency in vitro. But the CSR junctions recovered from the DNA-PKcs-/- or DNA-
PKcs5A/5A mice are highly enriched for MHs (Crowe et al., 2018a; Crowe et al., 2020). The 
results suggest that MH-mediated end-joining could be quite robust during CSR. Given the 
much more severe CSR defects in Lig4-/- B cells, the end-ligation that generates these small 
MHs likely includes contributions from both the cNHEJ pathway and the A-EJ pathway. The 
exact contribution of A-EJ to physiological CSR in cNHEJ-proficient cells also remains to be 
determined.  
3.2.3. The role of DNA damage response in CSR 
In contrast to V(D)J recombination that is only mildly affected by DDR-deficiency or in sensitized 
backgrounds, CSR highly depends on the DDR. CSR is significantly (>50%) impaired in cells 
lacking ATM (Lumsden et al., 2004; Pan-Hammarstrom et al., 2006; Reina-San-Martin, Chen, 
Nussenzweig, & Nussenzweig, 2004) or its downstream targets H2AX (Franco, Gostissa, et al., 
2006; Reina-San-Martin et al., 2003), MDC1 (Lou et al., 2006; Manis et al., 2004), RNF8, 
RNF168, or 53BP175, or even PTIP (Daniel et al., 2010; Starnes et al., 2016), REV7 (gene 
name MD2L2) (Ghezraoui et al., 2018; Xu et al., 2015), the SHIELDIN complex (Dev et al., 
2018; Findlay et al., 2018; Ghezraoui et al., 2018), or RIF1 (Chapman et al., 2013; Di Virgilio et 
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al., 2013). ATM kinase inhibitors or expression of kinase-dead ATM have similar impacts on 
CSR as Atm loss(Yamamoto et al., 2012), suggesting that ATM contributes to CSR mainly 
through its kinase activity. Notably, although 53BP1 has a similar, if not a weaker, role in 
general DSB repair and irradiation resistance than ATM or H2AX, loss of 53BP1 leads to a 95% 
reduction of CSR that is much more prominent than all other repair factors (Bothmer et al., 
2010; Franco, Gostissa, et al., 2006; Manis et al., 2004). More recently, it has also been 
proposed that 53BP1 ensures that the orientation of CSR junctions favors productive CSR 
beyond end-ligation (Daniel et al., 2010). Taken together, the dynamic process of CSR provides 
us a unique system to study the interplay between DDR factors and repair machinery during the 
lymphocyte maturation process. 
4. The role of CtIP in lymphocyte development 
CtIP is essential for embryonic development. Several attempts have been made to 
address the function of CtIP in B cells, especially during CSR. Knockdown of CtIP using shRNA 
in purified splenic B cells compromises CSR, which has been attributed to its direct contribution 
to Alt-EJ, or its indirect effects on CDK2 activation or cell viability (Buis, Stoneham, Spehalski, & 
Ferguson, 2012; Lee-Theilen, Matthews, Kelly, Zheng, & Chaudhuri, 2010; Polato et al., 2014).  
Knockin mouse models expressing S327A CtIP that cannot interact with BRCA1 can support 
both embryonic development (Reczek, Szabolcs, Stark, Ludwig, & Baer, 2013) and B cell CSR 
(Polato et al., 2014).  In transgenic mouse models that express exogenous human CtIP 
proteins, embryogenesis and CSR can be rescued by expression of the phospho-mimetic CtIP-
T847E mutant, but not the phospho-deficient CtIP-T847A mutant (Polato et al., 2014). In 
proliferating human cells, CtIP phosphorylation at T847 was proposed as a prerequisite for 
ATR/ATM-mediated hyper-phosphorylation of CtIP upon DNA damage (H. Wang et al., 2013). 
Yet, in G1 arrested murine B cells, CtIP can still resect unrepaired DSBs in an ATM-dependent 
manner, but only in the absence of H2AX or 53BP1 (Helmink et al., 2011; X. Liu et al., 2012; 
23 
Oksenych et al., 2012; Zha, Guo, et al., 2011), suggesting that CtIP can function outside S/G2 
when CDK activity is minimal. However, it is unclear which CtIP residues – T859 (Peterson et 
al., 2012; H. Wang et al., 2013) or other potential ATM sites (Makharashvili et al., 2014) are 
relevant in G1. 
Using developmental stage-specific Cre-recombinase and a conditional CtIP allele 
(Bothmer et al., 2012), I collaborated with Dr. Xiangyu Liu in the lab and inactivated CtIP in 
either pre-B cells via Mb1Cre (Hobeika et al., 2006) or the naïve B cell-specific CD21Cre (Kraus 
et al., 2001). We found that CtIP is essential for early B cell development, independent of V(D)J 
recombination, in part due to its ability to support continued proliferation at the G2/M transition. 
A genetic complementation screen reveals that the interaction of CtIP with CtBP, RB, and 
BRCA1 and its own nuclease activity is dispensable for B cell proliferation. Instead, the T847, 
but not the T859 phosphorylation of CtIP, is essential for B cell development and switch 
recombination. In pre-B cell lines, CtIP deletion causes G2/M arrest, hyperactivation of ATM 
signaling, and increased mitotic defects, suggesting a critical role of CtIP in resolving replication 
intermediates (X. Liu et al., 2019). In contrast, somatic deletion of CtIP in naïve B cells via the 
CD21Cre is very well tolerated, suggesting CtIP is NOT absolutely essential for cellular viability, 
but rather selectively required during replication/proliferation (X. Liu et al., 2019). 
Correspondingly, CtIP depletion significantly reduces CSR in B cells (X. Liu et al., 2019). Using 
HTGTS, we compared the CSR and internal deletion junctions involving 5' S breaks in CtIP+/+ 
and CtIP-/- B cells and found that CtIP-deficiency does not measurably affect the MH usage and 
end-resection in the residual junctions (Figs. 1.3A&B). Likewise, the T855A phosphorylation site 
mutation, which impairs ATR/ATM-dependent induction of CtIP-mediated resection, did not 
affect CSR efficiency or MH usage (Figs. 1.3C). These findings suggest that CtIP, and CtIP-
mediated end-resection per se, may play a limited role in CSR, at least when measured within 
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cNHEJ-proficient cells. In chapter 4, I deleted or mutated CtIP in cNHEJ-deficient cells to 
determine the impact of CtIP mediated resection on A-EJ mediated CSR.  
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5. Chromosomal translocations during lymphoid malignancy 
Mis-repair of the programmed DSBs generated during lymphocyte development can 
participate in oncogenic chromosomal translocations. Indeed, human lymphoid malignancies 
are often characterized by recurrent chromosomal translocations involving Ig and TCR loci, 
such as IgH-CyclinD1 translocation in Mantle cell lymphomas, IgH-BCL2 translocation in 
Follicular Lymphomas, and the IgH-Myc fusion protein found in Burkitt's lymphoma (Gelmann, 
Psallidopoulos, Papas, & Dalla-Favera, 1983; Groffen, Hermans, Grosveld, & Heisterkamp, 
1989; Kuppers & Dalla-Favera, 2001; Nowell & Hungerford, 1960). The mechanism of 
chromosomal translocation has been extensively studied. Using reporter systems and 
sequencing analyses, Jasin and colleagues suggest that the majority of chromosomal 
translocations in human cells are mediated by the cNHEJ pathway (Ghezraoui et al., 2014).  
In mouse models lacking core cNHEJ factors, programmed DSBs accumulate in 
immature B and T cells. In p53-deficient backgrounds, a subset of the DSBs at the IgH locus 
can be mis-joined with spontaneous DSBs downstream of the c-Myc or n-Myc oncogene, 
eventually leading to the co-amplification of IgH-Myc and aggressive lethal pro-B cell 
3. Figure 1-3: T859 phosphorylation of CtIP is dispensable for normal B cell development 
and CSR. 
(A) The spatial distribution of prey-break sites in Sγ1 presented as the frequency (%) of Sγ1 
prey-break sites that falls into each 100-bp bin. The pool of all data from each genotype was 
plotted. All (−, red, from telomere to centromere orientation) and (+, blue, from centromere to 
telomere orientation) strand prey breaks add up to 100%. For each genotype, the number of 
total (+) strand (blue) and (−) strand (red) junctions are marked on the right. The dashed lines 
indicate the percentage of (−) strand Sγ1 prey that fall outside the core Sγ1 region. (B) The 
distribution of IgH junctions by junctional sequence features (blunt). This panel represents the 
pool of IgH junctions from each genotype. The numbers of junctions from each genotype are 
listed in the small table in the figure (n > 2,300 for each genotype). Statistical significance was 
assessed using a two-tailed Student’s t test (n.s., P > 0.05; *, P < 0.05). (C) The CTV labeling 
for cell proliferation in activated splenic B cells from Ctip+/+ and CtipT855A/T855A mice. The switch 
percentage in each respective cell division is plotted on the right (P = 0.74 via Student’s t test).  
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lymphomas (Frank et al., 2000; Gao et al., 2000; Rooney et al., 2004b; Zhu et al., 2002). This is 
in contrast to the mature B cell lymphomas, in which the active IgH3' enhances can drive the 
de-regulated expression of oncogenic Myc without amplification (Gostissa et al., 2009). 
Analyses of the Igh-Myc junctions in cNHEJ/p53 double deficient B cell lymphomas reveal 
preferential usage of MHs, providing a good model system to examine the role of CtIP in A-EJ 
mediated oncogenic chromosomal translocation (Zhu et al., 2002). In addition to the initial 
translocation, the co-amplification of the IgH-Myc is thought to be mediated by a break-fusion-
bridge cycle, which is only possible in check point deficient background. Presumably, the 
absence of the p53-mediated checkpoint also helps the lymphoma cells to tolerate Myc-
deregulation. Accordingly, p53 loss markedly accelerated the development of Eµ-Myc driven 
lymphomas in mouse models (Post et al., 2010). In Chapter 3, we will use this system to 
investigate the role of CtIP and DNA damage-induced CtIP phosphorylation (T859) in oncogenic 
translocations in vivo.   
In summary, the goal of my thesis research is to determine the regulation (via chromatin 
accessibility) and role of CtIP in normal lymphocyte development and lymphomagenesis with a 
focus on its contribution through the A-EJ pathway. For this goal, I took advantage of mouse 
models carrying germline mutation or conditional deletion alleles of CtIP on both cNHEJ 
proficient and deficient backgrounds and applied high-throughput sequencing-based methods. 
The results will be summarized in the following chapters.  
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Chapter 2: Assessing Chromatin Dynamics and Genome Integrity upon DNA 
Damage 
 
Figures 1B, 1D, 2A, 2B, 3D, 3E, 5, 6, 8A-C, 9, 10A were generated using a generous share of 
an analytical software made by Dr. Antony Holmes. Analysis in figures 1C, 7, 8D, 11 were done 
by Dr. Junfei Zhao. Data shown in figures 1-3 B and C were generated by Dr. Xiangyu Liu. 
 
1. Introduction 
Human lymphoid malignancies often contain recurrent chromosomal translocations that 
place oncogenes (e.g., c-Myc, Bcl6, Bcl2) in proximity to the active antigen receptor gene 
enhancer and/or promoter and causes the deregulated expression of the oncogenic gene 
products. (Nussenzweig & Nussenzweig, 2010). The chromosomal translocations often rise 
from the mis-repair of programmed DSBs generated during V(D)J recombination or CSR. The 
nucleolytic processing could modify unrepaired breaks and facilitate repair events. But 
excessive processing can lead to large deletions and eventual translocations. Chromatin-
associated DDR factors play important roles in regulating end-resection. In this chapter, we 
utilize ATAC-Seq and EndSeq, two genome-wide sequencing methods, to test the hypothesis 
that 53BP1 and other chromatin-bound DDR factors limit end-resection by blocking chromatin 
accessibility around the breaks un-repaired DSBs. 
The transcriptional and post-translational regulation of RAG protein is cell cycle-
regulated to ensure the initiation and completion of V(D)J recombination in the G1 phase of the 
cell cycle when HR is not available (Bredemeyer et al., 2006; Schatz, 2004). RAG is also known 
to exclude A-EJ from V(D)J recombination (Corneo et al., 2007) and limit chromosomal 
translocations (Chaumeil et al., 2013). In v-abl kinase transformed B cells, STI571, a tyrosine 
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kinase inhibitor, can induce G1 cell cycle arrest, RAG expression, and robust chromosomal 
V(D)J recombination (Bredemeyer et al., 2006). Several studies, including our data, suggested 
that ATM, H2AX, and 53BP1 are essential for chromosomal cNHEJ and V(D)J recombination in 
XLF-/- lymphocytes (X. Liu et al., 2012; Oksenych et al., 2012; Zha, Guo, et al., 2011). The 
unrepaired ends accumulate in ATM/XLF double deficient cells, yet were rapidly degraded by 
CtIP-mediated resection in XLF/H2AX or XLF/53BP1 double deficient cells (Helmink et al., 
2011; X. Liu et al., 2012; Zha, Guo, et al., 2011). The processed free DNA ends can serve as 
substrates for A-EJ that preferentially use MHs at the junctions. Persistent DSB can participate 
into chromosomal translocations. Indeed, XLF/53BP1-double deficient mice developed 
spontaneous lymphomas involving antigen receptor gene loci (X. Liu et al., 2012). Taken 
together these findings provide a robust cellular system to address the role of chromatin-
associated DDR factors in DSB processing, error-prone end-joining and translocations events.  
DDR factors participate in the maintenance of genomic stability in part through 
phosphorylation of chromatin-bound DNA repair factors (Hauer & Gasser, 2017). In eukaryotic 
cells, DNA is wrapped around nucleosomes. Previous studies showed that chromatin 
remodeling following DDR and involving relaxation and disassembly of nucleosomes was 
necessary for end-resection and HR (Price & D'Andrea, 2013). But how chromatin dynamics 
affect cNHEJ remains unknown and will be one of the questions we tried to address in this 
chapter. DSBs activate ATM kinase. Activated ATM phosphorylates histone H2AX to form γ-
H2AX flanking the DSBs (Rogakou et al., 1998), which in turn recruits other chromatin-
associated DDR factors, such as MDC1 as well as RNF8 and RNF168 (Lou et al., 2006; 
Stewart et al., 2003; Stucki et al., 2005). The E3 ubiquitin activity of the RNF8/168 together 
deposit  Ub on histone H2A, which contribute to the recruitment of 53BP1, BRCA1, and other 
proteins (Ciccia & Elledge, 2010). Specifically, H2AK15ub directly recruits 53BP1 to facilitate 
NHEJ and binds to the BRCT domain of BARD1 to recruit the BRCA1-BARD1 complex (Becker 
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et al., 2020). While BRCA1 promotes end-resection and eventually homologous recombination, 
53BP1 limits end-resection, including those mediated by the CtIP and MRN complex (Bunting et 
al., 2010; Zhao, Kim, Kloeber, & Lou, 2020). Remarkably, the loss of 53BP1 rescues the 
embryonic lethality and the homologous recombination defects associated with BRCA1 deletion. 
Yet, the molecular basis of this functional division is not known.  
Recently, several groups have developed high-throughput sequencing-based methods 
to map genome-wide DNA features (Buenrostro, Wu, Chang, & Greenleaf, 2015; Canela et al., 
2017; Crosetto et al., 2013; Dorsett et al., 2014; Mimitou et al., 2017) in order to understand 
chromatin dynamics upon DNA damage or identify fragile sites under stress conditions. Here we 
performed ATAC-Seq to measure DNA accessibility changes and EndSeq to capture free DNA 
ends upon targeted DSBs induction. In end-joining deficient B cells (Xrcc4-/-) that also lacks 
53BP1, ATM promotes CtIP-facilitated MRN mediated end resection flanking un-repaired RAG-
generated DSB ends occurs without detectable changes in DNA accessibility. This might be in 
part due to the high baseline accessibility of the V(D)J recombination regions. In contrast, 
endonuclease generated breaks in the same cells (Xrcc4-/- or Lig4-/-) increased local accessibility 
and show limited resection within a ~ +/-1 kb window flanking the DSB sites. In the absence of 
53BP1, local chromatin becomes even more accessible and correlated with higher vulnerability 
to DNA breakages, showing as longer resection tracks within a +/- 1kb region. These results are 
in general agreed with the previous data with regards to the range of nucleosome disassembly 
and reassembly upon DSBs (X. Li & Tyler, 2016). Moreover, we showed that genome-wide DNA 
breakages were more likely to be found in more accessible regions. Interestingly, we also find a 
correlation between the DNA damage-triggered accessibility changes and the initial accessibility 




2.1. ATAC-Seq profiles at the TSS are consistent across genotypes and in independent 
cell lines. 
ATAC-Seq was originally developed to measure chromatin accessibility in 
transcriptionally active regions or super-enhancers (Fig. 2-1A) (Buenrostro et al., 2015), which 
are relatively consistent and stable features in a population of cells. To adapt ATAC-Seq to 
measure "heterogeneous" and often "transient" chromatin accessibility changes around DNA 
double-strand breaks, we made the following modifications: 1) created inducible site-specific 
breaks at the same genomic locations in all cells to reduce the heterogeneity of the response 
and enhance signal vs. noise ratio; 2) arrest the cells in the G1 phase of the cell cycle to avoid 
the impact of DNA replication and chromosomal segregation on the ATAC-Seq signals; 3) block 
the cNHEJ pathway to cause the accumulation of DSBs; 4) generated cell lines with inducible 
CtIP inactivation allele to preserve the otherwise resected DNA and boost the ATAC-Seq 
signals. Specifically, we generated v-abl kinase transformed pre-B cell lines (referred to as v-abl 
cells) with the following genotypes, WT, Lig4-/-, Xrcc4-/-, Xrcc4-/-53BP1-/-, and RosaERCRET2Xrcc4-/-
53BP1-/-CtIPC/C from germline engineered mouse models. The v-abl cells are known to have a 
karyotype-stable diploid genome. As expected, the ATAC-Seq signals were enriched at the 
known transcriptional start sites (TSSs) (Fig. 2-1B) and highly reproducible between two 
independently derived WT v-abl cell lines (Fig. 2-1C). As such, nearly 75% of the ATAC-Seq 
peaks were overlapping between the two cell lines (Fig. 2-2A). Moreover, v-abl cells of different 
genotypes listed above also showed a high degree of consistency with respect to the location of 
the peaks at TSSs and the magnitude of the accumulative signals (Fig. 2-1D, 2B-D). Together 
these data established the low background and high reproducibility of ATAC-Seq in v-abl cells 
before the induction of DSBs.  
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2.2. EndSeq can effectively detect RAG-generated breaks at highly accessible regions.  
In previous studies, we and others showed that in v-abl cells, v-abl kinase inhibitor 
STI571 (also known as imatinib, 3M) could induce robust G1 cell cycle arrest, RAG protein 
accumulation, and efficient V(D)J recombination at the integrated pMX-INV substrate 
(Bredemeyer et al., 2006; W. Jiang et al., 2015). The pMX-INV contains an inverted GFP 
flanked by two recombination signal sequences (RSSs, triangles) followed by IRES-hCD4 (Fig. 
2-2C). RAG expression and successful rearrangement lead to GFP expression that can be 
visualized by FACS (Fig. 2-2C). The completion of the rearrangement requires cNHEJ-mediated 
end-ligation. Thus, in cNHEJ-deficient cells (e.g., Xrcc4-/- or Lig4-/-), there was an accumulation 
of the un-repaired coding ends (CEs) and signal ends (SEs) (Fig. 2-3A and B) and no GFP 
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expression after STI571 treatment (Fig. 2-2C). As we and others show, the loss of 53BP1 led to 
nearly complete  
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4. Figure 2-1: Experimental schematic and performance for studying RAG generated 
DSBs. 
(A) Simplified experimental setup and workflow. B cells with or without targeted DSBs were 
collected in parallel for ATAC-Seq or EndSeq analysis. (B) ATAC-Seq signal enrichment within 
a 2 kb window around all TSSs annotated in the mouse genome (mm10), indicating open 
chromatin region. (C) A pair of biological replicates of ATAC-Seq were performed on wildtype 
cells arrested in the G1 phase. Each point represents a peak with fixed width (501bp, +-250bp 
around the summit) called by MACS2 using the default parameters. (D) Example ATAC-Seq 
profiles of a random 1 Mb region (chr14:102,700,000-103,700,000) from cells collected at 
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control (STI treated G1 arrest) condition. Locations of reference genes contained within this 
region are marked at the bottom. 
 
5. Figure 2-2: Experimental performance and validation. 
(A) Overlap of all peaks called by MACS2 using the default parameters from biological repeats 
of wildtype cell lines. (B) Overlay of ATAC-Seq signal enrichment within a 2kb window around 
all TSS sites from WT, Lig4-/-, Xrcc4-/-, and Xrcc4-/- 53BP1-/- CtIP-/- cells under G1 arrested 
condition. (C) Left panel: schematic of the pMX-INV substrate. Right panel: representative 
FACS analyses of WT and Xrcc4-/- cells with or without 24 hours treatment with 3 µM STI571. 
(D) Representative PCR genotyping of CtIP allele in Rosacre/cre CtIPc/c Xrcc4-/- 53BP1-/- cells 
before and after 24 hours of 1 µM 4OHT treatment with Rosa+/+ CtIPc/c Xrcc4-/- 53BP1-/- cells as 
control.  
degradation of the 3'CEs (Fig. 2-3B). ATM inhibitor, and even better, the combination of ATM 
and DNA-PKcs inhibitors blocked the end-degradation and restored the accumulation of the 
3'CEs (Fig. 2-3B). The end-degradation depended on CtIP. Deletion of CtIP completely 
prevented the end-degradation and restored the 3'CEs (Fig. 2-3C). Restore all the ends 
including the 3'CEs are important for measuring accessibility via ATAC-Seq since the ATAC-
Seq signal depends on the robust amplification of the involved DNA fragments.  
To compare and contrast ATAC-Seq with the degree of DNA end-resection at the 
nucleotide levels, we adapted the EndSeq method developed by the Nussenzweig laboratory 
(Canela et al., 2016) (Fig. 2-1A). Briefly, the DNA ends or ssDNA overhangs were blunted by 
Exo T nuclease before ligated with a biotin-hairpin adaptor for signal enrichment and followed 
by amplification. Upon the induction of RAG cutting, Xrcc4-/- cells displayed a prominent peak at 
the expected location for the 5' and 3' CEs & SEs (Fig. 2-3D). Consistent with efficient repair, 
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only a very small peak at the correct genomic location can be identified in WT cells (Fig. 2-3D). 
No EndSeq peaks were found within the ~5 kb pMX-INV substrate in Xrcc4-/-53bp1-/- cells, 
consistent with the excessive end-degradation. CtIP-deletion partially restored the CEs and 
presumably SEs as well (Fig. 2-3D). Those results showed that the DSBs could be effectively 
mapped via EndSeq in our cells. However, when ATAC-Seq was applied to measure the 
chromatin accessibility, we noted that samples showed high and similar pMX-INV substrates 
accessibility, regardless of the genomic integration site and genotypes. While this observation is 
consistent with the requirement for transcription and acetylated histone for proper RAG-induced 
cleavage, the high initial accessibility covered any DSBs associated accessibility changes in 
Xrcc4-/- cells over the WT controls (Fig. 2-3E). Notably, consistent with excessive end-
degradation, almost no ATAC-Seq signal was detected within the pMX-INV substrate in Xrcc4-/-
53bp1-/- cells (Fig. 2-3E). This data suggested that the DSB induced chromatin accessibility 
changes cannot overwrite the open chromatin at the transcriptionally active regions. It might 
also imply that the open chromatin might facilitate the aggressive resection at the pMX-INV in 
Xrcc4-/-53bp1-/- cells. We hypothesized that DSBs in less accessible regions might provide lower 
background to measure DSB-induced chromatin accessibility changes, if there is any.  
 
2.3. ATAC-Seq reveal a correlation between loss of 53BP1 and higher endonuclease-
induced accessibility.  
Next, we adapted the tamoxifen-inducible I-PpoI endonuclease and estrogen receptor 
(ER) fusion to generate site-specific breaks in G1 arrest cells. The I-PpoI endonuclease 
recognizes 18 unique sites in the mouse genome, plus one site within the 28s rDNA repeats. I-
PpoI cleavages generates a four bp 3' overhang on both sides of the DNA ends (Fig. 2-4A).  
The I-PpoI-ER-IRES-hCD8 cassette was introduced into v-abl cells via retroviral infection (Fig. 
2-4B). The expression of human CD8 serves as an indicator of infection and the nuclear 
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translocation of I-PpoI-ER is induced by 4-hydroxy tamoxifen (4OHT). In the experiments 
described here, the 4OHT was added after the cells were arrested in G1 via STI571 for 24hr. In 
contrast to the RAG accumulation and cleavage, which takes a few days (Fig. 2-3A-C), I-PpoI 
cleavage is fast and very robust. When qPCR was used to measure the loss of intact DNA 
around the PPO1 site, the DSBs is detectable in WT cells after only 5 hours of 4OHT treatment, 
in part due to the ability for I-PpoI to continually cut the perfectly repaired junctions (Fig. 2-4C). 
In WT cells, the loss of the across-DSB signal (by PCR) at the representative I-PpoI site (site 1) 
attenuates at 24hr after induction, potentially due to mutagenic repair and the gained resistance 
to I-PpoI cutting (Fig. 2-4C). Accordingly, in NHEJ-deficient cells (e.g., Lig4-/- or Xrcc4-/-), the 
unrepaired ends accumulated at both 5 and 24 hours (Fig. 2-4C, lanes 6-10). Similar to the 
RAG-generated breaks, loss of 53BP1 promotes extensively end-resection around the 
unrepaired break, which can be rescued by CtIP conditional deletion or by ATM inhibition (Fig. 
2-4C, lanes 11-16, 18-21). Quantitative PCR analyses of additional I-PpoI cutting sites (site 5 
and 9) also show similarly effective cutting in cNHEJ-deficient cells (Fig. 2-4D). 
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6. Figure 2-3: Free DNA ends stably accumulated in RAG-generated breaks. 
(A) Schematic diagram of the pMX-INV substrate for V(D)J recombination. The triangles 
represent the recombination signal sequence (RSSs), and the location of the Southern probe 
used in B and C was marked. The 3'conding ends (CEs) were drawn in red. UR: un-rearranged, 
CJ: coding join, CE: coding end, RV=EcoRV, N=NcoI. (B) Southern blot analyses for V(D)J 
recombination at the pMX-INV substrates in WT, Xrcc4-/-, and Xrcc4-/-53BP1-/- cells with or 
without ATM or DNA-PK inhibitor (C) Southern blot analyses of V(D)J recombination in 
RosaERCreXlf-/-53bp1-/-CtIPC/C cells, with or without genomic CtIP deletion (+/- 4OHT). The 
predicted location of the 3' CE smear was marked with a red bracket. (D&E) Normalized 
EndSeq (top, D) or ATAC-Seq (bottom, E) signals within the pMX-INV substrate from WT, 
Xrcc4-/-, and Xrcc4-/-53bp1-/- CtIP-/- cells arrested in G1 phase, after treated for 48 hours with 3 
µM STI571. For EndSeq signals not visible due to differences in signal strength, marked by 
arrows, traces of the first 2.2 kb with adjusted Y-axises were shown on the side. RSS site was 




7. Figure 2-4 Experimental schematic and performance of inducible I-PpoI endonuclease 
system. 
(A) Simplified experimental setup and workflow. Targeted cells were infected with I-PpoI-ER-
IRES-htCD8a construct, arrested in the G1 phase using 3 µM STI571 for 24 hours before the 
addition of 500 nM 4OHT to initiate nuclear translocation of the I-PpoI protein. (B) 
Representative FACS analyses of WT, Xrcc4-/-, Xrcc4-/-53BP1-/-, and Xrcc4-/-53BP1-/- CtIP-/- cells 
with 24 hours treatment with 3 µM STI571 after infection. (C) Southern blot analysis of WT, Lig4-
/-, Xrcc4-/-, Xrcc4-/-53BP1-/- CtIP-/-, and Xrcc4-/-53BP1-/- cells with or without ATMi, collected at 0 
hour, 5 hours or 24 hours after I-PpoI induction, using site 1 specific probe (chr1:191122295-
191122817). EV, empty vector. (D) I-PpoI in vivo cutting efficiency measured by qPCR using 
primers flanking site 1 (chr1:191121001-191121015), 5 (chrX:116287262-116287276), and 9 
(chr4:72028080-72028094), and internal control (200bp upstream from I-PpoI cutting site 1). 
Fold enrichment (2^(-∆∆CT)) was calculated using 100 ng genomic DNA input relative to WT STI 
control condition and actin. 
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Next, we performed parallel ATAC-Seq and EndSeq analyses on cells collected before 
or 24 hours after I-PpoI induction. The accessibility around the 18 I-PpoI sites was similar in STI 
treated cells regardless of genotypes (Fig. 2-5A, left panel, and 2-5B). I-PpoI induction for 5 or 
24 hours did not markedly affect the local accessibility in WT cells, caused a moderate increase 
of local (+/- 1kb) accessibility at 5 hours yet decreased slightly at 24 hours in Xrcc4-/- or Lig4-/- 
cells, while caused a persistent marked increase of accessibility in CtIP-/-Xrcc4-/-53bp1-/- cells 
(Fig. 2-5A, mid and right panel, and 2-5C-E). No significant increase of accessibility was noted 
in Xrcc4-/-53bp1-/- cells, potentially due to the loss of DNA template in resection. ATM inhibition 
does not significantly affect the accessibility changes in Xrcc4-/-53bp1-/- cells (Fig. 2-5A), 
suggesting that ATM might function downstream of accessibility (e.g., MRN and CtIP) to 
modulate end-resection. These results revealed that accumulated DSB can increase local 
chromatin accessibility and 53BP1 suppresses the local accessibility increase. 
2.4. The increase of accessibility affects a broader region than physical end-resection. 
 To understand the cause-effect relationship, we compared the regions affected by 
increased accessibility vs end-resection. We first performed EndSeq in parallel with ATAC-Seq 
on the same cell pools. As a highly dynamic region with over 300 repeats, the 28s rDNA loci as 
a whole contains significant DSBs even without I-PpoI induction, and contributed to 60-80% 
(57.7% in WT cells and 82.1% in Xrcc4-/- cells) of EndSeq reads mapped to all I-PpoI sites at 24 
hours after induction. Upon I-PpoI induction, sharp EndSeq peaks representing unprocessed 
DSBs could be detected in WT cells (Fig. 2-6A). Xrcc4-/- cells accumulated a broader peak 
within the boundary of the increased accessibility (Fig. 2-6A and B). Xrcc4-/- 53BP1-/- cells had 
reduced EndSeq signals that were mildly restored by ATM inhibition (Fig. 2-6A). CtIP deletion 
further restored the DNA ends in Xrcc4-/-53BP1-/- cells, leading to the accumulation of a 
significant EndSeq signal around the breaks (Fig. 2-6A and C). Nevertheless, the extent of end-
resection (~0.5kb) always stayed within the boundary of increased accessibility (~1kb). To 
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better visualize the resection at each I-PpoI site, the EndSeq data were replotted by each site in 
Fig. 2-7. The comparison of EndSeq before and after I-PpoI induction among different cell lines 
was included in Fig. 2-8 A, B, and C. We note, while the I-PpoI only induced a countable 
number of DSBs on the genome, principal component analyses of all the EndSeq peaks can 
readily distinguish the cells with I-PpoI induction from those without, suggesting a potential 
global and indirect impact of I-PpoI-generated breaks (Fig. 2-8D).  
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8. Figure 2-5: Persistent DSBs caused increased chromatin accessibility in the local 
region. 
42 
(A) Heatmap for relative accessibility (RPM) measured within 10 kb window of 18 predicted I-
PpoI cutting sites, ranked by signal intensity (100 bp bin). (B) Overlay of accumulative 
normalized ATAC-Seq signal (RPM) around 6 kb window flanking all I-PpoI sites before I-PpoI 
cutting in WT, Xrcc4-/-, Xrcc4-/-53BP1-/-, and Xrcc4-/-53BP1-/- CtIP-/- cells (100 bp bin). (C-D) 
Overlay of accumulative normalized ATAC-Seq signal (RPM) around 6 kb window flanking all I-
PpoI sites before and after 24 hours I-PpoI cutting in WT (C) or Lig4-/- cells (D) (100 bp bin). (E) 
Overlay of accumulative normalized ATAC-Seq signal (RPM) around 6 kb window flanking all I-
PpoI sites after 24 hours I-PpoI cutting in WT, Xrcc4-/-, Xrcc4-/-53BP1-/-, and Xrcc4-/-53BP1-/- CtIP-




9. Figure 2-6: Free DNA ends accumulate surrounding persistent DSB sites. 
(A) Representative normalized EndSeq signal (RPM) of 2 kb window flanking I-PpoI site 17 
(chr17:24665012-24667012) from WT, Xrcc4-/-, Xrcc4-/-53BP1-/- (with and without ATMi), and 
Xrcc4-/-53BP1-/- CtIP-/- cells (10 bp bin). A 400 bp window flanking I-PpoI recognition site is 
marked with a blue bar at the bottom of the trace. (B) Overlay of accumulative normalized 
ATAC-Seq (purple) and EndSeq (blue) signal (RPM) within 10 kb window flanking all I-PpoI 
sites before and after 24 hours I-PpoI cutting in Xrcc4-/- cells (100 bp bin). (C) Overlay of 
accumulative normalized changes in ATAC-Seq signal (STI baseline subtracted from 24 hours 
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induction) (purple, right secondary vertical axis) and EndSeq (blue left primary vertical axis) 
signal (RPM) within 10 kb window flanking all I-PpoI sites before and after 24 hours I-PpoI 
cutting in Xrcc4-/-53BP1-/- CtIP-/ cells (100 bp bin). 
10. Figure 2-7: Increased amount of free DNA ends accumulate in the absence of 53BP1. 
Normalized EndSeq signal within +- 5kb window flanking I-PpoI sites collected after 24 hours of 
I-PpoI cutting induction. The top panel shows accumulated signals from all I-PpoI cutting sties 
(bin =50 bp). In the bottom panel, each lane represents a unique I-PpoI cutting site (bin =50 bp), 
ranked by signal intensity. 
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2.5. Persistent DNA damage response altered the chromatin accessibility at distal 
regions 
While analyzing the ATAC-Seq, we noted some highly accessible chromatin regions 
were free of increased breaks, such as increased accessibility around open RAG1 and RAG2 
promoters without increase breaks (Fig. 2-9A). A similar phenotype was noted in the enhancer 
of eukaryotic translation initiation factor 4E transporter (Fig. 2-9B). Yet, the adjacent TSS of 
Centrin Binding Protein (Sfi1) showed a significant amount of breakage among all conditions 
(Fig. 2-9B). This observation prompted us to ask whether there was a general increase of 
accessibility in highly accessible regions after persistent DSBs. To do so, we ranked all TSS 
based on their accessibility before I-PpoI induction in Xrcc4-/- cells (Fig. 2-10A) and plotted the 
accumulative accessibility change of the 50 most accessible TSSs (Fig. 2-10B), and found a 
clear increase of accessibility after I-PpoI induction. Curiously, these changes were largely 
diminished in CtIP-/-Xrcc4-/-53BP1-/- cells (Fig. 2-10C). If we do the same for the moderately 
accessible TSS (Fig. 2-10D) or the not-so-accessible (Fig. 2-10E) TSS in Xrcc4-/- cells, we noted 
a positive correlation between basal accessibility and the DSB-induced increase. No significant 
changes of accessibility were noted in TSSs from CtIP-/-Xrcc4-/-53BP1-/- cells with moderate or 
low accessibility (Fig. 2-10F and G). Out of the 23938 TSSs, 3 have I-PpoI sites within 5 kb and 
5 have within 5-10 kb; the others are not close to any DSB sites (10 kb above distance). These 
accessibility-dependent changes are abrogated in the absence of 53BP1. Based on these data, 
we propose that accessible chromatin with lower histone density cannot effectively recruit 
53BP1, a histone binding protein, and therefore might be more vulnerable under persistent DNA 
damage. 
Next, we asked whether the increased accessibility has any biological consequence. To 
do so, we performed gene-set enrichment analyses (GSEA) on EndSeq peaks from each 
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sample. The result showed that DSBs tend to occur in accessible regions regardless of 




11. Figure 2-8: Free DNA ends can be detected upon persistent DSBs induction. 
(A-C) Overlay of accumulative normalized EndSeq signal (RPM) within 3 kb window flanking all 
I-PpoI sites before and after 24 hours I-PpoI cutting in WT (A), Xrcc4-/- (B) or Xrcc4-/-53BP1-/- 
CtIP-/- cells (C) (10 bp bin). (D) Principal component analysis plot of the consensus peaks of all 
EndSeq samples, before (light blue) and after (dark blue) DSBs induction.   
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12. Figure 2-9: Side-by-side comparison of normalized ATAC-Seq signal and EndSeq 
signal. 
(A) Normalized ATAC-Seq (left) and EndSeq (right) signal of a 30 kb window containing G1-
transcribed RAG1 and RAG2 gene loci among WT, Xrcc4-/- or Xrcc4-/-53BP1-/- CtIP-/- cells 
before and after DSBs (100 bp bin). (B) Normalized ATAC-Seq (left) and EndSeq (right) signal 
of a 70 kb window containing highly accessible regions among WT, Xrcc4-/-, or Xrcc4-/-53BP1-/- 
CtIP-/- cells before and after DSBs (100 bp bin). 
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13. Figure 2-10: DNA damage-induced global accessibility changes are 53BP1 dependent. 
(A) Heatmap of normalized accessibility (RPM) at 23,938 annotated TSS before (Ctrl) and after 
I-PpoI 24 hours induction in Xrcc4-/-and TKO (Xrcc4-/-53BP1-/- CtIP-/-) cells, averaged from two 
independent repeat experiments. (B-G) Average of accumulative accessibility in a group of 50 
TSSs with top signal intensity (rank 1-50) (B-C), medium signal intensity (rank 9951-10000) (D-
E), and low signal intensity (rank 14951-15000) (F-G), at before (STI dash line) and after I-PpoI 
induction (24hr solid line), in Xrcc4-/- (B, D, F) and TKO (Xrcc4-/-53BP1-/- CtIP-/-) (C, E, G) cells, 




 The H2AX- and 53BP1- dependent DNA damage response can limit end-resection in the 
chromatin context. Recent advance in biochemical characterization has identified RIF1, 
SHIELDIN complex and CST complex as the downstream effectors. But how those factors 
prevent extensive end-resection remains elusive. Here we adapted the ATAC-Seq to measure 
the accessibility changes at site-specific DSBs. We showed that accessibility does not 
measurably change in WT cells upon endonuclease induced DSBs, but increases in cNHEJ-
deficient cells with persistent breaks. Moreover, we found that deletion of 53BP1 further 
increases the accessibility to flanking regions. By combining EndSeq with ATAC-Seq, we found 
that increased accessibility often precedes end-resection, supporting the model in which 53BP1 
and its downstream factors suppress chromatin accessibility and prevent end-resection. 
Perhaps, most unexpectedly, we noted the accessible regions become more accessible upon 
DSB. This increase of relative accessibility requires 53BP1 and can potentially contribute to 
increased DSBs in transcriptionally active regions.  
In the course of the studies, we also noticed some limitations of our approach. First, 
since the DSB induced accessibility is relatively moderate in WT and even in cNHEJ-deficient 
cells, ATAC-Seq based approach can only detect DSB induced accessibility change in the 
previously un-accessible region. As an example, the V(D)J recombination substrate is 
accessible before the DSBs, and no significant changes are noted. Alternatively, the difference 
could be unique to RAG-generated breaks, which require specific histone modifications for the 
cleavage (A. G. Matthews et al., 2007; Ramon-Maiques et al., 2007). Second, we note the 
ATAC-Seq quantifies relative accessibility, not absolute accessibility. A gain in a region could 
14. Figure 2-11: GSEA enrichment. 
Results from WT, Xrcc4-/-, Xrcc4-/-53BP1-/-, and Xrcc4-/-53BP1-/- CtIP-/- cells with or without 
targeted DSBs. Each analysis represents the relative enrichment for the signature ATAC-Seq 
peaks that overlap with EndSeq peaks from the corresponding sample. The p-value for each 




mean a loss in another region. We have tested whether fly S2 cells could serve as a spike-in 
standard as they were broadly used in CHIP-seq analyses. Unfortunately, S2 cells were shown 
to be aneuploidy (Y. Zhang et al., 2010), which cannot serve as a standard for copy number 
quantifications. Also, we found a different level of preferential amplification between libraries 
prepared using the same ratio of target B cells and S2 cells, suggesting the penetration ability or 
preference may vary due to the status of target B cells and can skew the number of signals 
absorbed by the S2 cells. Third, ATAC-Seq might not be very sensitive to small changes, since 
we did not find measurable accessibility changes in WT cells. Alternatively, this could be due to 
the G1 phase arrest, which limits end-processing.  
 Perhaps most unexpectedly, ATAC-Seq revealed a global change of accessibility in 
regions distal from the designed DSBs and without a marked increase of DSBs. Specifically, we 
found that the accessible chromatin region became more accessible after persistent DSBs. Our 
preliminary data also suggest that such changes might depend on 53BP1 and, by extension, its 
downstream markers. While speculative, we propose a model in which persistent DSBs and 
widespread ATM kinase activation might cause the phosphorylation of H2AX and the 
recruitment of 53BP1 to other "less accessible" chromatin with a relatively high histone density. 
As a consequence, the accessible region with low histone density becomes more accessible. 
We further hypothesize that this dynamic balance of DNA damage responses based on 
chromatin might explain why the majority of tissue- or cell type-specific translocations occurred 
between actively transcribed genes and why the frequencies of spontaneous DSBs have been 
correlated with transcription. In future studies, we will focus on selected promoters placed at 
different distances from the DSBs to determine the parameters that affect the relative gain of 
accessibility. Moreover, we will also test different time points and different cell cycle phases.  
 Another type of difference we found was between Southern blot analyses and the 
sequencing-based method. Firstly, different from the recovered CE smear found in the RAG-
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generated breaks or I-PpoI ends, the addition of ATMi only mildly recovered the EndSeq signal 
and did not affect the ATAC-Seq signal. This inconsistency could be caused by several factors. 
In EndSeq assay, we used Exonuclease T to blunt and modify the free DNA ends before ligating 
sequencing adaptors, which is a robust enzyme that could digest away some recovered DNA 
ends in the ATMi treated conditions, such as long single-strand overhangs or nicked DNA 
substrates that could be detectable via Southern blotting analyses. Early biochemistry studies 
also suggested that the original Tn5 had a preference towards dsDNA, and the ability to invade 
ssDNA substrate is less stable or require a dsDNA template nearby (Egner & Berg, 1981). 
Therefore, long ssDNA may not be amplifiable in the ATAC-Seq assay. 
Unlike the EndSeq method, which is developed for detecting DNA breakages, the ATAC-
Seq method was widely used as a transcriptional tool to measure robust changes in chromatin 
status. In our hands, the differences caused by induced DSBs did not lead to major alterations 
in global chromatin accessibility. From the PCA on EndSeq consensus peaks, the WT group 
with or without DSBs was separated from the rest of the end-joining deficient samples and also 
from each other. Meanwhile, all samples with XRCC4 deficiency were grouped and separated 
by with or without DSBs, suggesting that the global DNA breakage pattern was affected by the 
induced DSBs. In comparison, ATAC-Seq signals did not have clear separation except in 
53BP1 deficiency conditions (data not shown), suggesting that we have not altered major 
players in controlling global chromatin dynamics. Similarly, from GSEA applied on several 
biological replicates on different conditions (Fig. 1-11), we concluded that DNA breakage tends 
to take place in the accessible regions. However, we cannot argue any mild differences caused 
by DNA damage or genetic background due to the limitation of GSEA power. Moreover, we 
observed a potential 53BP1 dependent redistribution of nucleosome occupancy upon DNA 
damage. The relaxation of the heterochromatin region upon DNA damage can be modulated by 
ATM and ATR (Hauer & Gasser, 2017), which agrees with our observations, but direct 
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measurement of global chromatin accessibility is still lacking without an independent internal 
control. Also, even the most accessible TSS regions did not show an increased amount of 
breaks after DNA damage, suggesting multiple players protecting open chromatin from 
randomized attack.  
In conclusion, in this chapter, we applied high-throughput sequencing methods to study 
the connection between chromatin accessibility and the vulnerability of free DNA ends 
generated from RAG- or endonuclease-mediated DSBs. To avoid significant contribution from 
the dynamic S phase activities, all the experiments discussed in this chapter were performed in 
the G1 phase, and the more complex situation in S and G2 phases are still to be investigated, 
especially to ask the impact on chromatin dynamics and chromosomal translocations. One 
aspect we have not looked at is the translocation products or in what portion of the recovered 
DNA breakages will lead to a translocation event. Therefore, translocation assays, introduced in 
the previous chapter and will be widely used in the following chapters, need to be applied to 
answer the ultimate correlation between DNA damage response, global accessibility changes, 
the vulnerability of the breaks, and translocations. 
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Chapter 3: CtIP-mediated DNA resection is dispensable for IgH class switch 
recombination by alternative end-joining * 
 
* Work described in this chapter is published under: 
Wang XS, Zhao J, Wu-Baer F, Shao Z, Lee BJ, Cupo OM, Rabadan R, Gautier J, Baer R, Zha 
S. CtIP-mediated DNA resection is dispensable for IgH class switch recombination by 
alternative end-joining. Proc Natl Acad Sci U S A. 2020 Oct 13;117(41):25700-25711. doi: 
10.1073/pnas.2010972117. Epub 2020 Sep 28. PMID: 32989150; PMCID: PMC7568320. 
XW contributed to all the figures 
 
1. Introduction 
In peripheral lymphoid organs, B lymphocytes undergo Immunoglobulin (Ig) class switch 
recombination (CSR) to generate antibodies with different effector functions. At the DNA level, 
CSR replaces the C exons that encode the Ig heavy chain constant region of IgM antibodies 
with exons encoding other isotypes (e.g., C1 for IgG1) to generate antibodies with different 
effector functions (Chaudhuri et al., 2007). CSR is initiated by the B cell-specific activation-
induced cytidine deaminase (AID), which converts cytosine to uracil in the transcribed switch (S) 
regions preceding each set of constant region exons (Hwang, Alt, & Yeap, 2015). The 
mismatches generated by AID are eventually converted to DNA double-strand breaks (DSBs) in 
proliferating B cells. The IgH isotype switch is then achieved by joining a DSB in the initially 
expressed IgM switch region (S) with a DSB in a downstream switch region (e.g., S1 for 
IgG1). Two DSBs within the S region can also be joined to form an internal deletion that 
removes intervening S sequences without achieving isotype switch. The ligation of these AID-
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initiated DSBs is primarily mediated by classical non-homologous end-joining (cNHEJ) that can 
directly ligate two unprocessed, or minimally processed, DSB ends. B cells deficient for core 
cNHEJ factors, such as LIG4 or its obligatory binding partner XRCC4, can still achieve a 
remarkable 25% of normal CSR, using the mechanistically distinct Alternative-End-Joining (A-
EJ) pathway (Boboila, Yan, et al., 2010; Yan et al., 2007b). In addition to the specific repair 
pathways, ATM kinase and its chromatin bounded substrates (e.g.,53BP1, H2AX, etc.) promote 
efficient CSR (Franco, Alt, et al., 2006). But whether ATM specifically promotes cNHEJ-
mediated CSR or both cNHEJ and A-EJ mediated CSR remains elusive.  
 
Studies using endonuclease-generated DSBs have shown that the A-EJ and the related 
MH-mediated end-joining (MMEJ) pathways both depend on DNA end-resection, a nucleolytic 
process that converts the two ends of a DSB into 3’ single-strand DNA overhangs (Bennardo, 
Cheng, Huang, & Stark, 2008; Symington & Gautier, 2011). End-resection is important for A-EJ 
by exposing the flanking MH (McVey & Lee, 2008; Sfeir & Symington, 2015) Short stretches of 
MH within the two opposing overhangs can then anneal to each other and, after further 
nucleolytic processing (e.g., flap removal by FEN1 or DNA2 nucleases), converting a DSB to 
two single-stranded DNA gaps or nicks, which can then be filled in and joined by LIG1 or LIG3, 
both of which have been implicated in A-EJ mediated CSR (Boboila, Oksenych, et al., 2012; 
Masani, Han, Meek, & Yu, 2016). Thus, the most widely recognized feature of A-EJ or MMEJ 
mediated repair is the prevalence of MH at the junctions. In this context, the High-Throughput 
Genome-wide Translocation Sequencing (HTGTS) (Hu et al., 2016), a linear-amplification 
based method to recover thousands of junctions involving a single bait DSB, has greatly 
improved the efficiency for isolating CSR junctions(Dong et al., 2015; Panchakshari et al., 
2018). When the bait break site is placed at the 5’ Sμ region, HTGTS can efficiently recover 
thousands of CSR junctions and internal-deletion junctions. Using HTGTS, we and others have 
shown that the A-EJ events arising in cNHEJ-deficient (e.g., Xrcc4-/- or DNA-PKcs-/-) B cells are 
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markedly enriched for junctions bearing both short (1-3 nt) and long (>=4nt) MHs (Crowe et al., 
2018a; Dong et al., 2015; Panchakshari et al., 2018). In addition, A-EJ mediated CSR correlated 
with extensive use of junctions beyond the 3’ (distal) boundaries of the core S and S1 regions, 
suggesting DNA end-resection (Crowe et al., 2018a; Dong et al., 2015; Panchakshari et al., 
2018). Nevertheless, why A-EJ mediated repair is particularly efficient during CSR and whether 
resection is required for A-EJ mediated CSR (and if so, the pathway of resection), remains 
poorly understood. 
 
In addition to A-EJ, DNA resection is also essential for homologous recombination (HR) 
that repairs DSBs using homologous sequences. In eukaryotes, DNA resection can be initiated 
by the nucleolytic activities of the MRE11-RAD50-NBS1 (MRN) complex in association with the 
CtIP protein, while long-range resection was carried by EXO1 or DNA2 (Symington & Gautier, 
2011). While both the DNA2 and MRN-CtIP pathways have been implicated in A-EJ mediated 
repair of endonuclease generated breaks (Bennardo et al., 2008; Howard, Yanez, & Stark, 
2015), the study of their yeast orthologs suggests that CtIP promotes both DNA2 and MRN 
mediated end-resections (T. Y. Yu, Kimble, & Symington, 2018). Specifically, the CtIP mediated 
end-resection is most active in the S and G2 phases of the cell cycle due to high CtIP protein 
expression (X. Yu & Baer, 2000) and CDK-mediated phosphorylation of CtIP at residue T847 
(Sartori et al., 2007). Moreover, upon DNA damage, the ATM and ATR kinases further promote 
end-resection by phosphorylating CtIP at T859 (T855 in mouse) and other sites (X. Liu et al., 
2019; Makharashvili et al., 2014; Peterson et al., 2012; H. Wang et al., 2013). CtIP is specifically 
implicated in A-EJ.  Bennardo et al. (2008) showed that CtIP facilitates A-EJ mediated repair of 
an MMEJ-reporter in murine embryonic stem cells, presumably by promoting end-resection and 
thereby exposing the flanking MHs in the resulting single-strand DNA overhangs (Bennardo et 
al., 2008). In this regard, several studies have shown that CtIP-depletion significantly reduces 
CSR in B cells activated in vitro (Buis et al., 2012; Lee-Theilen et al., 2010; X. Liu et al., 2019; 
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Polato et al., 2014). In addition to a direct role in A-EJ (Lee-Theilen et al., 2010), other possible 
mechanisms have also been proposed to explain how CtIP loss impairs CSR, including its 
ability to modulate AID function (Lee-Theilen et al., 2010) and CDK2 regulation (Buis et al., 
2012). However, since the loss of CtIP abrogates the proliferation of activated B cells (X. Liu et 
al., 2019; Polato et al., 2014) and proliferation is essential for successful CSR, whether the 
impact of CtIP loss on CSR is due to impaired end-resection or through other indirect 
mechanisms, including impairing proliferation, remains difficult to sort out. Using the HTGTS 
assay, we recently compared the CSR and S internal deletion junctions that arise in CtIP+/+ 
and CtIP∆/∆ B cells. To our surprise, the CSR junctions recovered from these cells were largely 
indistinguishable for their MH usage and resection patterns (X. Liu et al., 2019). Likewise, the 
T855A phosphorylation site mutation, which partially blocks ATR/ATM-dependent induction of 
CtIP-mediated resection, also has no impact on the efficiency, end-resection, or MH usage of 
CSR (X. Liu et al., 2019). These findings suggest that CtIP, and by extension CtIP-mediated 
end-resection may be dispensable for end-ligation required for CSR, at least when measured 
within cNHEJ-proficient cells. But whether CtIP contributes to A-EJ mediated CSR specifically 
remains unknown.  
 
Studies of A-EJ-mediated CSR are complicated by the fact that junctional MHs, a 
characteristic feature of A-EJ, can also be generated by cNHEJ. Although the MHs of cNHEJ 
junctions are thought to be shorter than those generated by A-EJ, the cutoff is not absolute and 
junctions with short MHs (1-3nt) cannot be definitively attributed to either DSB repair pathway. 
To circumvent this ambiguity, we examined CSR in B cells that are genetically deficient for 
cNHEJ owing to loss of the core cNHEJ factor XRCC4, an obligatory partner of LIG4. The role 
of CtIP in A-EJ-mediated CSR in Xrcc4-/- murine B cells was then evaluated by either conditional 
inactivation of CtIP or non-phosphorylatable CtIP mutation (T855A). Unexpectedly, we found 
that isotype switching in Xrcc4-/- B cells was unaffected by either deletion or mutation (T855A) of 
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CtIP.  Moreover, despite a significant reduction in end-resection, the CSR junctions recovered 
from Xrcc4-deficient alone and Xrcc4-deficient & CtIP-T855A mutant cells displayed similar MH 
usage, suggesting that MH-mediated end-ligation can occur without extensive end-resection 
during CSR. Similarly, ATM kinase inhibitor (ATMi) also attenuated end-resection without 
affecting MH-usage during A-EJ-mediated CSR. The analysis of ATMi-treated Xrcc4-/- cells also 
identified an end-resection independent role for ATM in regulating the orientation of CSR by 
both cNHEJ and A-EJ. Finally, when CSR junctions were analyzed by cell division, MHs (4-15 
bps) are significantly enriched in early internal deletion junctions even in cNHEJ-proficient B 
cells. Taken together, our findings show that A-EJ-mediated CSR can occur independent of 
CtIP-mediated end-resection, suggesting that the repetitive IgH switch regions are uniquely 
prone to MH-mediated repair.  
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2. Results 
2.1 CtIP and ATR/ATM mediated phosphorylation of CtIP(T855) are dispensable for A-EJ-
mediated class switching. 
Xrcc4 and CtIP are both essential for early B cell development (Gao, Sun, et al., 1998; 
X. Liu et al., 2019). To investigate the role of CtIP-dependent resection in A-EJ-mediated CSR, 
we used a CD21-driven Cre recombinase to conditionally inactivate the Xrcc4 and/or CtIP 
genes in naïve B cells (X. Liu et al., 2019; Pelanda et al., 1997; Yan et al., 2007b). The 
efficiency of CtIP and Xrcc4 inactivation in splenic B cells was validated by genomic PCR and 
Western blotting (Fig. 3-1 A and B). As noted previously (X. Liu et al., 2019), successful Cre-
15. Figure 3-1: Effective deletion of CtIP and Xrcc4 in B cells. 
(A) Representative PCR genotyping of CtIP or Xrcc4 in purified CD43- B cells, and after 3 or 4 
days of stimulation. (B) Western blotting for CtIP and Xrcc4 protein in purified splenic B cells 
collected on day 2 after stimulation. Both short exposure (SE) and long exposure (LE) are 
shown. *: truncated CtIP protein lacking the N-terminal tetramerization domain. The molecular 
weight markers for 100 and 150KDa are marked on the figure. 
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mediated recombination of the CtIPC allele generates CtIP, which encodes a truncated CtIP 
protein that lacks most of the oligomerization domain (Fig. 3-2 A-D). The oligomerization domain 
of CtIP is essential for the end-resection function of CtIP (Davies et al., 2015). Accordingly, 
CtIP/ mice died during embryonic development (Bothmer et al., 2012), consistent with the 
CtIP-null mice described before (P. L. Chen et al., 2005).  Somatic inactivation of CtIPC/C 
16. Figure 3-2: The nature of the truncated CtIP protein expressed by the CtIP  allele. 
(A) Diagram of murine CtIP protein with the N-terminal oligomerization domain (1-165) and C-
terminal Sae2 like domain (789-893) annotated. The position of the 2nd (Met98), 3rd (Met 121) 
and 4th (Met 141) are marked on the diagram. The CDK phosphorylation site (T844) and 
ATM/ATR phosphorylation site (T855) are marked in green and red, respectively. (B) The 
sequence of murine CtIP protein with all 16 Met annotated by number (in red). The first 36 aa 
encoded by exon 2 deleted in the CtIP allele are crossed out. (C) The calculated molecular 
weight of full length CtIP and putative truncated CtIP protein initiated from different downstream 
methionines. (D) The classical Kozak seq. distribution (top) and the sequence surrounding the 
first 4 ATGs (code Met) of murine CtIP. The 2nd has a poor Kozak (-). 
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(converted to CtIP/) in progenitor B cells abrogates proliferation and normal B cell 
development (X. Liu et al., 2019; Polato et al., 2014), suggesting that CtIP acts as a CtIP null 
allele in vivo. Inactivation of Xrcc4 alone (CD21CreXrcc4C/CCtIP+/+(C)), CtIP alone 
(CD21CreXrcc4+/+(C) CtIPC/C) or both together (CD21CreXrcc4C/C CtIPC/C) did not affect the 
frequency of the IgM+B220+ B cells in the spleen (Fig. 3-3, and 3-4A). In the presence of anti-
CD40 and IL-4, purified splenic B cells undergo CSR to express IgG1 or IgE (Wesemann et al., 
2011). Xrcc4-deletion reduced IgG1 switching to ~25 % of control levels at both days 3 and 4 (at 
day 4, IgG1+% = 29.02±6.83% in control vs. 8.25±1.23% in CD21CreXrcc4C/CCtIP+/+(C)) (Fig. 3-3, 
3-4B, C) (Boboila, Yan, et al., 2010; Yan et al., 2007b). Although CtIP inactivation compromised 
B cell proliferation (Fig. 3-3) (X. Liu et al., 2019; Polato et al., 2014), CtIP inactivation did not 
further reduce the frequency of IgG1+live cells% from Xrcc4-deficient B cells (CD21CreXrcc4C/C 
CtIPC/C) (Fig. 3-3, 3-4B, C), suggesting that CtIP is not required for A-EJ-mediated CSR.  
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Given the important role of CtIP in proliferation, we used two additional approaches to 
18. Figure 3-3: CtIP-deficiency or mutation did not reduce A-EJ mediated CSR in Xrcc4-
deficient B cells. 
Representative flow cytometry analysis of purified splenic B cells, stimulated with IL-4 and anti-
CD40, at day 3 or day 4, from control (WT or CD21CreXrcc4C/+CtIP+/+(C)), 
CD21CreXrcc4C/CCtIP+/+(C), CD21CreXrcc4C/C CtIPC/C, and CD21CreXrcc4C/C CtIPT855A/T855A mice, with 
representative CTV labeling for cell proliferation upon stimulation. Cells that underwent two cell 
divisions were gated based on CTV dilution and plotted for IgG1+ frequency.  
17. Figure 3-4: Characterization and CSR efficiency of CtIP-deficiency or mutation in 
Xrcc4-deficient B cells. 
(A) Splenic naïve B cell (B220+IgM+) percentage by genotype. The data represents the average 
and standard derivations of n>=4 mice per genotype. (B) The percentage of live and IgG1+ cells 
at day 3 after stimulation. Two-tailed Mann-Whitney test, **** p<0.0001. (C) The percentage of 
live and IgG1+ cells at day 4 after stimulation. Two-tailed Mann-Whitney test, **** p<0.0001 (D) 
The relative (to control analyzed in parallel) percentage of live and IgG1+ cells at day 3 after 
stimulation in cells with 2 divisions, measured by CTV.  
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ascertain whether CtIP has a proliferation-independent role in A-EJ-mediated CSR. First, we 
labeled activated B cells with a surface dye (CTV) to monitor cell division and then compared 
CSR efficiency between cells with the same number of divisions. As shown in Fig. 3-3 and 
quantified in Fig. 3-4D, CtIP-loss has no impact on A-EJ-mediated IgG1 switching in Xrcc4-
deficient B cells even after controlling for cell division.  Second, we took advantage of the 
CtIPT855A allele, which harbors a phosphorylation site mutation that partially blocks ATR/ATM-
induced CtIP-mediated end-resection without affecting B cell proliferation (Fig. 3-3) (X. Liu et al., 
2019). IgG1 switching is comparable in CD21CreXrcc4C/C or CD21CreXrcc4C/CCtIPT855A/T855A B 
cells, even after controlling for cell division status (Fig. 3-3 and 3-4B). DNA2 is essential for 
murine embryonic development (Lin et al., 2013) and a conditional allele for DNA2 is not yet 
available. We found that a selective inhibitor for DNA2 – C5 (W. Liu et al., 2016) – compromised 
the viability, but not the A-EJ mediated CSR to IgG1 in CD21CreXrcc4C/C B cells (Fig. 3-5). 
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Together, these data indicate that CtIP, CtIP phosphorylation at T855, and DNA2 activity are 
dispensable for A-EJ-mediated CSR.  
2.2 CtIP and its resection activity are necessary for extensive S-region resection in 
cNHEJ-deficient B cells.  
Next, we performed HTGTS analyses of CSR junctions. Briefly, a linear amplification-
based method was used to identify DNA junctions involving AID-generated breaks at the 5’ S 
region (called the “bait”) and another DSB (called the “prey”) (Crowe et al., 2018a; Dong et al., 
2015; Hu et al., 2016). In switching B cells, most preys reside in the switch regions, representing 
internal deletion (to another S break) or CSR (to breaks in S1 or S) (Fig. 3-6A). Notably,  
19. Figure 3-5: The impact of DNA2 inhibition on A-EJ mediated CSR. 
Representative flow cytometry analyses of CSR in WT or Xrcc4-/- cells treated with DNA2 




HTGTS recovers both types of junctions and the orientation of the joining products (Fig. 3-6A). 
For this study, we analyzed >5000 junctions from 3 independent mice of each genotype (Fig. 3-
6B). While the majority of the prey resided in the IgH locus (~6% of the prey junctions from 
wildtype B cells mapped outside the IgH locus (Fig. 3-6C).  The frequency of non-IgH prey 
increased significantly in Xrcc4-deficient (14% in CD21CreXrcc4C/CCtIP+/+(C)), and double-
deficient (14% in CD21CreXrcc4C/CCtIPC/C and 13.5% in CD21CreXrcc4C/C CtIPT855A/T855A) B cells 
(Fig. 3-6C), consistent with increased chromosomal translocations. Figure 3-6D illustrates the 
relative distribution of prey junctions within the IgH locus. In wildtype B cells, roughly 20% of all 
IgH preys reside in S (majorities are the products of S-S internal deletions), 40% in Sγ1, and 
another 40% in Sε (Fig. 3-6D). Xrcc4 deficiency preferentially affected the S-Sε junction 
frequency (to 15%, p=0.016) without affecting S-S1 junction (~40%, p>0.05) (Fig. 3-6D). 
These results are consistent with sequential switching, thus two end-joining events are often 
needed to achieve Sε switching in adult B cells (Tong & Wesemann, 2015). Correspondingly, 
selective depletion of S-Sε junctions has also been noted for ATM or DNA-PKcs-deficient B 
cells (Crowe et al., 2018b; Panchakshari et al., 2018). CtIPT855A mutation (CD21CreXrcc4C/C 
CtIPT855A/T855A) did not affect the IgH prey distribution in Xrcc4-deficient B cells (Fig. 3-6D).  
20. Figure 3-6: CtIP deficiency reduces end-resection in Xrcc4-deficient B cells. 
(A) Diagram of the HTGTS assay with a single bait site at the 5’ Sμ region. The IgH locus is 
drawn in its native orientation on mouse chromosome 12. The solid and the dash lines 
represent junctions made in the (-) (normal internal deletion and CSR) and (+) (inversion) 
orientation, respectively. The different switch regions are color-coded. The bait site is marked 
with a red arrow. The bait starts from 114,664,910 near the telomere of Chr. 12. (B) The number 
of unique junctions in each genotype group. (C) The distribution of prey sites inside (IgH all) and 
outside (non-IgH) the IgH locus. (D) The distribution of IgH prey sites by switch region - S, Sγ1, 
Sε, and others. (E-F) Relative frequency of distal preys among the prey in each respective 
switch region. Two-tailed Mann- Whitney test, * p<0.05; ns is not marked. (E) for S, 
distal=downstream/centromeric to Chr12: 114,662,100. (F) for Sγ1, distal= 
downstream/centromeric to Chr12:114,568,500. For (B) to (E), the data represent >=3 
independent repeats of each genotype. Error bar= Standard deviation 
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HTGTS analyses of wildtype B cells confirm that most CSR junctions fall within the core 
S-regions (Crowe et al., 2018b; Dong et al., 2015; Panchakshari et al., 2018), where AID-
hotspots and RGYW motifs are slightly enriched (Fig. 3-7 for S, Fig. 3-8 for S1, and Fig. 3-9 
for S). In contrast, in Xrcc4-deficient cells, a significant fraction of CSR junctions falls beyond 




21. Figure 3-7: Diagram and relative distribution of S preys in Xrcc4-deficient B cells. 
The diagram of ~ 10 Kb (chr12: 114,658,100 - 114,668,100, mm10) Sµ region and the counts of 
RGYW motifs per 50 bp by orientation ((+), blue and (-), red). The percentage of preys that fall 
into the distal region (<Chr 12: 114,662,100, mm10, indicating extensive resection, 2.810Kb 
from the bait) are marked on the left and the frequency of (+) and (–) oriented preys are marked 
on the right. The Sµ preys were divided into three regions: proximal, middle and distal, as 
marked on the graph. The distal region is the same as the extensively resected region. The data 
represents the pool of at least three independent libraries per genotype per treatment.  
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S1 (3.5% vs 0.6% in control, p=0.016) (Fig. 3-6F and Fig. 3-8) regions (Crowe et al., 2018b; 
Dong et al., 2015; Panchakshari et al., 2018), which defined as extensive resection. We thus 
categorize junctions beyond the core switch region (114,662,100< in S, 114,568,500 < in S1 
and 114,510,500 < in S) as extensive resection. The exact location of the boundary and their 
22. Figure 3-8: Diagram and relative distribution of Sγ1 preys in Xrcc4-deficient B cells. 
The diagram of ~ 30 Kb (chr12: 114,558,500 - 114,588,500, mm10) Sγ1 region and the counts 
of RGYW motifs per 150 bp by orientation ((+), blue and (-), red). The percentage of preys that 
fall into the distal region (<Chr 12: 114,568,500, mm10, indicating extensively resection region, 
96.410kb from the bait) are marked on the left and the frequency of (+) and (–) oriented preys 
are marked on the right. The Sγ1 preys were divided into three regions: proximal, middle and 
distal, as marked on the graph. The distal region is the same as the extensively resected region. 
The data represents the pool of at least three independent libraries/mice per genotype per 
treatment.  
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base pair numbers are included in the Figures. Distal junctions are less prevalent in Sε (1.9% to 
3.5%, p=0.56) (Fig. 3-9), potentially due to the low number of S-S junctions. These distal 
junctions could arise by extensive resection of unrepaired switch region breaks due to cNHEJ- 
 
23. Figure 3-9. Diagram and relative distribution of Sε preys in Xrcc4-deficient B cells. 
The diagram of ~ 8 Kb (chr12: 114,506,500 - 114,514,500, mm10) Sε region and the counts of 
RGYW motifs per 50 bp by orientation ((+), blue and (-), red). The percentage of preys that fall 
into the distal region (<Chr 12: 114,510,500, mm10, indicating extensive resection 153.210Kb 
from bait start) are marked on the left and the frequency of (+) and (–) oriented preys are 
marked on the right. The data represents the pool of at least three independent libraries per 
genotype.  
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deficiency. Alternatively, they could reflect the joining with AID-initiated breaks outside the core 
switch region generated due to the lack of productive CSR. CtIP deletion 
(CD21CreXrcc4C/CCtIPC/C) largely eliminated the formation of distal CSR junctions at all three 
switch regions in Xrcc4-deficient B cells (Fig. 3-7 for S, Fig. 3-8 for S1, and Fig. 3-9 for S) 
and CtIPT855A mutation markedly reduced distal junctions %, especially in S, and to a much less 
extent in S1 and Sε (Fig. 3-6E, 3-7, 3-8, and 3-9). Together, these observations indicate that 
CtIP-mediated end-resection is essential for the formation of distal CSR junctions outside the 
core switch region.  
2.3 MH-mediated CSR in cNHEJ-deficient cells requires CtIP, but not T855 
phosphorylation. 
MH is the characteristic feature of A-EJ-mediated DSB repair. We then asked whether 
reduced resection associated with CtIP deficiency affects MH usage during A-EJ-mediated 
CSR. To do so, we binned the CSR junctions according to the extent of MH (0=blunt, 1, 2-3, 4-
5, etc.), and the size of insertions (INS, 1-10nt) (Fig. 3-10). Since MH usage cannot be 
determined at junctions bearing insertions, the INS and MH junctions are mutually exclusive. In 
wildtype cells, roughly 25% of all IgH junctions are blunt, 25% have 1nt MH, and 25% have 2-
3nt MH (Fig. 3-10A). In wildtype cells, MH-distribution is similar in S-S (Fig. 3-10C) and S-
S1 (Fig. 3-10E) junctions. As expected, Xrcc4-deficiency (CD21CreXrcc4C/CCtIP+/+(C)) increased 
the proportion of junctions with 2-3nt (from 25% to 35%) and >=4nt MH (from ~9% total in WT to 
~25%) with a concurrent drop in blunt (from 25% to 8%) and 1nt MH (from 25% to 10%) 
junctions (p<0.0001, Kolmogorov-Smirnov test) (Fig. 3-10A and B) (Yan et al., 2007b). Co-
deletion of both Xrcc4 and CtIP (CD21CreXrcc4C/CCtIPC/C) largely eliminated the skew toward 
longer MHs (Fig. 3-10A, p<0.0001, Kolmogorov-Smirnov test, relative to 
CD21CreXrcc4C/CCtIP+/+(C)) in all IgH junctions (Fig. 3-10A and B), suggesting that, although 
dispensable for A-EJ CSR efficiency, CtIP promotes MH-end joining during CSR. In contrast, 
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although the CtIPT855A mutant (CD21CreXrcc4C/C CtIPT855A/T855A cells) reduced resection, it did not 
alter the MH pattern of Xrcc4-deficient (CD21CreXrcc4C/CCtIP+/+(C)) cells (Fig. 3-10A-F, p=0.67, 
Kolmogorov-Smirnov test). Correspondingly, ATM inhibition also reduced resection without 
affecting MH usage (Fig. 3-10A-F).  Thus, in contrast to endonuclease generated breaks, end-
resection, and MH usage can be uncoupled during A-EJ mediated CSR. 
At endonuclease-generated breaks, end-resection facilitates A-EJ by revealing flanking 
MH in the single-strand DNA overhangs (Sfeir & Symington, 2015). If it is also true during A-EJ 




To test this, we divided the S and S1 into three mutually exclusive regions, proximal, middle, 
and distal (Fig. 3-7 and 3-8) and analyzed MH-usage in each region separately (Fig. 3-11). In 
WT cells, where the CSR junctions are largely mediated by cNHEJ, there is a clear preference 
to MH in the middle and distal Sμ regions (Fig. 3-11A), consistent with a correlation between 
resection (distal junctions) vs MH usage. In contrast, in Xrcc4-/- cells, where all junctions were 
24. Figure 3-10: The MH usage of IgH junctions recovered from Xrcc4-deficient B cells. 
(A) The graphic distribution of all IgH preys by MH, blunt, and insertion (INS). (B) The 
percentage of IgH junctions with >= 4nt MH by genotype. (C) The graphic distribution of all S 
preys by MH, blunt, and insertion (INS). (D) The percentage of S junctions with >= 4nt MH by 
genotype. (E) The graphic distribution of all Sγ1 preys by MH, blunt, and insertion (INS). (F) The 
percentage of Sγ1 junctions with >= 4nt MH by genotype. (A), (C) and (E) represent the pool of 
at least three independent libraries per genotype. For A, C, and E, Kolmogorov-Smirnov test, * 
p<0.05, **** p<0.0001. In (B), (D), (F), the bar and error bars represent the average and the 
standard derivations. The p-values in B, D, F were calculated via unpaired student’s t-test. * 
p<0.05, ** p<0.01, *** p<0.0005, **** p<0.0001 
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mediated by the A-EJ pathway, there is no skew of the MH usage (Fig. 3-11B), suggesting that 
end-resection and MH usage are uncoupled in A-EJ mediated CSR. There were insufficient 
junctions that fell into the Sγ1 distal region in WT cells, so we only compared the proximal and 
middle regions (Fig. 3-11C). In both WT and Xrcc4-/- cells, MH usage did not correlate with prey 
location (Fig. 3-11C). Together, these findings confirm that end-resection and MH usage can be 
uncoupled during A-EJ-mediated CSR. 
2.4 ATM signaling promotes A-EJ-mediated CSR through both CtIP-T855 
phosphorylation-dependent and CtIP-independent mechanisms.   
ATM/ATR phosphorylates several other substrates in addition to CtIP (T855) to promote 
end-resection. Next, we tested the impact of ATM inhibition on end-resection and A-EJ 
mediated CSR. In contrast to the CtIP-T855A mutation, ATM kinase inhibition (ATMi, KU55933, 
7.5 M) significantly reduced IgG1 switching of Xrcc4-deficient splenic B cells (Fig. 3-12A and 3-
12B), indicating a CtIP independent role of ATM in A-EJ-mediated CSR. HTGTS data show that 
ATM inhibition reduced the extensive resection at S (Fig. 3-6E and 3-7) and S1 (Fig. 3-6F and 
3-8) in Xrcc4-/- B cells, without significantly affecting the MH usage in Xrcc4-/- B cells 
(CD21CreXrcc4C/CCtIP+/+(C)) (Fig. 3-10). Thus, like in CtIP-mutant cells, end-resection can be 
uncoupled from MH-usage during A-EJ mediated CSR by ATM inhibition.  
What is the CtIP independent function of ATM in A-EJ mediated CSR? ATMi-treated 
cells display several features that are not found in CtIP-deficient cells. First, ATM inhibition, but 
not CtIP deletion, further reduced the relative frequency of S-S junctions in Xrcc4-/- cells 
25. Figure 3-11. The MH usage by position in the Sµ and Sγ1 regions. 
The MH, blunt, and insertion (INS) distribution among preys recovered from the WT Sµ (A), 
CD21CreXrcc4C/CCtIP+/+(C) Sµ (B) or Sγ1 (C) regions. The definition of proximal, middle, and 
distal are marked on Figure 3 for S and Figure 4 for Sγ1. S: Distal <114662100, Middle 
=114662100-114664100, Proximal=114664100-114666100; Sγ1: Distal <114568500, 
Middle=114568500-114573500, Proximal=114573500-114578500. Kolmogorov-Smirnov test, 
n.s. p>0.05, * p<0.05, *** p<0.0005.  
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(p=0.036) (Fig. 3-12C and D), suggesting ATM promotes A-EJ mediated end-ligation. Second, 
ATM inhibition altered the orientation-distribution of the S-S junctions (Fig. 3-12E). As noted 
in Figure 3-6A, the bait break at the 3’Sμ can either be joined in the centromere-to-telomere 
orientation (defined as positive, +) or in the telomere-to-centromere orientation (defined as 
negative, -). Since the IgH locus resides in a telomere (5’ IgH) to centromere (3’ IgH) orientation 
on murine chromosome 12 (Fig. 3-A), the productive CSR junctions and the S-S internal 
deletions both fall in the negative orientation (telomere-to-centromere) (Fig. 3-6E, 3-7, 3-8, and 
3-9). Indeed, in control cells, the vast majority of IgH preys (76.1% S, 91.8% S1, and 94.9% 




switch recombination and internal deletion (X. Zhang et al., 2019). Meanwhile, prey breaks on 
other chromosomes (non-Chr12) are evenly distributed between (+) and (–) orientations (Fig. 3-
12F). IgH preys that fall in the positive orientation could arise by true inversional joining (as 
shown in Fig. 3-6A diagram) or through inter-homolog or inter-sister chromatid translocation 
(Crowe et al., 2018b; Panchakshari et al., 2018). Loss of Xrcc4 (CD21CreXrcc4C/CCtIP+/+(C)) 
increased chromosomal translocation and moderately increased the frequencies of positively-
oriented preys (24% to 30% in S-S, 8.2% to 16.5% in S-S1, p=0.016, and 5.1% to 7.1% in 
S-S) (Fig. 3-12E). Further loss of CtIP or CtIP-T855A mutation did not affect the +/- ratio of S 
junctions recovered from Xrcc4-deficient B cells (Fig. 3-12E). In contrast, ATM inhibition 
significantly increased the +/- ratio of S preys in both WT cells and Xrcc4-deficient cells 
(p=0.029, and p=0.036, respectively) (Fig. 3-7 and 3-12E), indicating an important role of ATM 
in promoting orientation-specific joining mediated by either cNHEJ or A-EJ. Taken together, 
these observations confirm a role of Atm in end-resection and also identify a CtIP-independent 
role of ATM in suppressing inter-chromosomal/inter-sister recombination to promote CSR. 
2.5 Earlier Sμ internal deletions tend to use MH-mediated end-joining even in cNHEJ 
proficient cells. 
A-EJ-mediated CSR is thought to be the backup for cNHEJ and occur slower, potentially 
due to the time needed for resection (Han & Yu, 2008). Consistent with the dispensible role of 
26. Figure 3-12: The impact of ATM inhibition on A-EJ mediated CSR. 
(A) Representative flow cytometry of Xrcc4-/- B cells, with or without ATMi (7.5 µM, KU55933), 
at day 4 of stimulation. (B) Quantification of live IgG1+% at day 4 after stimulation, with and 
without 7.5 uM ATMi (KU55933). Two-tailed Mann-Whitney test, ** p<0.01, * p<0.05. (C) The % 
of IgH preys that fall into each Switch region by genotype. (D) The quantification of the fraction 
of Sε preys among all IgH preys.  (E) The ratio of S preys that fall into (-) vs (+) orientation. For 
(B), (C), (D) and (E), the bars and error bars represent average and standard deviations. Two-
tailed Mann-Whitney test, ** p<0.01, * p<0.05 (F) The total number of preys mapped outside of 
Chr12 by orientation ((-) orientation and (+) orientation). There is a similar number of preys that 
fall into each orientation.  
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end-resection in A-EJ mediated CSR, CSR junctions recovered from Xrcc4-/- cells at day 3 or 
day 4 post-stimulation show no difference in MH usage (Fig. 3-13A). Next, we asked whether 
MH-usage changes in a temporal manner in cNHEJ-proficient cells. To our surprise, WT CSR 
junctions harvested at day 3 display moderately higher MH usage than those obtained at day 4 
(Fig. 3-13A). In particular, early S-S events preferentially use MHs (2-15bp) at day 3, followed 
by an accumulation of blunt joints at day 4 (Fig. 3-13B). Meanwhile, MH usage at S-S1 
junctions does not differ significantly between days 3 and 4 (Fig. 3-13B).  
27. Figure 3-13: Early CSR events preferred to use MH-mediated joinings. 
(A) The MH, blunt, and insertion (INS) pattern of all IgH junctions on day 3 or day 4 after 
stimulation. Kolmogorov-Smirnov test, ** p<0.01. (B) The MH, blunt, and insertion (INS) 
distribution of WT S and Sγ1 junctions at day 3 or 4 by switch region (S or Sγ1). Kolmogorov-
Smirnov test, ** p<0.01.  
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As revealed by the Cell Trace Violet (CTV) analyses (Fig. 3-3A), the cells harvested at 
day 4 contain a mixture of B cells with different post-stimulation proliferation histories (from 2 to 
7 cell divisions each). To better understand the kinetics of MH-mediated joining, we sorted the 
cells by cell division according to CTV staining (Fig. 3-14A): group I with 1 or 2 divisions and 
moderate CSR (9.33%±2.90% IgG1+%), group II with 3 divisions (13.9%±2.43% IgG1+%), 
group III with 4 divisions (28.4%±4.56% IgG1+%), and group IV with 5 or more divisions 
(41.8%±3.77% IgG1+%).  As shown in Fig. 3-14A, productive isotype switching steadily 
increased with the number of cell divisions. Correspondingly, the fraction of Sε preys increases 
from 24% in group I to 42% in group IV (Fig. 3-14B), consistent with sequential CSR from S- 
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28. Figure 3-14: CSR junction analyses by cell division. 
(A) Representative CTV labeling analyses of B cells from WT BL6 mice. The IgG1+% of cells 
with the defined number of cell divisions plotted below. The underlines marked the division 
groups used for sequence analyses. Cells with the least divisions were in group I and the most 
divisions in group IV. (B) The relative distribution of IgH preys among different switch regions by 
cell divisions.  The bars and error bars represent average and standard deviations. (C) The MH, 
blunt, and insertion (INS) usage among S preys by cell division. Kolmogorov-Smirnov test, * 
p<0.05, ** p<0.01 (D) The frequency of junctions with 4 or more MH (in Sμ) by cell divisions. 
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S1 first, then to Sε (Tong & Wesemann, 2015). Most notably, MHs larger than 4nt was 
significantly more common in group I + II (22%) than either group III (15%) or group IV (10%) 
cells, while 1nt MHs were rare in group I + II compared to groups III and IV (10%, 17%, 17%, 
respectively) cells (p=0.039 and p=0.0053) (Fig. 3-14C and D). Again, this difference is only 
observed within S-S, but not S-S1, junctions. Collectively, these findings support a model in 
which MH at the repetitive S regions promote cNHEJ mediated internal deletion in the earlier 
phases of CSR.  
3. Discussion 
Immunoglobulin CSR is mediated primarily by cNHEJ. But in cNHEJ-deficient cells, a 
remarkable 25% of CSR can be achieved by the A-EJ repair pathway characterized by 
extensive usage of MHs in the junctions (Yan et al., 2007b). While subsequent studies 
established that, in addition to its lymphocyte-specific role in CSR, the A-EJ pathway can also 
contribute to DSB repair during the DNA damage response in a range of cell types, why CSR is 
particularly prone to robust A-EJ remains elusive. In this context, Bennardo et al. (2008) showed 
that efficient A-EJ of an endonuclease-generated DSB in ES cells requires CtIP, presumably 
reflecting a role for DNA resection in unmasking the flanking MH sequences necessary for A-EJ. 
Using HTGTS, we examined the role of CtIP and end-resection in A-EJ-mediated CSR. In 
contrast to endonuclease-mediated breaks (Bennardo et al., 2008), CtIP is dispensable for A-
EJ-mediated CSR. Indeed, the ability of cNHEJ-deficient naïve splenic B cells to achieve IgG1-
expression was unaffected by either CtIP deletion or a CtIP mutation (T855A).  
What accounts for the different dependence on CtIP by A-EJ mediated repair at 
endonuclease-initiated breaks vs during CSR? Perhaps the difference lies in the unique 
structural and functional features of the switch regions. As these regions are comprised largely 
of repetitive sequences enriched for somatic hypermutation hotspot motifs, AID can generate 
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multiple DSBs within a given S region(Hwang et al., 2015; K. Yu & Lieber, 2019), mitigating the 
need for extensive CtIP-mediated end-resection to expose complementary MHs. Moreover, the 
closely spaced nicks generated by the base excision repair (BER) pathway can lead to staged 
breaks directly or crease the entry point for Exo1 without MRN-CtIP or DNA2(K. Yu & Lieber, 
2019). This notion is supported by the HTGTS analyses, which revealed that A-EJ-mediated 
CSR occurs efficiently with CtIPT855A and ATM inhibition, and maintains a strong skew toward 
longer MH stretches. Accordingly, the role of CtIP in A-EJ may be context-dependent: required 
for general DSB repair by A-EJ in most cell types for a single DSB (Bennardo et al., 2008), but 
dispensable for CSR by A-EJ in B lymphocytes.  
In cNHEJ-deficient cells, but not wild-type cells, a proportion of CSR junctions (e.g., 1-
5%) falls beyond the 3’ boundaries of the core S and S1 regions (Crowe et al., 2018b; Dong 
et al., 2015; Panchakshari et al., 2018).  Using HTGTS, our data provide the unequivocal proof 
that the formation of distal CSR junctions in Xrcc4-deficient cells is indeed achieved by CtIP-
mediated end-resection and significantly reduced by CtIP-deletion, the CtIP-T855A mutation, or 
ATM kinase inhibition. Moreover, the observation that CtIP is required for the generation of CSR 
junctions lying distal to the switch regions but not for junctions in the core switch regions further 
supports the argument that core switch sequences are compatible for A-EJ even without 
additional resections. In addition to the repetitive nature of the switch region, the AID generated 
breaks might contain natural small overhangs. Notably, A-EJ mediated CSR junctions recovered 
from KU-deficient B cells have less long MHs (Boboila, Yan, et al., 2010), suggesting that while 
long MHs promote A-EJ, they are not required for A-EJ mediated CSR. 
By phosphorylating multiple distinct substrates, ATM can influence different aspects of 
CSR beyond end-resection. Using HTGTS analysis together with ATM inhibitor treatment, our 
results indicate that ATM kinase activity regulates the orientation of CSR to promote 
intrachromosomal deletions, including distal Sµ-Sε joins while suppressing non-productive 
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interchromosomal or inter-sister translocations. Interestingly, the ATM-enforced preference for 
intra-chromosomal deletions affects CSR events mediated by either cNHEJ or A-EJ – in both 
cNHEJ proficient and cNHEJ-deficient cells (Fig. 3-12C). While the exact mechanisms remain 
unclear, ATM is known to phosphorylate several chromatin-bound factors, including H2AX and 
53BP1, that have been implicated in establishing and maintaining topologically-associated 
domains (TAD) during CSR (Dong et al., 2015; X. Zhang et al., 2019). Moreover, ATM-
phosphorylated H2AX, and the MDC1 protein that binds phosphorylated H2AX, facilitate the 
lateral spread of DNA damage signals in cis along the chromosome (Savic et al., 2009). Since 
CSR requires germline transcription (A. J. Matthews, Zheng, DiMenna, & Chaudhuri, 2014) and 
ATM facilitates DNA damage-induced transcriptional suppression, ATM may also influence CSR 
patterns by limiting breaks on sister chromatids or homologs (Shanbhag et al., 2010). 
Using a surface dye to monitor cell division after B cell activation, we were able to 
monitor the formation of CSR junctions over time. Interestingly, in both cNHEJ-proficient and 
cNHEJ-deficient cells, we observed that S-Sε switching occurs later than S- S1 switching 
and is preferentially suppressed by either cNHEJ deficiency or ATM inhibition. These findings 
can be potentially explained by the sequential CSRs – first to Sγ1, then to Sε, which would 
predict that two or more DSB repair events are needed to achieve IgE switching (Tong & 
Wesemann, 2015). Moreover, Sε is relatively small (4Kb in the BL6 strain used here) and distal 
from the Sμ. Moreover, we found that short MH (2-14 nt) mediated joining occurs earlier in S-
S even in cNHEJ-proficient cells, suggesting annealing mediated by short MHs might promote 
cNHEJ as well. This finding agrees with the previous in vitro characterization of cNHEJ using a 
plasmid substrate, which showed that cNHEJ can occur efficiently with 1-2 nt and up to 4nt of 
MH (Lieber, 2010).  
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Together, the combination of the CtIP and XRCC4 conditional alleles and HTGTS 
allowed us to uncover several unique features of A-EJ in switch regions and uncovered the 
temporal regulation of CSR at nucleotide resolution. The results explain the robust CSR in both 




Chapter 4: Lack of DNA damage-induced CtIP phosphorylation at T855 delays 
lymphomagenesis in NHEJ/p53-double deficient mice * 
 
* Work described in this chapter is under a prepared manuscript 
Lack of DNA damage-induced CtIP phosphorylation at T855 delays lymphomagenesis in 
NHEJ/p53-double deficient mice 
 
Xiaobin S. Wang1,3, Foon Wu-Baer1, Marco Fangazio1, Stefanie N. Meyer1, Zhengping Shao1, 
Yunyue Wang1, Brian J. Lee1, Olivia M. Cupo1, Jean Gautier1,6, Laura Pasqualucci1.2, Riccardo 
Dalla-Favera1.2.5.6, Richard Baer1,2, and Shan Zha1,2,4,5, 
 
1 Institute for Cancer Genetics, Vagelos College for Physicians and Surgeons, Columbia 
University, New York City, NY 10032 
2 Department of Pathology and Cell Biology, Herbert Irvine Comprehensive Cancer Center, 
Vagelos College for Physicians and Surgeons, Columbia University, New York City, NY 10032 
3 Graduate Program of Pathobiology and Molecular Medicine, Vagelos College for Physicians 
and Surgeons, Columbia University, New York City, NY 10032 
4 Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of 
Pediatrics, Vagelos College for Physicians and Surgeons, Columbia University, New York City, 
NY 10032 
5 Department of Immunology and Microbiology, Vagelos College for Physicians and Surgeons, 
Columbia University, New York City, NY 10032 
6 Department of Genetics and Development, Vagelos College for Physicians and Surgeons, 
Columbia University, New York City, NY 10032 
XW contributed to all the figures except Figure 4-11 A-D  
89 
1. Introduction 
Human B cell lymphomas often carry oncogenic chromosomal translocations involving 
the immunoglobulin (Ig) genes (Nussenzweig & Nussenzweig, 2010), where programmed DSBs 
are generated during the assembly and subsequent modifications of the Ig loci. While the RAG-
generated breaks are exclusively repaired by the cNHEJ pathway during V(D)J recombination 
that assembles the functional Ig genes, Ig heavy chain (IgH) CSR can be completed at up to 25-
50% of the wildtype level in cNHEJ-deficient cells via the alternative-end joining (A-EJ) pathway 
that preferentially uses micro homologies (MHs) at the junctions (Boboila, Yan, et al., 2010; 
Crowe et al., 2018a; Crowe et al., 2020; X. S. Wang, Zhao, et al., 2020; Yan et al., 2007a). DNA 
end-resection, the selective removal of 5’ strands around a DSB to generate the 3’ single-strand 
DNA overhang (Symington & Gautier, 2011), promotes A-EJ by exposing the MHs flanking a 
DNA double-strand breaks. The C-terminal binding protein (CtBP)–interacting protein (CtIP) and 
its yeast ortholog Sae2 initiated DNA end-resection together with the MRE11-RAD50-NBS1 
(MRN) complex (Sartori et al., 2007) and was implicated in A-EJ-mediated chromosomal 
translocations in reporter systems (Bennardo et al., 2008). CtIP expression and protein levels 
are cell-cycle-regulated, higher in S and G2 phases, and low in the G1 phase (Limbo et al., 
2007; X. Yu & Baer, 2000). Like the MRN complex, CtIP is essential for murine embryonic 
development (P. L. Chen et al., 2005) and the proliferation of normal lymphocytes (X. Liu et al., 
2019; X. S. Wang, Zhao, et al., 2020), rendering it impossible to examine the role of CtIP during 
oncogenesis using the null or conditional-null alleles. CtIP is phosphorylated by CDK at T847 in 
S and G2 phases of the cell cycle (Huertas et al., 2008) and by ATM and ATR kinases at T859 
(T855 in mouse) and other sites upon DNA damage (Makharashvili et al., 2014; Peterson et al., 
2012; H. Wang et al., 2014; H. Wang et al., 2013). While T847 phosphorylation of CtIP is 
essential for murine development (Polato et al., 2014), mice carrying an alanine substitution at 
T855 phosphorylation site of CtIP (CtIPA) develop normally with mild end-resection defects (X. 
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Liu et al., 2019). Moreover, lymphocyte development and lymphocyte proliferation are not 
affected in CtIPA/A mice (X. Liu et al., 2019; X. S. Wang, Zhao, et al., 2020).  
In addition to supporting CSR, the A-EJ pathway also promotes chromosomal 
translocation. CtIP has been implicated in A-EJ mediated chromosomal translocations using 
reporter system (Boboila, Jankovic, et al., 2010; Y. Zhang & Jasin, 2010). But due to the 
essential role of CtIP in murine development, whether CtIP mediated end-resection has any role 
in oncogenic chromosomal translocation remains elusive. In this context, almost all cNHEJ/Tp53 
double deficient mice succumbed to pro-B cell lymphomas with IgH-Myc translocations and co-
amplification (Rooney et al., 2004a; X. S. Wang, Lee, & Zha, 2020; Zhu et al., 2002). Moreover, 
the translocation junctions recovered from Myc-overexpressing lymphomas routinely have long 
MHs (Rooney et al., 2004a; Zhu et al., 2002), providing an ideal system to examine the role of 
A-EJ and CtIP-mediated DNA-end-resection in lymphomagenesis. Mechanistically, the initial 
translocation joins an accumulated unrepaired DSB at RAG1/2-catalyzed IgH locus with 
sequences downstream of c-Myc oncogene to form a dicentric (15;12) chromosome in Xrcc4-
deficient lymphocytes (Zhu et al., 2002). In the proceeding anaphase, the dicentric intermediate 
breaks. The genomic fragment contains the IgH-Myc translocation joined with its sister to form a 
new dicentric chromosome to initiate the breakage-fusion-bridge (BFB) cycle (Figure 4-1), which 
eventually leads to gene amplification (Nussenzweig & Nussenzweig, 2010; Zhu et al., 2002). 
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Since this occurs in cNHEJ-deficient cells, both the initial translocation and the dicentric 
formation are mediated by the A-EJ pathway. Moreover, a permissive cell cycle environment 
(e.g., Tp53 deficiency) is necessary to tolerant the genomic instability and the subsequent 
overexpression of Myc oncogene. In addition to Xrcc4/Tp53 mice, other cNHEJ/p53 deficient 
models, including end-processing defective Artemis- deficient and DNA-PKcs-deficient mice, 
also develop pro-B cell lymphomas with Ig-Myc co-amplification (Gao, Sun, et al., 1998; Nacht 
et al., 1996; Rooney et al., 2004a; Vanasse et al., 1999), although the exact organization of 
amplicons remains undetermined. In addition to the experimental pro-B cell lymphoma models 
described here, BFB also serves as a general model for oncogenic co-amplicon formation that 
underlies tumor-initiation and drug resistance in human cancers (Shoshani et al., 2020; Tanaka 
& Watanabe, 2020). 
29.Figure 4-1: Diagram of Breakage-fusion-bridge (BFB) cycles. 
Simplified diagram representing the formation of IgH-Myc translocation through Breakage-
fusion-bridge (BFB) cycles. 
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In this study, we examine how CtIP-mediated resection contributes to A-EJ mediated 
lymphomagenesis by characterizing cNHEJ/Tp53- double deficient mice with or without CtIP-
T855A mutation. We found that CtIP-T855A mutation does not affect the embryonic 
development of Xrcc4-/-Tp53-/- mice, but all the CtIPA/AXrcc4-/-Tp53-/- mice died by three weeks 
without any sign of lymphoma. Flow cytometry and histology analyses of CtIPA/AXrcc4-/-Tp53-/-  
mice suggest that T855A mutation does not further compromise hematopoiesis but induced a 
mild yet consistent G2/M arrest in the olfactory neurons in the CtIPA/AXrcc4-/-Tp53-/- mice, 
suggesting a role of CtIP in resolving replication errors in Xrcc4-deficient cells. Moreover, CtIP-
T855A mutation delayed the lymphomagenesis and changed the tumor spectrum of the DNA-
PKcs-/-Tp53-/- mice. High-throughput sequencing analyses of junctions involving RAG- and 
endonuclease-generated DSBs showed that CtIP T855 phosphorylation is not required for 
hairpin opening and initiation of end-resection but promotes extensive end-resection. Moreover, 
we found that CtIPA/A cells show defects in maintaining the DNA damage-induced G2/M 
checkpoints. Correspondingly, CtIP-T855A mutation delays Myc-induced lymphomagenesis in 
the λ-Myc model, suggesting a role of CtIP during lymphomagenesis beyond chromosomal 
translocation.  
2. Results 
2.1 CtIP-T855A mutation causes early lethality in Xrcc4-/-Tp53-/- mice 
To elucidate the physiological functions of CtIP phosphorylation and DNA end-resection 
in lymphomagenesis, we introduced the CtIP-T855A mutation (CtIPA/A) into Xrcc4-/-Tp53-/- mice, 
which routinely succumbed to pro-B cell lymphomas with A-EJ mediated IgH-Myc translocations 
(Zhu et al., 2002). Xrcc4-/-Tp53-/- and Xrcc4-/-Tp53+/- mice were small and born at reduced rates 
(Gao, Sun, et al., 1998), and CtIP-T855A mutation did not further reduce the weight or the birth 
rate of Xrcc4-/-Tp53-/- mice (Fig. 4-2A, and B). However, all CtIPA/AXrcc4-/-Tp53-/- (n=6) and 
CtIPA/AXrcc4-/-Tp53+/- mice (n=5) mice died by 21 days of age without any sign of lymphomas. 
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Meanwhile, all Xrcc4-/-Tp53-/- mice succumbed to B220+IgM-CD43+ pro-B cell lymphoma by ~10 
weeks of age as described before (Fig. 4-2C and D) (Gao, Sun, et al., 1998; Zhu et al., 2002). 
The frequency of red blood cells, platelets, and hematopoietic stem and progenitor cells (HSPC, 
Lin-Scal+cKit+) are comparable between CtIPA/AXrcc4-/-Tp53-/- mice and the viable Xrcc4-/-Tp53-/- 
mice (Fig. 4-2 E-I), excluding anemia and bone marrow failure as the sole reason for the 
neonatal lethality.  
Loss of Xrcc4 induces p53-dependent post-mitotic neuronal apoptosis, so then we 
examined whether CtIP-T855A mutation compromised neuronal development. In mice, 
neurogenesis in the olfactory bulb continues after birth (Brann & Firestein, 2014). CtIPA/A does 
not affect the proliferation index (Ki67+% Fig. 4-3A) and the apoptotic rate (cleavage Caspase 3 
staining, Fig. 4-3B) of the Xrcc4-/-Tp53-/- olfactory neurons. In this course, we noted that both 
Xrcc4-/- Tp53-/- and the CtIPA/AXrcc4-/-Tp53-/- mice accumulated large dark nuclei in olfactory 
bulbs (Fig. 4-3C), consistent with potential G2 arrest and replication stress. Indeed, the mitotic 
nuclei (positive for phosphorylated Serine 10 of Histone H3, pH3+) reduced in Xrcc4-/-Tp53-/- 
mice (p=0.0021) and further reduced in CtIPA/AXrcc4-/-Tp53-/- mice (p<0.001 vs. WT, and 
p=0.044 vs. Xrcc4-/-Tp53-/-) (Fig. 4-3D). There are three types of pH3 staining pattern: small 
puncta without pan-nuclear staining (purple, type I, late G2 phase), large nucleoli puncta with 
diffused nuclear stained (blue, type II, early M phase/prophase), and condense dark staining 
(red, type III, M phase) (Fig. 4-3E). T855A mutation markedly reduced the frequency of type II 
and type III (mitosis, p<0.0001) nuclei in Xrcc4-/- Tp53-/- mice, suggesting G2/M arrest (Fig. 4-
3F). Taken together, the results show that DNA damage-induced CtIP phosphorylation at T855 




2.2 CtIPA mutation delayed the lymphomagenesis in DNA-PKcs-/- Tp53-/- mice 
To study the impact of CtIPA mutation on lymphomagenesis and circumvent the neonatal 
lethality, we introduced the CtIP-T855A mutation into the DNA-PKcs-/-Tp53-/- mice that also 
develop spontaneous pro-B cell lymphomas (Jhappan, Morse, Fleischmann, Gottesman, & 
Merlino, 1997; Kurimasa et al., 1999; Nacht et al., 1996). CtIP-T855A mutation did not affect the 
birth rate and embryonic development of DNA-PKcs-/-Tp53-/- mice (Fig. 4-4A). Yet, CtIPA/A 
mutation moderately extended the overall survival of DNA-PKcs-/-Tp53-/- (Fig. 4-4B). Specifically, 
the CtIP-T855A mutation reduced the frequency (from 94% to 68%) and extended latency (T1/2 
from 73 days to 89 days) of pro-B cell lymphomas (B220+IgM-CD43+) in DNA-PKcs-/-Tp53-/- 
mice (Fig. 4-4 C and D, 4-5A). While 94% (31 out of 33) DNA-PKcs-/-Tp53-/- mice developed pro-
B cell lymphomas, only 68% (17/25) of CtIPA/ADNA-PKcs-/-Tp53-/- mice developed pro-B cell 
lymphomas, including 3 with concurrent immature thymic lymphomas (CD3lowsTCRneg) (Fig. 4-
4D and 4-5B). The rest (n=8) of the CtIPA/ADNA-PKcs-/-Tp53-/- mice succumbed to thymic 
lymphomas (n=5), teratomas (n=2) or sarcoma (n=1) (Fig. 4-4C). The oncogenic translocations 
30. Figure 4-2: Bone marrow defects or anemia do not explain the early death of CtIPA/A 
Xrcc4-/-Tp53-/- mice.  
(A) The number of mice born from intercrossing between Xrcc4+/- mice. The p-value was 
calculated with the chi-square test. (B) Bodyweight of CtIP A/AXrcc4-/-Tp53-/-, Xrcc4-/-Tp53-/-, and 
littermate controls on 8 days or 20 days. Unpaired T-test, ns, not significant. (C) Kaplan-Meier 
survival curve of CtIP A/AXrcc4-/-Tp53-/-, CtIP A/AXrcc4-/-Tp53+/-, and Xrcc4-/-Tp53-/- controls. Log-
rank (Mantel-Cox) test, **** p<0.0001; ns, not significant. (D) Representative flow cytometry 
analyses of enlarged spleen from Xrcc4-/-Tp53-/- mouse with B220+ clonal expansion and 
wildtype control. (E) The concentration of red blood cells (RBC) in the peripheral blood of 16-19 
days CtIP A/AXrcc4-/-Tp53-/-, Xrcc4-/-Tp53-/-, and wildtype controls. (F) Quantifications of bone 
marrow hematopoietic stem cell (Lin−SCA1+c-KIT+) absolute counts (G) The concentration of 
platelets in the peripheral blood of 16-19 days CtIP A/AXrcc4-/-Tp53-/-, Xrcc4-/-Tp53-/-, and wildtype 
controls. (H) Representative flow cytometry analyses of bone marrow RBCs from 16-19 days old 
CtIP A/AXrcc4-/-Tp53-/-, Xrcc4-/-Tp53-/-, and Tp53+/- control. The different stages of RBCs 
development were distinguished by CD71 and TER119 staining. The TER119+ population is 
projected to forward scatter on the side. (I) Flow cytometry analyses of bone marrow 
hematopoietic stem cell (Lin−SCA1+c-KIT+) and megakaryocytes and erythroid progenitors 
from the same groups mentioned above.  
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in the DNA-PKcs-/-Tp53-/- pro-B cell lymphomas were not fully characterized as those in Xrcc4-/-
Tp53-/- mice (Zhu et al., 2002). Using fluorescent in situ hybridization (FISH) and probes specific 
for the IgH (chr.12) and c-Myc (Chr. 15) (Gostissa et al., 2009), we found that 4/4 DNA-PKcs-/-
Tp53-/- and 4/5 CtIPA/ADNA-PKcs-/-Tp53-/- pro-B cell lymphomas contained clonal IgH-Myc 





32. Figure 4-3: Analyses of olfactory neurons from 16 days old CtIPA/AXrcc4-/-Tp53-/-, 
Xrcc4-/-Tp53-/-, and Xrcc4+/+ controls. 
(A) Frequencies of proliferative cells with positive Ki67 staining. (B) Frequency of apoptotic cells 
with positive cleaved Caspase 3 staining. (C) Top panel, representative histological analyses of 
sagittal brain sectioning, enlarged cells with darkly stained nuclei are pointed with orange 
arrows. (D) Frequency of pH3 positive cells. (E) Example picture illustrating different patterns of 
positive pH3 signal corresponding to different cell stages. (F) Frequency of G2M and M phase 
cells quantified by positive pH3 signal. Quantifications shown in A, B, D, and F were done from 
5 WT, 4 Xrcc4-/-Tp53-/-, and 3 Ctip A/AXrcc4-/-Tp53-/- mice, at least seven independent fields from 
each mouse.  
31. Figure 4-4: CtIPA mutation delayed IgH-Myc driven pro-B cell lymphomas and altered 
tumor spectrum in DNA-PKcs-/-Tp53-/- mice.  
(A) The number of mice born from intercrossing between DNA-PKcs+/- mice. The p-value was 
calculated with the chi-square test. (B) Kaplan-Meier survival curve of DNA-PKcs-/-Tp53-/- and 
CtIPA/ADNA-PKcs-/-Tp53-/- mice, the median overall survival of DNA-PKcs-/-Tp53-/- mice is 73 
days, 80 days for CtIPA/ADNA-PKcs-/-Tp53-/- mice. Log-rank (Mantel-Cox) test, * p<0.05. (C) 
Kaplan-Meier survival curve of DNA-PKcs-/-Tp53-/- and CtIPA/ADNA-PKcs-/-Tp53-/- mice, the pro-B 
cell lymphoma only median survival of DNA-PKcs-/-Tp53-/- mice is 73 days, and 89 days for 
CtIPA/ADNA-PKcs-/-Tp53-/- mice. Log-rank (Mantel-Cox) test, ** p<0.01. (D) Tumor spectrum of 
DNA-PKcs-/-Tp53-/- and CtIPA/ADNA-PKcs-/-Tp53-/- mice.  
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older CtIPA/ADNA-PKcs-/-Tp53-/- mouse (143 days) with concurrent thymic lymphomas processed 
an IgH-Myc translocation pattern consistent with a dicentric intermediate and minor amplification 
(Fig. 4-5C, lower right panel). These data indicated that IgH-Myc translocation and co-
33. Figure 4-5: Characterization of tumors found in CtIPA/A DNA-PKcs-/-Tp53-/- mice.  
(A) Representative flow cytometry analysis of BM from DNA-PKcs-/-Tp53-/- and CtIPA/ADNA-
PKcs-/-Tp53-/- mice that were analyzed with a sign of tumor growth or discomfort. (B) 
Representative flow cytometry analyses of enlarged thymus from CtIPA/A DNA-PKcs-/-Tp53-/- 
mice. (C) Representative FISH images, from wildtype control samples (upper left), IgH-Myc 
translocations and amplifications in splenic lymphoma cells from DNA-PKcs-/-Tp53-/- mice (lower 
left), and two splenic cells from CtIPA/ADNA-PKcs-/-Tp53-/- mice with IgH-Myc co-amplification 
(upper right), or co-localization but less amplification (lower right). (D) Quantifications and 
breakdowns of FISH analyses. Collective information of 4 DNA-PKcs-/-Tp53-/- tumor samples 
and 5 CtIPA/ADNA-PKcs-/-Tp53-/- tumor samples harvested for FISH analysis, including the 
number of metaphases counted for each sample and the number and percentage of 
metaphases with co-localization and co-amplification of IgH-Myc signal.  
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amplification drove lymphomagenesis in DNA-PKcs-/-Tp53-/- mice, and CtIP-T855A mutation 
delays the pro-B cell lymphomagenesis in DNA-PKcs-/-Tp53-/- mice in part by suppressing IgH-
Myc co-amplification.   
2.3 T855 phosphorylation promotes end-resection and is dispensable for CE hairpin 
opening. 
To understand how CtIP-T855A mutation delays the pro-B cell lymphomagenesis, we 
examined the impact of T855A mutation on the translocation initial and amplification. For the 
IgH-Myc translocation to form, the coding ends (CEs) hairpins at the IgH loci of the DNA-PKcs-
deficient B cells have to be opened (W. Jiang et al., 2015; Y. Ma et al., 2002). CtIP and its yeast 
ortholog Sae2 have been implicated in the hairpin opening (X. Liu et al., 2019; Oh & Symington, 
2018; Trujillo & Sung, 2001; W. Wang, Daley, Kwon, Krasner, & Sung, 2017). To determine 
whether CtIP-T855 phosphorylation affects hairpin opening, we derived v-abl kinase 
transformed DNA-PKcs-/-Tp53-/-and CtIPA/ADNA-PKcs-/-Tp53-/- B cells and introduced the 
integrated V(D)J recombination substrate (pMX-INV) into them (Fig. 4-6A) (Bredemeyer et al., 
2006; W. Jiang et al., 2015; B. S. Lee et al., 2013). In these cells, v-abl kinase inhibitor, STI571 
(also called imatinib) induced efficient G1 cell cycle arrest (Fig. 4-6 B and C) and RAG initiated 
cleavage of the pMX-INV substrate (Bredemeyer et al., 2006) (Fig. 4-6A). Since CtIP protein 
level and end-resection activity increase significantly in S and G2 phases of the cell cycle 
(Limbo et al., 2007; X. Yu & Baer, 2000), we included two conditions in which the cells were 
released (wash away STI571) to the S/G2 phase after 12 hours (b) or 24 hours (c) of G1 arrest 
(Fig. 4-6 B and C). To prevent the cells from entering mitotic and the subsequent cell cycles, we 
applied a CDK1 inhibitor – Ro3306 to block mitosis (Fig. 4-6C). The effective release and G2 
arrested were validated by flow cytometry analyses (Fig. 4-6B). Unrepaired CEs accumulated in 
G1 arrested (a) DNA-PKcs-/-Tp53-/-and CtIPA/ADNA-PKcs-/-Tp53-/- cells and reduced in the cells 
released to S/G2, regardless of the CtIP genotype (Fig. 4-6D). While ligation-mediated PCR can 
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readily detect opened CEs in Xrcc4-/-Tp53-/- cells, CEs from G1 arrested or released DNA-PKcs-
/-Tp53-/- and CtIPA/ADNA-PKcs-/-Tp53-/- cells cannot be readily amplified even after release to 
S/G2 (Fig. 4-6E).  
To recover and compare the pattern of hairpin opening in DNA-PKcs-/-Tp53-/- and 
CtIPA/ADNA-PKcs-/-Tp53-/- cells, we adapted the High Throughput Genome-wide Translocation 
Sequencing (HTGTS) method (Hu et al., 2016). HTGTS is a linear-amplification-based 
sequencing method that can characterize junctions involving a specific DSB (referred to as the 
bait break). In this case, we chose the 5' CE of the pMX-INV as the bait break. In WT and 
CtIPA/A cells, > 80% junctions involving the 5' CEs are within the pMX-INV V(D)J recombination  
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34. Figure 4-6: CtIPA mutation contributes to hairpin processing in DNA-PKcs-/- cells. 
(A) Schematic of pMX-INV substrate including the unrearranged substrate (UR) and hairpin-
sealed coding ends (CE). The recombination signal sequence (triangle) and CD4 probe are 
indicated as well. The opened hairpin structure can be detected by TdT-assisted PCR assay, I4 
oligo probe is indicated. Specifically, the TdT enzyme can add a poly(A) tail to the opened 
hairpin ends, which can be amplified with primers containing poly(T) sequence. (B) 
Representative cell cycle analyses of PI-stained samples from the asynchronized controls, G1 
arrest via STI571 treatment for 72 hours (a), STI571 treated for 12 hours (b) or 24 hours (c) to 
induce RAG expression and release to S/G2 phase with CDK1 inhibitor (Ro3306) for 48 hours.  
(C) Workflow for experimental conditions used in C-G: v-abl-transformed B cells were arrested in 
G1 via STI571 treatment for 72 hours (a), STI571 treated for 12 hours (b) or 24 hours (c) to 
induce RAG expression and release to S/G2 phase with CDK1 inhibitor (Ro3306) for 48 hours. 
(D) Southern blot analyses of pMX-INV substrates from the time points (a, b, c) described in 
(A&B). UR, un-rearranged, CE, coding ends, o: asynchronized. (E) Product of TdT-assisted PCR 




substrate (Fig. 4-7A), and 75-80% are classical CJs with the 3' CEs (Fig. 4-7B). Consistent with 
hairpin opening defects and increased chromosomal translocations, in DNA-PKcs-/- and 
CtIPA/ADNA-PKcs-/- cells, only < 40% of the junctions fall into the pMX-INV substrate (Fig. 4-7A). 
Nevertheless, more than 70% of junctions within the pMX-INV are still the 3'CEs with a 
moderate increase (3% to 5-8%) of inversions or hybrid join formation (with the SEs) (Fig. 4-7B). 
Moreover, the CJ recovered from both DNA-PKcs-/- and in CtIPA/ADNA-PKcs-/- cells have much 
longer deletions than those from WT and CtIPA/A cells (Fig. 4-7C). CtIPA slightly reduced the 
frequency of very long deletions (> 50bp) in DNA-PKcs-/- cells. Next, we asked whether CtIPA 
affected hairpin opening in DNA-PKcs-/- cells by examining the 5'CEs recovered from the 
junctions. In WT and CtIPA/A cells, ~70% of the hairpin opened at or around the apex (-2 to 4bp), 
regardless of whether the cells were arrested in G1 (Fig. 4-8A) or released to S/G2 (Fig. 4-8B). 
This pattern is consistent with the preferred cleavage sites of Artemis endonuclease in vitro (Y. 
Ma et al., 2002; Pannicke et al., 2004). The junction spread broadly in DNA-PKcs-/- cells, 
consistent with endonuclease cleavage by MRN or DNA2 and T855A mutation limited the 
spread, especially in G2 arrested cells (Fig. 4-8A and B). The presence of T855A mutation did 
not affect the spreading to the flanking region (Fig. 4-8A and B), yet partially restored the peak 
at the first bp of the hairpin end (Fig. 4-8B bottom). As an S-phase expressed protein, samples 
without the S phase release step did not show obvious restoration of the first bp peak (Fig. 4-
35. Figure 4-7: CtIPA mutation does not affect proper repair products from RAG-
generated breaks. 
(A) Frequency of recovered HTGTS junctions mapped to within pMX-INV substrate or 
elsewhere in the genome (Others) from one G1 arrested sample (STI) and two independent 
repeats of G1 arrested, and S/G2 released samples (STI CDK1). (B) Relative frequency of 
preys within the pMX-INV substrate in DNA-PKcs+/+, CtIPA/A, DNA-PKcs-/-, and CtIPA/ADNA-
PKcs-/- cells, with black traces indicating preys aligned to the + strand and grey traces indicating 
preys aligned to the – strand. The frequencies of preys that fall into the 3’CE region (black, CJ) 
or 5’SE (grey, HJ) were indicated on each graph. (C) Frequency of CJ deletion length by 
combining two independent repeats. The deletion length was measured by the distance 
between bait end location and 5’CE location plus the distance between prey start location and 
3’CE location.  
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8A). Together, these data suggested that CtIP-T855 phosphorylation is not required for end-
resection but may play a role in the progression of the resection. Accordingly, meiosis 
recombination and spermatogenesis that required the endonuclease cleavage of Spo11 
covalent complex by MRN-CtIP is not blocked by the CtIPA mutation (Fig. 4-8C).  
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36. Figure 4-8: CtIPA mutation does not affect end-resection initiation. 
(A) Schematic of pMX-INV substrate for V(D)J recombination (top panel), the black arrow 
indicating the bait PCR primer starting position. The footprint of hairpin-sealed coding ends 
opening in the G1 phase, showing as the relative frequencies of the last aligned base pair on 
the bait end of the junctions with translocation patterns within the substrate. (B) Top panel: 
schematic diagram of pMX-INV substrate for V(D)J recombination with coordinates of RSSs, the 
black arrow indicating the bait PCR primer starting position. Middle panel: The footprint of 
hairpin-sealed coding ends opening in the S/G2 phase, showing as the relative frequencies of 
the last aligned base pair on the bait end of the junctions with translocation patterns within the 
substrate. Bottom panel: diagrams of aligned base-pair locations and sequence at the coding 
end, zoom-in frequency of the adjacent 12 base pairs around the opened hairpin end. (C) 
Representative histological analyses on testis from CtIP+/+, DNA-PKcs-/-Tp53-/-, and CtIPA/ADNA-
PKcs-/-Tp53-/- mice, showing normal spermatogenesis. 
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2.4 T855 phosphorylation is dispensable for inter-sister joining 
The next step of the BFB cycle is the dicentric chromosome formation that precedes the 
gene amplification (Zhu et al., 2002). Concurrent breaks at two sister chromatids could be joined 
together to form a dicentric chromosome. In this context, we asked whether CtIP-T855 mutation 
affects sister chromatid fusion. Specifically, we transduced the v-abl cells with an inducible I-
PpoI endonuclease (Fig. 4-9A), which have 19 predicted cleavage sites in the mouse mm10 
genome (X. Li & Tyler, 2016), then performed HTGTS using the cleavage site No.10 on 
chromosome 5 as the bait break. In WT cells, ~10% of the joining occurs within the four bp 
overhang generated by I-PpoI (Fig. 4-9B). Consistent with cNHEJ-deficiency, <1% of the local 
junctions recovered from DNA-PKcs-deficient cells utilized the overhangs (Fig. 4-9B). Joining 
between sisters or with homologous chromosomes could generate a negative-strand junction 
(Fig. 4-9A, grey arrowheads), which increased in relative frequency in DNA-PKcs-deficient cells 
(Fig. 4-9B). CtIP-T855A mutation did not reduce the frequency of the negative strand joining in 
DNA-PKcs-deficient cells, suggesting T855A mutation is compatible with dicentric chromosomal 
formation. Given the overhang, most junctions recovered from WT or DNA-PKcs-deficient cells 
utilized 0-3 bp MH regardless of CtIP genotypes (Fig. 4-10).  
2.5 T855 phosphorylation of CtIP plays a role in G2/M checkpoint maintenance  
In addition to A-EJ, CtIP and Sae2, namely the Mec1 phosphorylation of Sae2, have 
also been implicated in checkpoint control (H. Chen et al., 2015; Oh & Symington, 2018; 
Symington & Gautier, 2011). Specifically, extensive resection by CtIP/MRN complex converts 
DSBs that usually activate ATM kinase to extensive ssDNA that activates ATR kinase (Shiotani 
& Zou, 2009). Given the relatively moderate effect of T855A mutation in hairpin opening and the 
repair products, we asked whether T855 phosphorylation plays a role in ionizing radiation (IR) 
induced cell cycle checkpoint using BrdU labeling cell cycle analysis. To distinguish the mitotic 
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cells from G2 cells, we co-stained the samples with the mitotic marker – pH3.  Before IR, WT 
and CtIPA/A B cells showed similar cell cycle distribution (Fig. 4-11A). Three Gy IR induced 
robust G2/M arrested in both WT and CtIPA/A B cells at 1 hour, but at 2 hours after IR, CtIPA/A B 
cells started to enter mitosis while the WT B cells maintained G2 arrest (Fig. 4-11A, B), 
suggesting that CtIP T855 phosphorylation might play a role in checkpoint maintenance. 
Western blotting analyses of irradiated WT and CtIPA/A cells showed reduced phosphorylation of 
ATR substrate – Chk1 and hyper-phosphorylation of ATM kinase substrates – Kap1, Chk2, and 
Histone H2AX in CtIPA/A cells (Fig. 4-11C). Consistent with reduced end-resection as the cause 
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of damped ATR kinase activity, the marker for ssDNA – phosphorylated RPA (T21) was also 
attenuated in IR-treated CtIPA/A cells (Fig. 4-11C). Based on these data, we  
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propose that CtIP phosphorylation at T855 promotes end-resection and the transition from ATM 
to ATR activation and the maintenance of the G2/M checkpoint. 
38. Figure 4-9: CtIPA mutation does not alter endonuclease-generated DSBs. 
(A) Schematic of translocations from I-PpoI-generated breaks, joining directions indicated with 
dashed arrows. (B) Relative distribution of local preys within + and – 200 bp from the cutting site 
in DNA-PKcs-/-Tp53-/-, and CtIPA/ADNA-PKcs-/-Tp53-/- v-abl-transformed B cells after 24 hours I-
PpoI induction in G1 phase or S/G2 phase. The frequencies of prey that fall into each region are 
indicated on each graph. With black traces indicating preys aligned to the + strand and grey 
traces indicating preys aligned to the – strand. Left arrow, -200 bp to -3 bp; middle square, -2 bp 
to +2 bp sticky ends from enzyme cutting; right arrow, +3 bp to +200 bp. 
37. Figure 4-10: CtIPA mutation does not alter the MH usage at I-PpoI-induced 
translocations. 
The microhomology usage or insertions found in the G1 phase (A) or S/G2 phase (B) among 
the junctions plotted in Figure 4-8B. Kolmogorov–Smirnov test, * p<0.05, ** p<0.01, **** 




2.6 CtIPA mutation delays MYC-driven lymphomagenesis  
Next, we asked whether CtIP and its phosphorylation at T855 have a role in 
lymphomagenesis beyond translocation-driven using the Burkitt Lymphoma λ-Myc transgenic 
model (Kovalchuk et al., 2000) that develop spontaneous Myc-driven lymphomas. First, we 
somatically inactivated CtIP in B cells from Myc+ mice using CD19Cre (Rickert, Roes, & 
Rajewsky, 1997) and the CtIP conditional allele (Polato et al., 2014). Unexpectedly, no 
difference in overall survival, spleen weight, or immune phenotypes were noted among the 
λMyc+ mice regardless their CtIP genotypes (CD19Cre+CtIP+/+, CD19Cre+CtIPC/+, or 
CD19Cre+CtIPC/C) (Fig. 4-12 A-D). Although CtIP was efficiently inactivated in the tumors arisen 
from CD19Cre+CtIPC/+ mice (T2-T4), lymphomas from CD19Cre+CtIPC/C mice retained 
significant CtIPC alleles (Fig. 4-12E).  Thus, we tested whether germline CtIP T855A mutation 
affects Myc-driven lymphomagenesis using CtIPA/Aλ-Myc+ and control λ-Myc+ mice.  At 100-day 
of age, 73% (8/11) λ-Myc+ mice have splenomegaly defined as spleen/body weight ratio > 
99.7% CI of those of Ctrl WT mice (Fig. 4-13A). Meanwhile, only 20% (2/10) CtIPA/Aλ-Myc+ mice 
developed splenomegaly at the same age (Fig. 4-13A). Flow cytometry analyses revealed 82% 
of λ-Myc+ mice showed B cell blasts in the spleen, in contrast to 33% in CtIPA/Aλ-Myc+ mice (Fig. 
4-13B-C). These data support the role of CtIP T855 phosphorylation in supporting Myc-driven 
lymphomagenesis beyond translocation.  
39. Figure 4-11: Phosphorylation of CtIP at T855 contributes to G2/M checkpoint 
maintenance. 
(A) Representative flow cytometry analyses of cell cycle distribution with BrdU/PI staining and 
the percentage of pHistone3 Ser10 positive population within BrdU-G2/M subpopulations in 
CtIP+/+ and CtIPA/A primary B cells before and recovery after 3 Gy IR at 1 hour, 2 hours, and 24 
hours. (B) Quantifications of positive pHistone3 Ser10 percentage within BrdU-G2/M populations 
from five independent experiments. Paired T test, * p<0.05. (C) Western blotting analyses of 
CtIP+/+ and CtIPA/A primary B cells before or after IR 3 Gy. LE: light exposure, DE: dark exposure 
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40. Figure 4-12: CtIP inactivation with CD19cre is dispensable for Myc-driven 
lymphomagenesis. 
(A) Kaplan-Meier survival curve for CD19cre+ λ-Myc+ Ctip+/+ (WT), CD19cre+ λ-Myc+ Ctip+/C 
(HET), and CD19cre+ λ-Myc+ CtipC/C (KO) mice. (B) Percentage of spleen weight (g)/ body 
weight (g) among WT, HET, and KO groups and wildtype λ-Myc- control. Mann Whitney test, ** 
p<0.01. (C) Tumor spectrum among WT, HET, and KO groups. (D) Representative flow 
cytometry analyses of enlarged spleen samples from WT, HET, and KO groups. (E) 





The molecular process of the A-EJ pathway and the related MH-mediated end-joining 
(MMEJ) pathway has been extensively studied and has been widely implicated in chromosomal 
translocations. CtIP promotes end-resection, a critical step in the repair pathway choice 
between A-EJ and cNHEJ. In this study, we tried to dissect how the DNA damage-induced CtIP 
41. Figure 4-13: CtIPA mutation delays lymphomagenesis in the λ-Myc mouse model. 
(A) Per-mille Spleen weight (g)/ body weight (g) among WT Ctrl (n=9), λ-Myc+ (n=11), and 
CtIPA/Aλ-Myc+ (n=10) mice. 99.7% CI calculated from the WT Ctrl group is marked on the graph. 
(B) Representative flow cytometry analyses of spleen samples, enlarged or normal size from all 
three groups. (C) Percentage of enlarged splenic B cells, calculated using the percentage of 
B220+ splenic cells multiplied by the percentage of the gate with the largest size (indicated in 
B). 99.7% CI calculated from the WT Ctrl group is marked on the graph. 
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T855 phosphorylation affects A-EJ mediated oncogenic chromosomal translocation in vivo. 
Unexpectedly, we found that although dispensable for normal murine development, T855 
phosphorylation is essential for neonatal development of Xrcc4-/- Tp53-/- mice and delays IgH-
Myc driven lymphomagenesis in DNA-PKcs-/- Tp53-/- mice. While we initially thought that CtIP 
T855 phosphorylation promotes lymphomagenesis via chromosomal translocations, we failed to 
find consistent and measurable defects in the hairpin opening, sister-chromatid ligation, and 
junctional feature changes in CtIPA/ADNA-PKcs-/- Tp53-/- cells in comparison to DNA-PKcs-/- 
Tp53-/- controls. Moreover, we noted that B cell lymphomas that arose in CtIPA/ADNA-PKcs-/- 
Tp53-/- mice carried the signature IgH-Myc translocation and co-amplification, suggesting CtIPA/A 
did not prevent the initial translocations and the co-amplification. Indeed, using HTGTS, we 
documented moderately reduced end-resection and a bias in hairpin opening position in 
CtIPA/ADNA-PKcs-/- cells, but the overall frequency and pattern of DSB repair at the RAG 
generated breaks or endonuclease generated breaks did not alter fundamentally.  
Meanwhile, we note that CtIPA/A B cells display defects in maintaining IR-induced cell 
cycle arrest, and CtIPA/AXrcc4-/-Tp53-/- olfactory neurons accumulate enlarged cells, implying 
defects in resolving replication stress. In earlier studies, we and others have found that CtIP 
promotes end-resection at DSBs accumulated in cNHEJ-deficient cells (Helmink et al., 2011; X. 
S. Wang, Zhao, et al., 2020), which might explain why Xrcc4-/-Tp53-/- cells and mice are 
hypersensitive to CtIP defects. This need for CtIP in end-resection is in part due to the presence 
of KU, which prevents Exo1 mediated extensive end-resection (Karanjawala et al., 2002; 
Mimitou & Symington, 2010). Consistent with this model, we found that CtIPA/AKu70-/- mice, 
although small, are viable even in the presence of Wildtype Tp53 (data not shown). While the 
CtIP-T855A mutant also reduced end-resection in DNA-PKcs-/- cells (Fig. 4-7 and 4-8), the 
residual cNHEJ activity in DNA-PKcs-/- mice is sufficient for embryonic development. In this 
context, the normal meiosis and the normal frequency of translocations outside the pMX-INV 
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substrates during V(D)J recombination in CtIPA/A mice and cells suggest that T855 is not 
required for the initiation of end-resection but likely plays a role in the progression of end-
resection. In this regard, T855 phosphorylation was thought to enhance the chromatin retention 
of CtIP (Peterson et al., 2012), which could promote its processibility. Whether other ATM and 
ATR-mediated phosphorylation of CtIP have a similar role or distinct roles remains to be 
determined.  
If T855 phosphorylation is not required for the hairpin opening and subsequent initial 
translocations and amplification, how could CtipA/ADNA-PKcs-/-Tp53-/- mice have delayed 
lymphomagenesis? Three pieces of evidence suggest that the T855A mutation might affect cell 
cycle checkpoints. First, CtipA/A B cells have attenuated G2/M checkpoints and cannot generate 
efficient ssDNA and therefore show reduced ATR activation. This might prevent feedback 
regulation on replication fork progression and allow dormant origin firing that is mostly mediated 
through the ATR kinase (Saldivar, Cortez, & Cimprich, 2017) rather than the ATM kinase. 
Second, Myc overexpression has been linked to oncogene-induced replication stress, which 
often requires ATR kinase to be tolerant (Bartkova et al., 2006). The CtIP and MRN complex 
have been implicated in ATR activation and replication stress control (Petroni et al., 2018; Syed 
& Tainer, 2018). The accumulation of giant nuclei in CtIPA/AXrcc4-/-Tp53-/- olfactory neurons is 
also consistent with replication stress. Finally, the T855A mutation suppressed 
lymphomagenesis of λ-Myc+ mice that already carry an oncogenic transgene. Together those 
data support an important role of CtIP phosphorylation in lymphomagenesis beyond 
chromosomal translocation per se. 
In summary, our data identified two in vivo functions of CtIP T855 phosphorylation – 
escape from cNHEJ failure and enforcement of G2/M checkpoints to cope with replication 
stress. We showed that ATM/ATR mediated phosphorylation of CtIP at T855, while dispensable 
for normal development, is required in Xrcc4-deficient cells and during Myc-induced 
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lymphomagenesis. These findings might explain why CtIP is amplified in a subset of human 
cancers. The translocation-independent function of CtIP in tumorigenesis highlights the 
important role of CtIP in linking DNA repair with cell cycle checkpoint. CtIP is heavily modified 
upon DNA damage and in the S phase. Our findings suggest that oncogenic stress or cNHEJ 
might help to reveal the role of other ATM/ATR or CDK mediated phosphorylation sites of CtIP, 
such as the S327 phosphorylation that is also dispensable for murine development (Polato et 
al., 2014; Reczek et al., 2016). 
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Chapter 5: Closing remarks  
Genomic instability resulting from DNA damages generated from regular cellular events 
or exogenous assaults is a hallmark for human cancer. Mammalian cells have a comprehensive 
regulatory network to enforce the fidelity of DNA repair. Failure of precise DNA repair can lead 
to genomic instability, and when accompanied by loss of checkpoint functions, it could lead to 
tumorigenesis. My thesis work aimed to understand further how DDR, focusing on ATM and its 
downstream mediators, enforce genomic stability by regulating CtIP-mediated end-resection 
from three aspects: modulating chromatin accessibility (§ 2), translocations in B cells undergo 
physiological DSBs (§ 3 & 4).  
Firstly, we applied the newly developed ATAC-seq methods to monitor chromatin 
accessibility upon lymphocyte-specific RAG-initiated breaks or endonuclease (I-PpoI) generated 
breaks. We identified a local gain of chromatin accessibility around persistent DSBs that lead to 
increased DNA end-resection in end-joining deficient backgrounds. We found that DDR factor 
53BP1 limits the increase of accessibility, presumably through its interaction with modified 
nucleosomes. Correspondingly, we observed an increase in chromatin accessibility (reduced 
nucleosome occupancy) at the regions with high accessibility before the breaks. We 
hypothesize that the chromatin-bound DDR factors, such as 53BP1, could protect nucleosome-
occupied chromatin from CtIP-mediated DNA end-resection (e.g., 53BP1). We further suggest 
that nucleosome-free regions are vulnerable to additional DNA damage since they were not 
protected by the "chromatin-bound DDR factors". In the future, this experimental system we 
adapted can be used to examine the impact of other factors, such as MDC1 and RIF1, in 
regulating chromatin accessibility. Moreover, it can be used to measure the effect of chromatin 
remodelers, like CHD1 or SWI/SNF complexes on chromatin accessibility (Kari et al., 2016; 
Wiest, Houghtaling, Sanchez, Tomkinson, & Osley, 2017). Such a system can also be used for 
applications beyond targeted DNA damages. For example, genotoxic therapy (e.g., radiation or 
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chemotherapy) also induces DNA damage response and potentially causes dynamic changes of 
chromosomal accessibility, which will dictate the type of the 2nd translocation and vulnerability. 
Studying the breakages and translocations in primary and secondary tumor samples could 
potentially lead to the identification of the driving mechanisms for the formation of such 
secondary tumor development and the genomic signature of specific therapy applied. The 
identification and characterization of chromatin accessibility and vulnerability could not only 
provide insights on disease progression but also help predict genomic toxicity. 
 Next, we investigated the role of CtIP-mediated end-resection during programmed gene 
rearrangement, especially CSR, in lymphocytes. Utilizing naive B cell-specific conditional 
deletion of CtIP and high-throughput translocation assay, we dissected the requirement of CtIP-
mediated end-resection in MH-mediated A-EJ during CSR. For the first time, we characterized 
the temporal regulation of CSR at a nucleotide resolution and demonstrated that in the highly 
repetitive switch regions, end-resection is not required for A-EJ that preferentially use MH at the 
junctions. Agreed with the previous studies on the cNHEJ-proficient cells model (Dong et al., 
2015; X. Zhang et al., 2019), here we provided strong evidence for a role of ATM kinase activity 
in ensuring the correct orientation during CSR, potentially by maintaining topologically 
association between chromosomes by spreading the γ-H2AX linearly around the breaks (2-
dimensional spread, instead of 3-dimensional). 
 Lastly, we asked the role of CtIP in oncogenic transformation in vivo. To circumvent the 
embryonic lethality associated with the complete deletion of CtIP, we characterized the impact 
of ATM/ATR-dependent phosphorylation of CtIP at the T859 (T855 in mice). While we initially 
focused on the role of CtIP in regulating end-resection and chromosomal translocation, our 
study with the T855A mutant mice uncovered an important role of CtIP and its associated 
resection in enforcing the G2/M checkpoint. Correspondingly, T855A mutation also delays 
lymphomagenesis in a Myc+ transgenic mouse model with preassembled oncogenic 
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translocation. Moreover, while dispensable for murine development, the T859A phosphorylation 
of CtIP is critical for Xrcc4-/-Tp53-/- mice's neonatal development. Thus, we concluded that CtIP-
mediated resection suppresses oncogenic transformation in part by promoting resection and 
ATR mediated replication checkpoints.   
Recently, studies of CtIP highly focused on its role in DNA repair, such as its interaction 
with other repair factors, MRN complex or BRCA1, and the impact of post-translational 
modifications. With a more complex understanding combining structural and biochemical 
studies with physiological models, we can investigate more into the players of DNA repair 
pathways and the interplay among them. My thesis work contributed to the molecular 
mechanism of the initiation step of the DNA repair pathway. It also provided direct evidence for 
a novel connection between specific DNA damage-induced phosphorylation and cell cycle 
progression, proliferation under stress conditions. It opened several new angles in studying the 
maintenance of genomic stability during normal development and tumorigenesis.  
  
121 
Chapter 6: Materials and Methods 
Mice   
CD21Cre (Kraus et al., 2001), CtIPC (Reczek et al., 2016), CtIPT855A (X. Liu et al., 2019; 
X. S. Wang, Zhao, et al., 2020), Xrcc4C (Yan et al., 2007b) Xrcc4-/- (Gao, Sun, et al., 1998), 
DNA-PKcs-/- (Gao, Chaudhuri, et al., 1998), p53-/- (Jacks et al., 1994), CD19Cre (Rickert et al., 
1997), and Lambda-Myc (Kovalchuk et al., 2000) mice were previously described. Mice in the 
Xrcc4-/--, or DNA-PKcs-/-Tp53-/-cohorts were aged until they showed evident signs of a tumor 
and/or discomfort and then sacrificed for flow cytometry or cytogenetic analysis. CtIPA/A mice 
were crossed with Lambda-Myc+ mice, and Lambda-Myc+ mice or CtIPA/A Lambda-Myc+ mice 
were analyzed at 100 days. Bone marrow, spleen, lymph nodes, and thymus were analyzed by 
FACS, and tissue was also fixed for further histological analysis. All animal work was conducted 
in a specific pathogen-free facility, and all procedures were approved by the Institutional Animal 
Care and Use Committee at Columbia University Medical Center. Flow cytometry was 
performed on a FACS Calibur flow cytometer (BD Bioscience), LSR II (BD Bioscience), or an 
Attune NxT flow cytometer (Thermo Fisher Scientific).  
Class Switch Recombination and Cell Cycle analysis with Flow Cytometry 
Class switch recombination experiments were performed with 6-10-wk-old mice as 
previously described (Crowe et al., 2018b; X. Liu et al., 2019).  Splenic B cells were purified with 
anti-murine CD43 magnetic beads (MACS; Miltenyi Biotech) and cultured at 1 × 106 cells ml−1 in 
RPMI medium supplemented with 15% FBS, anti-CD40 (1 ng/mL; BD Pharmingen), and IL-4 
(20 ng/mL; R&D). Purified B cells were stained with FITC-conjugated anti-CD43 (BD 
Pharmigen), PE-conjugated anti-IgM (Southern Biotech), Cy5-conjugated anti-B220 
(eBioscience), and APC-conjugated anti-Ter119 and analyzed by flow cytometry to confirm over 
90% purity. Each CSR sample was collected on day 3 and day 4 after activation for flow 
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cytometry with FITC-conjugated anti-IgG1 (BD PharMingen) and Cy5-conjugated anti-murine 
B220 (eBioscience). For the CTV experiment, purified B cells were stained at 6 × 106 cells ml−1 
in PBS with 1 uL of 5 mM Cell Trace Violet (CTV) dye dissolved in DMSO (Thermo Scientific), 
following the standard protocol with two additional washes with the medium. Stained B cells 
were stimulated the same way and harvested on day 4 for flow cytometry analysis, stained with 
FITC-conjugated anti-IgG1 (BD PharMingen) and Cy7-conjugated anti-murine B220 
(eBioscience). For the wildtype CTV sorting experiment, splenic B cells from three wildtype 6-
wk-old C57BL/6J mice purchased from the Jackson Laboratory were pooled together and 
stained following the same protocol, analyzed, and sorted on day 4 after stimulation. To test cell 
cycle progression in primary B cells upon irradiation (IR), purified B cells were stimulated as 
described above for 60 hours before IR. For each time point, about 10 million cells were 
collected and fixed two times with cold 75% ethanol. Fixed cells were blocked with staining 
solution (5% BSA in PBS with 0.1% Tween-20) and permeabilized with a final concentration of 
0.05% Triton for 10 minutes at room temperature. After washout, cells were incubated with 
primary pH3 antibody (Millipore, 06-570, Rabbit anti-mouse) diluted 1:1000 in staining solution 
at 32°C for 45 minutes, and then secondary antibody Alexa 647 anti-rabbit diluted 1:3000 at 
32°C for 45 minutes. This was followed by the BrdU/PI cell cycle staining protocol as described 
before (Menolfi et al., 2018). Flow cytometry was performed on a FACS Calibur Flow Cytometer 
(BD Bioscience) or Attune NxT Flow Cytometer (Thermo Fisher Scientific). Sorting was done 
with Aria II Cell Sorter (BD Bioscience).  
Cell line generation and V(D)J recombination assays 
Total bone marrow was harvested from 4-week-old mice and introduced with v-abl 
kinase through retrovirus infection as previously described (Bredemeyer et al., 2006). Cells 
were cultured in DMEM with 15% FBS for at least two months to achieve stable immortalized 
cell lines. We then infected target cell lines with V(D)J recombination substrate as reported 
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before (Bredemeyer et al., 2006) and then purified to enrich for cells with a stable expression 
level of the substrate. To investigate the repair events in RAG generated breaks, we treated v-
abl-transformed B cells with the substrate with STI571 (3 µM; Novartis Pharmaceuticals) for 48 
or 72 hours, or first for 24 hours and then switched to CDK1 inhibitor (10 uM RO3306) 
containing medium for 48 hours. Samples were collected at these time points for cell cycle 
analysis and harvested for genomic DNA. For Southern blotting analysis to check substrate 
rearrangement, 20 ug of genomic DNA from each time point was digested with EcoRV and 
probed with C4 probe, which is the 960bp fragment generated by digestion of the pMX-INV 
substrate plasmid by HindIII and NheI as previously documented (Helmink et al., 2011; B. S. 
Lee et al., 2013). TdT-assisted PCR assay of pMX-INV coding ends was performed as 
previously described (Helmink et al., 2011). To be specific, genomic DNA was treated with TdT 
(NEB M0315L) according to the commercial protocol. 20 ng of treated template DNA was 
amplified (15 cycles) with primers IRES-REV5 (5′ REV5; 5′-CTCGACTAAACACATGTAAAG
CCTCGACTAAACACATGTAAAGC-3′) and T17- UNIV (5′-GTAAAACGACGGCCAGTCGAC
TTTTTTTTTTTTTTTTT-3′) with 52°C annealing temperature. 2% of the primary amplification 
product and two 1:10 serial dilutions were then used for secondary amplification (30 cycles) with 
primers IRES-REV4 (5′-AGTGTAGAATTCCCCTTGTTGAATACGCTTG-3′) and UNIV (5′-AGA
GCTGGATCCGTAAAACGACGGCCAGT-3′) with 56°C annealing temperature. The end 
products were analyzed on a 1% agarose gel, transferred onto a Zeta-Probe membrane (Bio-
Rad), and hybridized with the I4 oligo probe (TAAGATACACCTGCAAAGGCG) using γ-dATP. 
FISH  
Samples harvested from mice with enlarged spleens or lymph nodes were cultured in 
RPMI medium with 100 ng/mL colcemid (Gibco 15212-012) for 4 hours and harvested for 
metaphase analysis. Standard two-color FISH was performed with BAC199 as Igh locus probe 
and BAC RP23-307D14 as c-myc locus probe. The Igh probe was primarily labeled with biotin 
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(Invitrogen 18047-015), and Avidin-FITC (Sigma A2901) as secondary. The c-myc probe was 
labeled with DIG (Roche 11745816910), and DyLight 594 goat anti-Dig (Vector DI-7594-.5) as 
the secondary antibody for visualization. Images were acquired using ZEISS Imager Z2 and 
Metafer 4 system. About 15-50 metaphases were analyzed for each sample.  
High-throughput genome-wide translocation sequencing (HTGTS) 
High-throughput genome-wide translocation sequencing (HTGTS) experiments and 
analyses were performed as previously described (Crowe et al., 2018b; Hu et al., 2016; X. Liu et 
al., 2019). To study translocations in CSR samples, we harvested B cells after 3 or 4 days of 
cytokine stimulation to obtain genomic DNA. From each sample, about 20 µg of genomic DNA 
was sonicated (Diagenode Bioruptor) to 300bp – 1kb fragments, and linear amplified with an 
Sµ-specific biotinylated primer (5′/5BiosG/CAGACCTGGGAATGTATGGT3′) and then a nested 
(5′CACACAAAGACTCTGGACCTC3′) primer. Restriction enzyme (NEB) AflII was used to 
remove the germline sequence. When mice with mixed backgrounds were used, the IgH locus 
was genotyped to distinguish between the 129 vs BL6 alleles (primers: IgH_F: 
TGTGGACCTCCTTGTGAGACTG, and IgH_R: GGGACAGCAGAGGGATTAGG, 129 allele 
shows ~300bp band and BL6 allele shows ~360bp band). Only mice with both IgH loci from the 
C57/BL6 background were used for the HTGTS analyses. All sequencing reads for CSR 
samples were aligned to the mm9 (BL6) genome. To study RAG-generated breaks, 20 ug of 
genomic DNA at each time point from v-abl-transformed B cells with stable expression of the 
pMX-INV substrate was used as input. Sonicated DNA was linear amplified with biotinylated 
primer (/5BiosA/CAACCACTACCTGAGCACC) and nested amplified with (5’ 
CAAAGACCCCAACGAGAAGC3’) primer. The germline sequence was removed with BstBI 
(NEB) digestion. To study endonuclease-generated breaks, v-abl-transformed B cells were 
transiently introduced with a construct carrying ER-Cre induced I-PpoI. 20 hours after retrovirus 
infection, half of the cells were arrested in G1 phase with STI571 (3 µM; Novartis 
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Pharmaceuticals) for 24 hours, and then treated with 500 nM 4OHT to induce I-PpoI cutting for 
24 hours. The other half was arrested in the S/G2 phase with CDK1 inhibitor (10 uM RO3306) 
for 16 hours, and 500 nM 4OHT to induce I-PpoI cutting for 24 hours. Cells were collected at the 
end from both conditions for genomic DNA. Here, sonicated DNA was linear amplified with 
biotinylated primer (/5BiosG/ACTTAGAACTGGCGCTGAC) and nested amplified with (5’ 
AACCCCAAAGCATCGCGAAG3’) primer. The germline sequence was removed with I-PpoI 
(Promega) digestion. To specifically study the DNA repair junctions on the pMX-INV substrate, 
we added the substrate sequence as an additional chromosome on top of the mm10 genome 
during the alignment process. 
Downstream analyses were performed as described before (Dong et al., 2015; Hu et al., 
2016), with the pipeline deposited on Github (https://github.com/robinmeyers/transloc_pipeline). 
In brief, we took the Bowtie2-ranked top alignments, with a score bigger than 50, and ran 
through the best-path searching algorithm (Faust & Hall, 2012) to identify optimal sequences. 
Several filters were applied additionally, including, but not limited to, mispriming PCR products, 
multiple joinings, and duplications. To be specific, if the bait and prey sequences from two 
individual reads were aligned within 2 nt of each other, respectively, only one unique read would 
be kept after applying the “duplication” filter. Overlapping homologous sequences between the 
bait and the prey sites were characterized as MHs. Unaligned nucleotides in between bait and 
prey sites were defined as insertions. Reads containing no MHs or insertions were considered 
blunt junctions. To compare the MH use in distal vs. proximal areas within each switch region, 
the Sµ was divided at Chr 12: 114,662,500 and the Sγ1 at Chr 12: 114,570,500. We deposited 
all of the sequencing raw data used in chapter 4 to the Gene Expression Omnibus database 
with the accession number GSE156392.  
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Transposase-Accessible Chromatin using sequencing (ATAC-seq) 
The Transposase-Accessible Chromatin using sequencing (ATAC-seq) was performed 
using the published standard protocol (Buenrostro et al., 2015) or Fast-ATAC protocol (M. R. 
Corces et al., 2016). Specifically, v-abl transformed B cells arrested in G1 phase or after 24 
hours of I-PpoI induction were harvested for ATAC-Seq assays. About 50,000 cells were 
collected and spun down at 500g for 10 minutes at 4°C, and the supernatant was removed with 
great care. The loose pellets were washed twice with 100 μL of cold PBS buffer, spun down, 
and the supernatant was discarded, with all steps performed on ice. For the standard ATAC-
Seq assay, the cell pellet was resuspended gently in freshly made cold lysis buffer (10 mM Tris-
Cl pH 7.4, 10 mM NaCl, 3 mM MgCl2, 0.1% (Vol/Vol) Igpal CA630) and centrifuged at 500g at 
4°C for 12 minutes to pellet nuclei. The supernatant was removed, and nuclei were washed 
once with 2X TD buffer (2 mM Tris base, 10 mM MgCl2, adjust pH to 7.6, and 20% (Vol/Vol) 
DMF) (Q. Wang et al., 2013) to reduce mitochondria contaminants in the nuclei pellet. The 
washed nuclei were then directly suspended in the transposition reaction mix (25 μL of 2X TD 
buffer, 2.5 μL of Nextera Tn5 Transposase, and 22.5 μL of nuclease-free H2O) and incubated at 
37°C for 30 minutes with gentle taps on the tubes every 5-10 minutes to increase the 
transposition reaction efficiency. For the Fast-ATAC assay, the lysis step and wash step were 
skipped, and cells were directly suspended in Fast-ATAC transposition reaction mix (25 μL of 
2X TD buffer, 2.5 μL of Nextera Tn5 Transposase, 0.5 μL of 1% digitonin and 22 μL of 
nuclease-free H2O). The transposed DNA was collected using the Qiagen MinElute PCR 
purification kit and eluted in 15 μL of buffer EB. Transposed DNA were stored in -20°C until 
ready to perform the later amplification steps. Briefly, transposed DNA was first amplified 5 
cycles with 63°C annealing temperature to introduce sequencing primers (Ad1: 
AATGATACGGCGACCACCGAGATCTACACTCGTCGGCAGCGTCAGATGTG, and Ad 2.#: 
CAAGCAGAAGACGGCATACGAGATBarcode GTCTCGTGGGCTCGGAGATGT) as follows:  
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 10 μL of transposed DNA 
 10 μL of nuclease-free H2O 
 2.5 μL of 25 uM Ad1 primer (no barcode)  
 2.5 μL of 25 uM Ad2.# primer (with 8bp barcode) 
 25 μL of NEBNext High-Fidelity 2x PCR Master Mix 
5 μL of amplified transposed DNA was used to perform a side qPCR reaction to determine 
additional amplification cycles needed for each individual library as follows: 
5 μL of amplified transposed DNA 
 1.6 μL of nuclease-free H2O 
 1.25 μL of 5 uM Ad1 primer (no barcode)  
 1.25 μL of 5 uM Ad2.# primer (with 8bp barcode) 
 0.9 μL of 10X SYBER Green 
 5 μL of NEBNext High-Fidelity 2x PCR Master Mix 
The number of additional cycles needed was dteremined by plotting Rn vs. cycle number 
and calculating the number of cycles needed to reach one-third of the maximum fluorescence 
intensity. Depends on samples, usually between 4-7 additional cycles were needed. The rest of 
the amplified transposed DNA was then further amplified based on the calculated cycle number 
using the same PCR conditions in the protocol. The final PCR product was purified using the 
Qiagen PCR purification kit and sent for Bioanalyzer at 1:3 dilution to visualize the DNA 
fragment. Successful libraries showed major peaks with lengths of integral nucleosome distance 
between them (~140bp). The concentrations of individual libraries and the pooled library was 
quantified using KAPA qPCR-based quantification kit or Qubit and sequenced on an Illumina 
HiSeq 2500, Illumina HiSeq 4000, or Illumina NextSeq 500 platform, using 2*100bp or 2*75bp 
pair-end sequencing. Usually, 9-12 samples were pooled together for one sequencing run to 
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ensure read depth and quality. Raw sequencing output data was trimmed first to ensure no 
leftover adaptor sequences carried by the Tn5 transposases and aligned to the customized 
mm10 genome described above using Bowtie2 (Langmead & Salzberg, 2012). Peaks were 
called using MACS2 (Feng, Liu, Qin, Zhang, & Liu, 2012). 
EndSeq 
The EndSeq assays were performed with modifications based on the published protocol 
(Canela et al., 2017). Detailed steps are as follows: 
Prepare DNA in agarose plugs Premade 1.6% agarose (low melting temperature agarose in 1X 
PBS) was melted in a 68°C water bath and then moved to a 42°C water bath. The v-abl 
transformed B cells arrested in G1 phase or after 24 hours of I-PpoI induction were harvested 
for DNA. Cells with I-PpoI induction can suffer from cell death, therefore, we used Ficoll (Ficoll® 
Paque Plus, GE Healthcare) to remove dead cells and reduce noise caused by them, following 
the user protocol (1:2 Ficoll: cell suspension (Vol/Vol), centrifuge at 2000 rpm for 20 minutes 
with 0 descending force, and washed twice with 1X PBS). Cells were pelleted at 1200 rpm for 5 
minutes at room temperature. The supernatant was discarded and cells were resuspended in 
1X PBS to be counted. Cells were then pelleted again and resuspended in the desired volume 
of 1.6% melted agarose as 20 million cells per agarose plug (~70 μL) and put into the plug cast. 
Plug casts were put at 4°C to let the agarose solidify. Every 2 solidified plugs of the same 
genotype and treatment were transferred into 500 μL of ESP buffer (10 g of N-lauroylsarcosine 
(Sigma) in 500 ml of 0.5 M EDTA solution, pH 8.0) (Zhou & Paull, 2015), freshly supplemented 
with 1mg/mL of Proteinase K and 1 mM CaCl2, and incubated overnight in 12-well or 24-well 
plates floating in a 50°C water bath. The ESP buffer was aspirated the next morning, and plugs 
were rinsed 4 times with 1X wash buffer (50 mM EDTA pH 8.0 and 10 mM Tris∙HCl pH 8.0) and 
then 4 times with 1X TE buffer (10 mM Tris pH 8.0, 1 mM EDTA pH 8.0) for 10-15 minutes at 
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room temperature to completely remove the residual Proteinase K in the plugs. For each well 
containing 1-2 plugs, 200 μg of RNase A was added to 1X TE buffer with gentle shaking for 5 
minutes to dissolve, and then incubated at 37°C for 1 hour to digest the leftover RNA in the 
plugs. The plugs were washed 4 times with 1X TE buffer at the end of the RNase treatment and 
stored in 1X TE at 4°C. 
The first END blunting and ligation Desired plugs were collected and transferred to 24 well 
plates, and washed one time with EB buffer and three times with 1X NEB buffer 4 (50 mM 
Potassium Acetate, 20 mM Tris-acetate, 10 mM Magnesium Acetate, 1 mM DTT, pH 7.9) at 
room temperature. Plugs were then incubated with ExoT reaction mix (12.5 μL of 10X NEB 
buffer 4, 3-5 μL of Exonuclease T (NEB, 5 U/μL), 107.5 μL of H2O) at room temperature, with 
gentle shaking for 1 hour. The mix was aspirated after incubation, followed by four 15-minute 
washes with 500 μL to 1 mL EB buffer at room temperature. Plugs were then equilibrated with 
1X dA-tailing buffer (10 mM Tris, 10 mM MgCl2, 50 mM NaCl, 1 mM DTT, 0.2 mM dATP) with 
three 15-minute washes, and then incubated with dA-tailing reaction mix (12.5 μL 10X dA-tailing 
buffer, 5 μL of Klenow (Exo-) (NEB), 108 μL of H2O). The plate was placed on a room 
temperature shaker for 15 minutes to diffuse the enzyme and the plate was floated in a 37°C 
water bath for 1.5 hours. The dA-tailing mix was aspirated and the plugs were washed twice 
with EB buffer and twice with 1x NEB buffer 2 (50 mM NaCl, 10 mM Tris-HCl, 10 mM MgCl2, 1 
mM DTT, pH 7.9) for 15 minutes each to prepare for the ligation reaction. The plugs were 
transferred into Eppendorf tubes and the ligation reaction mix (112 μL 2X Quick ligase buffer 
(NEB), 1 μL of annealed biotinylated bridge adaptor (50 μM) 
(/5Phos/GATCGGAAGAGCGTCGTGTAGGGAAAGAGTGUU/iBiodT/U/iBiodT/UUACACTCTTT
CCCTACACGACGCTCTTCCGATC*T, *phosphorothioate bond) was added, 2 μL Quick ligase 
(NEB), 10.5 μL H2O). The tubes were shook at room temperature for 1.5 hours and transferred 
to a cold room 16°C heat block to continue overnight. After ligation, plugs were transferred back 
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to 24 well plates, and washed four times with 1X wash buffer, and four times with EB buffer for 
15 minutes each.  
Agarose melting and DNA shearing Each individual plug was transferred into a new Eppendorf 
tube, and the agarose plugs were melted in a 70°C water bath for 2 minutes and a 43°C water 
bath for another 5 minutes. 2.5 μL of β-agarase (NEB) was added with 10 μL of 10X buffer to 
each plug, mixed gently with cut tips, and incubated at 43°C for 1 hour without disturbing. 
Dialysis and DNA shearing were performed according to the protocol. Sheared DNA was 
transferred to a clean Eppendorf tube, bringing up the volume to 200 μL with EB. 1 μL of 
glycogen, 20 μL of 3M NaOAc pH 5.2, and 500 μL of 100% EtOH was added, vortexed briefly, 
and placed on dry ice or -80°C for 15 minutes. Precipitated DNA was spun down at max speed 
for 15 minutes at 4°C, and washed twice with cold 70% EtOH. The DNA pellets were dried, and 
70 μL of TE’ (0.1 mM EDTA, 10 mM Tris) was added into each tube, incubated at 50°C for 5 
hours, and left overnight at 4°C to dissolve completely.  
Biotin capture, second END ligation and PCR 35 μL of Dynabeads Myone C1 was washed per 
sample and washed again with 1x B&W buffer (10 Mm Tris-HCl, 1 mM EDTA, 1 M NaCl, 0.1% 
Tween-20). The beads were resuspended in 70 μL of 2X B&W buffer and mixed with the 
dissolved DNA samples. The samples were incubated for biotin capture at room temperature for 
1-2 hours while shaking. The beads-DNA mixture was then washed with 1X B&W 3 times and 
twice with 1X EB buffer, and resuspended in 50 μL of H2O to bring up the volume to 55.5 μL. 
The blunting of the second END and ligation of the second adaptor 
(/5Phos/GATCGGAAGAGCACACGTCUUUUUUUUAGACGTGTGCTCTTCCGATC* T) were 
performed using the NEBNext® Ultra™ kits (NEBNext® Ultra™ End Repair/dA-Tailing Module 
and NEBNext® Ultra™ Ligation Module, respectively). Hairpins were digested by adding 1.5 μL 
of USER enzyme (NEB) and incubating at 37°C for 45 minutes. The end product was purified 
using the Qiagen PCR purification kit and amplified using the NEB primers to add in sequencing 
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adaptors. The libraries were quantified using Bioanalyzer and Qubit. Sequencing was performed 
on an Illumina HiSeq 4000 or Illumina NextSeq 500 platform, using 100bp or 75bp single-end 
sequencing. 9-12 samples were pooled together for one sequencing run to ensure read depth 
and quality. Raw sequencing output data was aligned to the customized mm10 genome 
described above using Bowtie2 (Langmead & Salzberg, 2012). Peaks were called using MACS2 
(Feng et al., 2012). 
Sequencing analysis 
Peak calling For each EndSeq/ATAC-seq sample, the peak summits were extended by 250 bp 
on either side to generate a list of peaks with a fixed width of 501 bp. Then peaks within a single 
sample were processed using an iterative procedure designed by the previous study to remove 
any overlapping peaks (M Ryan Corces et al., 2018). We then merged all these high-quality, 
fixed-width peaks from all the samples of interest to build a consensus peak set. Similarly, the 
overlapping peaks in the consensus peak set were handled by the iterative procedure 
previously mentioned. 
Constructing counts matrix and normalization Based on the consensus peak set, we used 
bedtools to count the number of reads in each peak for each sample and compiled a consensus 
counts matrix. The counts matrix was then normalized by using edgeR’s counts per million 
(CPM) (matrix , log = FALSE, prior.count = 5) followed by a quantile normalization using 
preprocessCore’s normalize.quantiles() function in R.  
GSEA analysis For each ATAC-Seq sample, a signature peak set was constructed using the 
overlap peaks with the corresponding EndSeq sample. Then pre-ranked GSEA was performed 
against the full ATAC-Seq peak set using Python package gseapy. 
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Western blotting 
Samples at different time points after IR were collected and lysed with RIPA buffer (50 
mM Tris-HCl, pH 8.0, 150 mM NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% NP-40, and 
fresh 1mM PMSF, 10mM NaF, and proteinase inhibitor cocktail) followed by the standard 
Western blotting protocols. The following antibodies were used for detection and analysis: 
blotted with antibodies anti-CtIP (1:1,000 (X. Yu & Baer, 2000)), and anti-XRCC4 (1:1000; Santa 
Cruz, sc-8285) , anti-pho-KAP1 (1:1,000, A300-767A; Bethyl Laboratories), anti-KAP1 (1:1,000, 
4124S; Cell Signaling), anti-CHK1 (1:1,000, 2348S; Cell Signaling), anti-pho-CHK1(S345) 
(1:1,000, 2348S; Cell Signaling), anti-RPA32 (1:10,000, A300-244A; Bethyl Laboratories), and 
anti-pho-RPA(T21) (1:10,000, ab19109394; Abcam). HRP-conjugated anti-mouse secondary 
antibody (GE Healthcare), and anti-goat secondary antibody (Santa Cruz, sz2020) were used, 
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